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PREFACE
The introduction to this work is necessarily lengthy. It is 
partly clinical, being a review of the disease that is cystic fibrosis, 
and partly biochemical, being an exposition of possible endocrine 
aspects of the disease.
The biochemical investigations on children with cystic fibrosis 
were only made possible by the generous laboratory facilities made 
available by Professor J.H. Hutchison in the University Department of 
Child Health, Royal Hospital for Sick Children, Glasgow, and also by 
the co-operation of patients and fully-informed parents attending the 
hosnital. I am indebted to Professor J.H* Hutchison, Dr. Shanks and 
Dr. ¥. Hamilton in whose care were the patients who co-operated in 
this study.
The advice, guidance and encouragement of Dr. ¥. Hamilton has 
been unfailing and is greatly appreciated. I am also grateful 
to Professor R.H.S. Smellie for his interest and encouragement.
Valuable experience in the science and art of gas liquid chromatography 
was gained under the supervision of Dr. T. Simpson, Torry Research 
Station, Aberdeen®
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The expertise of the typist, Mrs® J. Macdonald, aided the smooth 
progression of this work and the final appearance of the volume has 
been greatly enhanced by my mother, Mrs. J. Gray, who extended her 
hobby to the production of the many photographs within this thesis.
The technical skills of Miss M. Thomson and formerly of 
Mrs. L. Judge were invaluable in the initial purification of urine 
and plasma extracts. Gifts of steroids were gratefully accepted 
from Professor ¥. IClyne, Honorary Curator of the M.R.G. Steroid 
Reference Collection®
The project was financed by a grant awarded to Dr. W. Hamilton 
by the Cystic Fibrosis Research Trust. Parts of the reported work 
were presented at the ninth annual meeting of the European Society for 
Paediatric Endocrinology, Lyon, 1970 and at the first annual meeting 
of the European Working Group for Cystic Fibrosis, Stockholm, 1970.
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CHAPTER ONE
1INTRODUCTION 
Historical Review
Cystic fibrosis of the pancreas is now recognised as probably 
the most frequent of inherited diseases to affect Caucasian populations* 
Its lethal nature is well known and it has been described as the 
most recently recognised of the major chronic diseases of man.
In the early part of this century various clinical facets of 
the disease seemed to justify the diagnosis of coeliac disease.
At this time there was scant information concerning the pathology of 
the coeliac syndrome and certainly no uniform opinion regarding 
pathogenesis* Several writers (Carrod and Hurtley (1912); Miller 
and Perkins (l920); Clarke and Hadfield (l924); Parmelee (l955)) 
had recognised, in some patients with * congenital steatorrhea*, a olinica 
course differing from that of coeliac disease. These children 
presented with large fatty stools, failure to gain weight and a 
"digestive" disturbance despite dietary management. Nearly all deaths 
were the result of broncho-pneumonia* Reported as "cystic fibrosis 
of the pancreas** for the first time by Fanconi of Zurich in 1956, this 
disease was not differentiated as a distinct disorder from coeliac 
disease by clinicians until the extensive work of Andersen, Blackfan,
May and Harper in 1958.
Andersen /
Andersen recognised a familial pancreatic steatorrhea which was 
readily distinguishable from idiopathic steatorrhea by the low 
percentage of split fat in the former as compared to the normal 
percentage characterising the latter. A study of the clinical 
histories of forty nine cases on which post-mortem investigation was 
carried out seemed to show three pathologies. Death in newborn 
infants was often the result of intestinal obstruction due to 
inspissated meconium* The pancreas showed extensive fibrosis 
with cyst formation. Infants dying before the age of six months 
had either predominantly respiratory or predominantly nutritional 
difficulties while children of an older age, presenting with symptoms 
resembling' those of coeliac disease, succumbed to chronic respiratory 
infection. The differences in the expression of the disease were 
already noted in this first comprehensive report for Andersen observed 
that some cases were largely troubled by nutritional disturbances and 
others by infection of the respiratory tract. Microscopic examination 
of post “-mortem tissues from these patients revealed bronchitis in 
all cases with the bronchial lumina filled with purulent exudate 
(Fig. l). The epithelium was often multilayered with squamous 
metaplasia and keratinization of the superficial layers. Staphylococc; 
(mainly Staphylococcus aureus) were present in the necrotic centres 
and alveoli showed patchy lobular pneumonia and emphysema (Fig. 2),
The /
Figure 1. Section of lung from a case of cystic fibrosis showing 
muco-purulent exudate within bronchioles and alveoli 
with emphysema of adjacent air spaces.
üFifOire 2. Extensive emphysema from a case of cystic fibrosis#
The microscopic structure of the pancreas was that described by the 
term "cystic fibrosis" - fibrous tissue encroaching on the exocrine 
areas of the gland and cyst formation within the acinar areas. In 
these early reports islets of Langerhans did not appear to be 
destroyed by the changes talcing place within the gland (Fig. 5).
An animal model has often been a useful tool in the investigation 
of disease and the counterpart of cystic fibrosis has been 
unsuccessfully sought. However, experiments on dogs by Ivy (1956) 
and Greenberg (l955) on the exclusion of pancreatic juice from the 
intestine by ligation of the pancreatic duct or the creation of an 
external fistula, created a clinical picture closely resembling that 
of the digestive aspect of cystic fibrosis of the pancreas. Survival 
and weight gain were maintained by feeding either a normal diet 
with high vitamin content or raw pancreas. Here was the rationale 
for the therapeutic administration of pancreatic extracts, in the form 
of Pancreatin, to patients with this disease. Tins recommendation was 
first made by Andersen in 1959.
Vitamin A deficiency was considered as a possible aetiological 
factor in Andersen*s initial report. However, she concluded that 
a deficiency of such fat-soluble vitamins may be due to the inadequate 
absorption of lipid from the alimentary tract. In 1942 Andersen 
proposed the most reliable means of diagnosis of pancreatic 
deficiency /
î%
3
Figure 3. Section of pancreas from a case of cystic fibrosis
demonstrating fibrosis, cyst formation and atrophy of 
the exocrine areas of the gland. Surviving islets of 
Langerhans are clearly seen.
deficiency to- be the assay of trypsin in duodenal juice. Parber et 
al. in 1945 reported a smaller volume and altered viscosity of duodenal 
juice in patients as compared with normal controls. There was also a
marked reduction in tryptic, lipolytic and amylolytic activity.
After a number of years it became evident that complete pancreatic 
achylia was not necessarily a requirement for the diagnosis of this 
disease.
Ideas of treatment for cystic fibrosis have followed the trend 
of thought on aetiology. Dietary therapy begun after the onset 
of respiratory infection appeared to prolong life but when the Infection 
was well established such treatment was only occasionally effective 
(di Sant’ Agnese and Andersen, 1946). Once established, pulmonary 
infection increased rapidly in severity. Digital clubbing, an index 
of chronic pulmonary disease, often became apparent. The sputum
became thick and mucopurulent and most deaths resulted from asphyxia. 
Early stages of upper respiratory tract infections were a.t this time 
moderately successfully treated with sulphonamides. However, these 
had little effect once the bronchitic and cyanotic stages had been 
reached. Intramuscular administration of penicillin had improved 
some patients with staphylococcic pneumonia. Following the introduoti 
of penicillin aerosol inhalation therapy by Bryson et al. (l944) and 
Barach /
8Barach et al. (1945)» di Sant’ Agnese applied this means of administration 
to patients with cystic fibrosis. Those patients responding, often 
continued to improve after the drug was discontinued. However penicillin 
was the first drug known to affect the course of fibrocystic disease.
Thus by 1946 management of the disease consisted of dietary control, 
sulphonamide administration during the stage of chronic cough and 
penicillin for the acute and often terminal suppurative bronchitis. 
Pathological changes in the respiratory system were well documented 
by di Sant* Agnese in 1955* Poor alveolar aeration, anoxia and carbon 
dioxide retention reflected the bronchial obstruction and obstructive 
emphysema characteristic of the disease.
As early as 1933 Wolbach had suggested that the loss of protective 
powers of the epithelium often seen in infants, was due to changes in 
mucus secretion and loss of ciliary motion. The abnormal mucus was 
implicated in the obstruction of acini and small and large ducts. Then 
followed cyst formation by pressure and subsequent degeneration of the 
parenchyma. In 1953 di Sant* Agnese considered this view adequate 
to account for the pancreatic lesions, the atresia of gall bladder and 
the fibrotic changes in the liver (Andersen and Hodges, 1946). Thus 
the concept of cystic fibrosis as a widespread disturbance of mucus 
secretion affecting many organs of the body was born. Farber (1944), 
the /
9the chief proponent of this theory, coined the term "mucoviscidosis" 
and suggested that an autonomic imbalance might be responsible for the 
altered secretion. However histological changes in the pancreas and 
lung are far from similar and neither the hypothesis of nutritional 
deficiency nor the concept of viscid mucus explained completely the 
relationship between pancreatic and pulmonary lesions. The findings 
of a sweat electrolyte abnormality by di Sant’ Agnese and co-workers in 
1953 lent further support to the view that this was a generalised 
disease affecting more than one organ system irrespective of mucus 
production.
It had already been reported by Kessler and Andersen in 1951 
that patients poorly tolerated long periods of high atmospheric 
temperature. A study of the sweat of these patients showed an elevate 
Na*^  and 01’ concentration (>70 mEq/l) compared with values from normal 
children. The increase in concentration of these electrolytes in
sweat is the most constant and clearly defined abnormality in cystic 
fibrosis and as such has been exploited for screening purposes. 
Estimation of sweat electrolytes following localised stimulation by 
iontophoresis of pilocarpine nitrate (Gibson and Cooke, 1958) is still 
generally accepted as the most accurate single confirmatory test for 
the diagnosis of cystic fibrosis. In conjunction with the first sweat 
studies, /
10
studies, it was shown that the levels of sodium and chloride in mixed 
saliva were also significantly higher than normal (di Sant* Agnese,
1953)» although the overlap was too great to be of practical value. 
Thereafter many reports, often with conflicting results, were made 
concerning the composition of secretions from various exocrine glands.
In 1958 di Sant* Agnese et al. reported a slight increase in the 
sodium chloride concentration of tears from patients with cystic 
fibrosis but this finding was not confirmed in a report by Shwachman 
and Antoniwicz (1962) on observations made by Khaw.
Although the ionic content of mixed saliva was abnormal, further 
investigation indicated that the defect was expressed differently in 
the parotid and submaxillary glands. Johnston (1956) and Barbero 
and Chemick (1958) found an increased rate of parotid secretion in 
patients and that sodium and chloride concentrations therein were 
significantly higher than in normal controls. There was however 
considerable overlap of values. The submaxillary gland on the contrary 
had a depressed rate of secretion with apparently normal electrolyte 
concentrations (Chernick et al. I96I).
Thus, since the first description of cystic fibrosis as a disease 
entity in the late 1930’s, an evolution has taken place in its clinical 
description as a result of an accumulation of clinical and research 
experience.
Treatment is therefore symptomatic since the basic defect is 
as /
I l
as yet speculative. Prophylactic administration of drugs to allay 
pulmonary infection, the decisive factor in determining the mortality 
of the disease, has led to an increased longevity among patients, albeit 
posing its omi problems. Growth retardation occurs throughout 
childhood and delayed sexual development is common. Adult females 
can reproduce while aspermla. has been an almost constant finding in 
males (Kaplan^  et al. 1968). This latter is a newly described 
phenomenon. Anatomical defects have been detected in the vas 
deferens, epididymis and seminal vesicles at post-mortem examinations 
and during surgical explorations of the area. With increased life 
span the progressive fibrotic and cystic changes in the pancreas often 
also affect the endocrine component of the gland resulting in classic 
diabetes mellitus. The incidence of diabetes in affected children 
has been reported as being slightly higher than in the general population 
(Rosan et al. 1962). Milner (1969) believed that the observed 
increased incidence of impaired glucose tolerance was due to a defect 
in the release of a glucogon-like substance from the alimentary system, 
in addition to impaired islet cell function. In a much larger 
group of patients studied by Handwerger et al* (1969) there were 
nevertheless individuals presenting with classical symptoms.
Now the generalised nature of cystic fibrosis is well demonstrated 
by its varied clinical features, most notably progressive bronchiolar 
obstruction /
12
obstruction and pulmonary infection leading to atelectasis, hssmoptysis 
and cor pulmonale, steatorrhea and fat soluble vitamin deficiency, 
malnutrition and growth failure. Meconium ileus is indicative of the 
condition. Biliary cirrhosis occurs occasionally giving rise to 
portal hypertension, hypersplenism and gastrointestinal haemorrhage,
(di Sant* Agnese and Blanc, 1956). Sweating can lead to salt 
depletion. The prognosis is poor particularly due to pulmonary 
involvement and treatment is but symptomatic. Relatively few patients 
survive to adulthood. These symptoms of the disease must however 
be regarded as complications since the basic defect of cystic fibrosis 
still eludes the investigators.
The pathogenesis of cystic fibrosis with its many and diverse 
manifestations is still unknovm since the basic genetic defect has 
not yet been determined* That cystic fibrosis of the pancreas 
or fibrocystic disease are unsatisfactory names for this disorder is 
well recognised, but even the physiological terms such as mucosis and 
mucoviscidosis fail to embrace all aspects of the disease. The 
changing nomenclature reflected the increased awareness of the 
varying expressions of the disease together with the desire to link 
them to a common aetiology. Early workers inclined to the belief 
that /
13
that all features of cystic fibrosis could be explained as direct 
or indirect consequences of pancreatic achylia, that deficient fat 
absorption from the gut led to vitamin A deficiency which was in 
turn held responsible for lesions of the respiratory tract.
Other authorities upheld a generalised abnormality of mucus secretion 
as the basic harmful process, hence the terms mucosis and mucoviscidosis- 
The disease is inherited as a Mendelian recessive characteristic and 
is thus expressed in the homozygous state. It is truly an inborn 
error of metabolism. The several, apparently unrelated, abnormalities 
characterising the disease indicate that they are not themselves the 
primary defect but are several steps away from the primary molecular 
abnormality. Any unifying concept would require to explain the 
abnormality of mucous secretions, the striking electrolyte , changes 
in sweat and to a lesser extent in saliva, the increase in organic 
secretions as well as calcium in submaxillary saliva, the abnormal serum 
factor reported by Spock et al. (1967) and the parotid sodium- 
reabsorption-inhibitory-sweat factor of Mangos and McSherry (l967)«
ABNORMALITIES IN MCUS PRODUCTION.
Although the exocrine glands which produce mainly serous 
secretions (the eccrine sweat glands and parotid glands) show no gross 
or /
14
or histological change, mucus-producing glands throughout the body may 
show varying degrees of morphological change# The most serious 
manifestation of the disease is the accumulation of the apparently 
abnormal "insoluble" secretions responsible for obstruction and 
resulting in such pathological changes and clinical manifestations as 
pancreatic fibrosis and achylia, bronchial obstruction, submaxillary 
enlargement and hepatic cirrhosis. The involvement of the mucus 
secreting cells in the oral, respiratory and alimentary tracts in 
cystic fibrosis is well recognised (see Fig# 4 - hypertrophied 
Brunner’s glands) and recent reports by Oppenheimer (l970) and 
Oppenheimer and Esterly (l970) implicate hypersecretion of uterine 
cervical mucus in the decreased fertility observed in female patients#
Structure of Mucus#
The mucins are glycoproteins rich in carbohydrate units and are 
mostly responsible for the viscosity of these mucous exocrine 
secretions# The core is proteinous, rich in serine, threonine, 
glycine, alanine and proline# Carbohydrates are present as 
oligosaccharide units, in some cases as small as disaccharides#
These are attached as numerous side-chains from the protein core as a 
glycosidic linkage from a hexosamine to the hydroxyl group of the serine 
and threonine* The di- and oligosaccharides are composed of 
glucosamine, /
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Figure 4* Section of duodenum from a case of cystic fibrosis 
showing hypertrophy of the Brunner’s glands.
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glucosamine î» galactosaminey .'D-galactose, sialic acids and L^fucose,
The sialic acids or fucose units are the terminal groups. Each 
tissue apparently has its own characteristic carbohydrate units though 
the protein core is of similar composition. Thus it is to be 
expected that each type of cell of the oral, respiratory, gastro­
intestinal and reproductive tract secretes mucins of differing compositions 
The known mucins all have a specificity associated with some blood 
group•
Chemical and Immunochemical Studies.
No serious attempts at investigation of glycoproteins in cystic 
fibrosis were made until 1957. At first, attention was focussed 
on the suggestion of Dische et al. (l959) that the primary alteration 
in the mucous secretion in this disease might be a quantitative change 
in the glycoprotein fractions in the form of an increase in fucose in 
the carbohydrate moiety with a consequent change in the fucose/sialic 
acid ratio. The first studies by di Sant* Agnese et al. in 1957 
had indeed demonstrated that after the treatment of duodenal fluid 
with ethanol/benaene, a water-insoluble precipitate, unaffected by 
trypsin and in which the fucose/sialic acid ratio was raised, was 
present in most patients with cystic fibrosis. Dische postulated 
that such an abnormal shift in the sugar components of the glycoprotein 
molecule /
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molecule might have led to decreased solubility resulting in widespread 
obstructive changes. In recent years glycoproteins from glands of 
patients with cystic fibrosis have been much studied in the hope that 
the fundamental enzyme abnormality might be identified. Indeed many 
of the subsequent studies supported these early investigations. A 
similar increase in fucose/sialic acid ratio was found in urine 
(Dische 1961), submaxillary saliva (Chomick and Barbero 1963;
Dische 1970), sweat (Pallavicini et al. 1963) and rectal mucus (Roelfs 
et al. 1967)* Conflict has arisen in analysis of tracheobronchial 
secretions. Johansen (1963) reported an elevated fucose content in 
relation to sialic acid whilst Potter et al. (1963) found consistently 
elevated sialic acid and decreased fucose levels. Although it now 
seems that such chemical analyses will not reveal the underlying 
abnormality, nevertheless the production of mucus is still of prime 
importance to the clinical status of the patient. Considering the 
insolubility cf mucus in this disease, it is well recognised that elevated 
concentrations of calcium in the submaxillary gland are associated with 
the turbidity of its secretions (Chernick and Barbero I961). In 
his own studies Pallavicini (1976) has noted that with the addition of 
small amounts of calcium, submaxillary saliva of normal subjects became 
turbid and gave an electrophoretic pattern resembling that obtained 
from /
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from cystic fibrosis patients. Addition of EDTA to both ca3,cium- 
treated and patients’ saliva removed the turbidity and produced similar 
electrophoretic patterns.
Glycoproteins may be regarded as highly charged anionic 
particles exerting their forces by forming intermolecular calcium 
bridges. In this process of aggregation calcium seems to play 
an important linking role (Boat 1970). Experimental evidence would 
also seem to implicate disulphide linkages in mucins as among the 
factors contributing to their insolubility. It is accepted that mucus 
is a complex chemical substance. Human mucins have not been well 
studied chemically. Nonetheless, except for insolubility, no difference 
have been observed in secretions from cystic fibrosis patients and 
controls. Pallavicini (l963) had investigated carbohydrates in the 
sweat of cystic fibrosis patients and in normal subjects but could 
demonstrate no immunological differences* Johansen (l970) using 
histochemical techniques and autoradiography, studied mucus production in 
rectal biopsies from forty patients with cystic fibrosis and from normal 
controls. Ho consistent differences in the mucus glands were observed. 
Likewise exhaustive histochemical examination of rectal mucus failed to 
reveal any abnormality in the cells of the patients.
Extensive investigations have been made on urinary glycoproteins - 
particularly on the Tarmn-Horsfall urinary glycoprotein. These studies 
were intended as a logical model system of structural abnormalities 
of /
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of glycoproteins in cystic fibrosis since this glycoprotein is easily 
separable by methods which do not destroy its chemical or immunological 
properties. Investigations by Maxfield and Wolins (1962) indicated 
that the Tamm-Horsfall glycoprotein was present in an abnormally 
aggregated state in the urine of cystic fibrosis patients. However, 
subsequent intensive studies have failed to substantiate this finding. 
Friedmann and Johnson (l96?) by ultracentrifugation, starch-gel 
electrophoresis, assessment of amino acid composition, immunodiffusion 
and haemagglutination inhibition techniques could demonstrate no 
difference between patients with the disease and control subjects. 
Neuberger (l970) also reported no gross difference in the chemical 
structure or sub-unit structure in this glycoprotein in the urine of 
patients with cystic fibrosis.
The viscosity of mucus secretions is thought to be caused by 
mucins with a fibrillar structure. Destruction is effected by mild 
cystein reduction, and ultimate analysis of bronchial mucus by electro­
phoresis has demonstrated the presence of proteins, blood group substances 
acid glycoproteins (sialic acid or sulphate) and nucleic acids. In 
chronic pulmonary disease such as asthma and bronchitis an increase 
of the acid glycoprotein fraction has been recorded. Human 
tracheal /
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tracheal mucosa from pathological oonditions in incubation studies 
35using S synthesise sulphated acid glycoprotein in excess of the sialic 
acid fraction. Reid and de Haller (196?) have described the changing 
patterns of secretion of the sulpho- and sialomucins in children.
In the foetus and neonate there is an increase in sulphomucin 
production while after a few months of life there is a shift to the 
secretion of sialomucin.
Before pulmonary infection, cystic fibrosis patients show normal 
secretion patterns for their age but once infection is established 
sulphomucin production increases to the point of eliminating sialomucin. 
This swing in production cannot be attributed to hypertrophy of the gland 
alone since in patients with chronic bronchitis the glands are enlarged 
but the shift to sulphomucin is not so complete. Reid (196?) has 
also reported the biochemical analysis of sputum by Keal and Sturgess 
which showed that in cystic fibrosis cases there was a higher sulphate 
and lower sialic acid level than in chronic bronchitics.
Localization of Mucins.
v ine*""#
Histological quantitation, of sulphomucins by staining procedures 
presents problems. A careful correlation between stains and 
uptake of radioactive sulphate is necessary prior to histochemical 
analyses (Reid 1967; Spicer 1970), Often stains for sulphate 
only /
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only identify heavily sulphated compounds. Spicer (I97O) investigating 
sections of pancreas showing the classical changes associated with cystic 
fibrosis, concluded that in this disease the zymogenic epithelium is 
lost and is replaced by mucigenic epithelium which is normally only 
present as a lining of ducts but in cystic fibrosis also lines the 
cystic spaces. This epithelium appeared to be hypersecretory, the 
secretions having an increased content of sialo- and sulphomucins. 
Patients dying early as a result of pulmonary disease but with a-Mid 
pancreatic lesion, had epithelium normal in type and distribution but had 
also large amounts of insoluble concretions in the lumina of the ducts. 
This precipitation of zymogen secretion is believed to result in the 
obstruction and dilatation of ducts typical of the disease.
Abnormal mucopolysaccharide metabolism, as an aetiological factor, 
has been popularised by Danes and Bearn (1968, 1969)* Fibroblasts 
and later white cells, cultured from cystic fibrosis patients and from 
some parents, showed metachromatic staining with toluidine blue for 
acid mucopolysaccharide. It was hoped that this observation 
could act as a cell marker for the identification of the homozygote 
cases and perhaps also for the heterozygote carriers of the disease.
This recognition of cytoplasmic abnormality might then facilitate 
genetic /
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genetic and biochemical studies. It was reported that fibroblasts 
from patients cultured in a medium containing radioactive sulphate 
and acetate accumulated excess radioactive mucopolysaccharides.
These observations had also been made on fibroblasts from patients 
with mucopolysaccharidosis (Hurler and Hunter syndromes). Thus it was 
felt that the primary defect in cystic fibrosis might also be a disturbance 
of mucopolysaccharide metabolism. Unfortunately the results of 
Danes and Bearn have not been wholly confirmed* Wiesmann and Beufeld 
(1970) studying the turnover of sulphated mucopolysaccharide in 
fibroblasts from thirteen patients with cystic fibrosis failed to show 
an accumulation of radioactive sulphate*
However, Brown et al. (l970) demonstrated that the mean uptake of
35; S by cells from a group of fibrocystic patients was significantly 
greater than the corresponding mean of a group of control patients 
even although there was considerable overlap. Sulphate uptake rates 
of parents were indistinguishable from controls. Reed et al. (l970) 
also studied metachromasia as an in-vitro model for the disease and 
were indeed able to demonstrate an increase within the fibroblasts 
cultured from patients. However, the amount of metachromasia was 
found to be dependent on culture conditions and varied from one subculture 
to another even from the same patient. Such diverse observations 
obviously detract from the possible potential of tissue culture for 
diagnosing /
23
diagnosing the disease.
The clearance of mucus from the bronchial tree is of prime 
importance in cystic fibrosis and the physical nature of the secretion 
is a critical factor in the process. Viscosity and elasticity are 
the two major physical characteristics determining the rheological or flog 
properties. The production of excessive quantities of bronchial 
secretion, sufficient to cause sputum production, is characteristic 
of other chronic pulmonary diseases such as chronic bronchitis and 
bronchiectasis. Airways obstruction and progressive pulmonary 
involvement in cystic fibrosis have been attributed to the abnormal 
characteristics of the bronchial secretion (Fmrber 1944). Sturgess 
and Reid (1969) and Feather and Russell (l97ü) have compared the viscosity 
of sputum by shearing methods in these disease states. Mucoid sputum 
from cystic fibrosis patients was not found to be more viscous than in 
the other conditions. Viscosity increases with purulence and so 
changes appear to be associated with infection rather than with an 
abnormal mucus production. Also quantitative changes in bronchial 
secretion can be attributed to the pus formation. The clinical 
pulmonary problems of the disease are related to the high incidence of 
Staphylococcus aureus infection so characteristic of the 
disease. /
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disease. in increased level of p-hydroxyphenylacetic acid (May and 
Roberts, 1969) has been thought to favour colonisation by these 
organisms*
Attention has recently been given to Pseudomonas aeruginosa 
because there has been an increase in incidence of infection by this 
bacterium in cystic fibrosis patients. The organism is not normally 
encapsulated but in children with cystic fibrosis up to 70 per cent of 
Pseudomonas infections are caused by a mucoid encapsulated strain 
(Saggers, 1970). In post-mortem studies Doggett and Harrison 
(1969) have observed that the purulent material in the bronchi and 
pulmonary abscesses yields pure cultures of "mucoid”
Pseudomonas aeruginosa. Such strains produce profuse viscous 
capsular material containing polysaccharide similar to alginic acid 
(the marine algal polysaccharide). The possible obstructive role of 
this capsular polysaccharide in the tracheobronchial tree cannot be 
ignored. Alginic acid is knotm to form viscous solutions at relatively 
low concentrations, to form gels and fibres, to behave as polyelectrolytes 
and to form films on surfaces thus controlling viscosity and water 
penetration (Percival and McDowell, 1967). The mucoid strains of this 
organism are difficult to control (no enzymes from higher animals and 
only a few from lower animals will degrade alginates). An increase in 
serum /
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serum px*ecipitxns specific to mucoid Pseudomonas aeruginosa have been 
found in patients infected with this organism. Pseudomonas-specific 
precipitins could not be demonstrated in the sera of patients carrying 
rough strains of the species. Indeed, it has been noted that cystic 
fibrosis patients without specific precipitins or mucoid Pseudomonas
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in their sputa.amerana:,.-refleet a better clinical condition than 
those haying high precipitins and mucoid Pseudomonas.
ELECTROLTIIC DEFECTS.
The most constant and characteristic abnormality expressed in 
patients with cystic fibrosis is still the increase of sodium and chloride 
in eccrine sweat first noted in 1953 by di Sant* Agnese et al. albeit 
relatively late in the history of the disease. These elevated electro­
lyte levels are also found, though to a much lesser extent, in 
submaxillary saliva but in other biological fluids the electrolytes are 
normal. Urinary electrolytes behave normally (di Sant* Agnese et 
al. 1962) and indeed it is the disassociation between the inability 
of the sweat gland to retain electrolytes and the preserved ability of the 
kidney to conserve sodium chloride that makes the sweat defect the 
unique feature of cystic fibrosis. Serum sodium, chloride and 
potassium levels are normal except in patients with severe pulmonary 
distress /
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distress where impaired gaseous exchange gives rise to accumulation of 
carbon dioxide with a decrease in chloride. Massive salt depletion 
by excessive sweating may also lead to hypoelectrolytaemia.
Until the work of Balfe et al, (1968), it was considered that the 
sodium pump in erythrocytes of patients with cystic fibrosis was 
normal. However these workers detected defective transport across 
the membranes of red cells in homozygotes and also the heterozygote 
parents. They reported that the ouabain-sensitive adenosine 
triphosphatase is diminished in erythrocyte ghosts of cystic fibrosis 
patients and that the ouabain-sensitive and ethacrynic acid- 
sensitive efflux from erythrocytes of these patients are both decreased, 
The parents of affected children also demonstrated a reduced ethacrynic 
acid-sensitive sodium efflux. Gardner (1969) in Bethesda has 
confirmed that sodium outflux from the erythrocytes of patients is 
decreased in post-pubertal males and females. He was, however, 
unable to distinguish heterozygotes from normal individuals. The 
difficulties inherent to the interpx^etation of such studies are the 
differing rates of sodium transport observed during the life cycle of 
the red cell.
Faecal sodium and chloride levels have been reported as being 
normal (di Sant* Agnese et al. 1953) as have sodium, chloride and 
potassium concentrations in the duodenal contents (di Sant* Agnese 
et al. 1958). However investigation of secretion rates of fluid 
volume /
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volume, protein and electrolytes by the pancreas after hormonal 
stimulation, using pancreozymin and secretin (2 I,U*/Kg body wt. of each) 
has revealed a reduced fluid volume and electrolyte output (particularly 
bicarbonate) relative to the organic enzymic fraction produced by 
the pancreas (Hadorn et al. 1968; Zoppi et al. 1970).
Conflicting reports on comparable numbers of patients have been 
made on the sodium content of tears. di Sant* Agnese et al. 
in 1958 found elevated levels in their patients whereas normal concen­
trations were observed by Shwachman and Antonowicz in 1962.
Hope for a further diagnostic test was raised when Kopito et al.
(1965) discovered sodium and potassium to be increased in nails of 
children with the disease. Neutron activation analyses of nail 
clippings have shown the test to be reliable for diagnosis, after the 
first month of life. In the first few days of life considerable 
overlap occurs between normal and cystic fibrosis patients, this 
probably being related to contamination of the nails with sodium
chloride from amniotic fluid (Kollberg, 197l)«
Sweat Gland Abnormality.
The sweat gland abnormality is present from birth, 
throughout life and is unrelated to the heterogeneity of the clinical 
manifestations of the disease. The sweat test therefore remains 
the cornerstone for the diagnosis of cystic fibrosis. The range in 
sweat electrolyte values for both affected children and normal controls 
is /
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is quite broad but the overlap is minimal* Normally, chloride 
concentration is less than sodium but Lobeck (1966) has observed that 
in cystic fibrosis patients the chloride concentration approximates to 
the sodium levels because of the higher potassium concentration in these 
subjects. Therefore the chloride levels are less likely to overlap the; 
of controls and may be more useful than sodium levels in diagnosis.
Other diseases may be associated with elevation of sweat electrolytes 
but these are clinically distinct. High sodium or chloride levels 
have been reported for some patients with chronic pulmonary disease such 
as chronic bronchitis, bronchiectasis and emphysema. Addison's 
disease and congenital adrenal hyperplasia during salt deplètion 
are well Icnown to result in an increase in sweat electrolytes*
There are also indications of elevated levels in patients with 
glucose-6-phosphatase deficiency (hepatorenal glycogen storage 
disease), vasopressin-resistant diabetes insipidus and familial 
ectodermal dysplasia though numbers reported are small* A recent 
report has also indicated elevated sweat chloride levels in 
mucopolysaccharidosis (Spock and Renuart, 1970). Lobeck and 
Huebner (1962) failed to demonstrate a difference in the rate of 
sweating between children with cystic fibrosis and control children.
As well as high electrolyte values in eccrine sweat there is also 
an inability to restrict loss under stressful conditions such as hot 
weather, /
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weather, salt restriction and administration of steroids. Massive 
salt-loss and vascular collapse, as a result of failure to acclimatise 
to hot weather, was first noted by Kessler and Andersen (l95l) in 
New York in 1948. Normally following administration of large doses 
of deoxycorticosterone acetate or 9&-fluorohydrocortisone high levels 
of sweat sodium are reduced to low levels. Children with cystic 
fibrosis fail to regulate on this treatment which is suggestive of 
sweat gland insensitivity to mineralocorticoids (Lobeck and 
McSherry 1963; Grand et al. 1967). After adequate doses of salt- 
retaining steroids sweat sodium levels remain high while on the other 
hand kidney retention of sodium is preserved. All aspects of adrenal 
function studied in cystic fibrosis patients have been normal (Chodos 
et al. 1965). Increased excretion of urinary 17-hydroxycorticosteroids 
has. been demonstrated in response to ACTH administration. Secretion 
and excretion of aldosterone are normal as is the response to the 
metyrapone test used as an index of pituitary corticotrophin 
production. The degree of insensitivity to salt-retaining steroids 
is variable. Grand and colleagues (1967) were able to achieve 
significant decreases in sweat sodium levels following the administration 
of large doses of aldosterone though the response was not of the 
same order as shown by normal subjects.
Morphologically no difference has been found between the eccrine 
sweat /
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sweat glands of patients with cystic fibrosis and those of normal 
children. Ultrastructural studies made by Hunger et al. (l96l), 
Landing et al. (1970) and Mangos and McSherry (l967) have revealed 
no anatomical variance between the two groups.
The composition of sweat is considered to be the elaboration 
at the base of the gland of a secretion (the precursor secretion) 
which is modified as it passes through the sweat duct on to the 
skin surface. It is believed that the precursor fluid secreted 
in the coil of the sweat gland is isotonic with plasma and is 
modified in the duct by reabsorption of sodium chloride in excess 
of water resulting normally in hypotonic sweat. Using* micropuncture 
techniques (Schulz 1967) it has been demonstrated that in cystic 
fibrosis patients the newly formed sweat in the coil is isotonic 
with plasma. However, the final secretion is always significantly 
less hypotonic than in control subjects and this phenomenon has been 
attributed to defective reabsorption of sodium chloride in the ducts.
The human sweat gland duct has coiled proximal and straight 
distal components, differentiated not by cell type, but functionally 
regarding sodium transport. It would appear that in the distal 
portion, sodium is mainly exchanged for potassium, a process 
regulated by aldosterone. However, it is the coiled region that is 
normally /
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normally responsible for most of the sodium reabsorption. Sodium 
and chloride ions and some water diffuse into the duct cell by a 
rate limited process. Grand et al. (l96?) demonstrated some 
response after aldosterone administration and therefore the sweat 
gland defect in cystic fibrosis would seem to be located in the 
coiled region of the duct. Active transport of sodium does occur 
in the kidney, erythrocytes and sweat glands following aldosterone 
administration and it would be in accord with the theory of Gordon 
and Cage (l966) if the passive diffusion phase rather than active 
sodium transport were affected in patients with cystic fibrosis.
Salivary glands.
In conjunction with the first sweat studies, electrolytes in 
mixed saliva were analysed (di Sant' Agnese et al. 1953) and it was 
shown that sodium and chloride levels were significantly higher 
than normal. Controversy arose concerning the results obtained 
from the analysis on each of the component parts - the submaxillary 
and the parotid saliva. Some investigators reported an elevated 
secretory rate and increased sodium and chloride levels in the parotid 
gland while others found these parameters to be normal (Handel et al. 
1967). The secretion rate of the submaxillary gland has undisputedly 
been regarded as normal though discrepancies have been described in 
electrolyte studies. However, Handel studying a large number of 
patients, /
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patients, found, values to be significantly elevated.
Host of the information concerning the elaboration of normal 
saliva is based on animal studies. Comparison of the structure 
and composition of the salivary secretions suggests that human glands 
are probably very similar (Mangos and Braun^Schubert, 196?) to those 
of animals. Hicropuncture studies of the submaxillary glands of 
rats have established the existence of a gradient from isotonic or 
slightly hypertonic secretory fluid in the acini to a hypotonic 
secretion in the mouth. Although there are distinct differences 
in the structure of sweat and salivary gland excretory ducts, they are 
both regions of reabsorption of electrolytes by the active transport 
of sodium ions.
Pancreatic Function•
In 1968 in a study of pancreatic function on cystic fibrosis 
patients lacking the malabsorptive symptoms of the disease, Hadorn 
et al. (1968) observed an unusual secretion produced in 
response to pancreozymin and secretin stimulation (2 I.U./Kg body wt. 
of each). The scanty viscous secretion had a low bicarbonate ion 
content in contrast to the watery fluid with high bicarbonate levels 
found normally. Under normal conditions the final secretory product of 
the pancreas is a mixture of a small amount of concentrated enzyme 
solution (organic fraction) and a larger volume of secretion containing' 
mainly /
33
mainly electrolytes and bicarbonate (electrolyte fraction). Secretion 
of the organic fraction can be stimulated by pancreozymin and is 
usually attributed to the acinar cells of the pancreas* Secretion 
of the electrolyte fraction is stimulated by secretin acting on the 
centro-acinar and intercalary duct cells. The abnormal pattern 
in cystic fibrosis is the decrease in the electrolyte fraction 
resulting in a final secretion largely organic in content. High 
enzyme concentrations reported are due to a reduction in the dilution 
of the organic phase. Total output of pancreatic enzjmies are 
usually within the normal range. Hormonal stimulation of the 
exocrine pancreas has also been studied by Zoppi et al* (1970) with 
regard to water and electrolyte movement. Control children had 
higher sodium and bicarbonate secretion rates following secretin 
stimulation whereas those of protein, calcium and magnesium were 
higher after pancreozymin stimulation. Secretion rates of fluid 
volume and potassium did not show any significant difference. In 
cystic fibrosis patients secretion rates of sodium, potassium and 
magnesium were more reduced after secretin whereas those of calcium 
and protein were more reduced after pancreozymin. The secretion 
rates of fluid volume and bicarbonate were reduced after both hormonal 
stimulations.
The mechanisms of secretion of water and the various electrolytes
were /
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were apparently altered to different degrees. However sodium, 
bicarbonate and fluid volume are all reduced following intravenous 
injection of hormone. The lower bicarbonate concentrations 
contributing to the duodenal juice must be an important factor in the 
digestive disturbance of the disease since the pH of the fluid is 
lower than that required for optimal enzyme activity in the duodenum.
HUHOHAL FACTORS.
Spock et al. (196?) observed that serum from cystic fibrosis 
patients and their parents had a ciliostatic effect on rabbit 
respiratory epithelial cells. In the same year Mangos et al.
(1967) and Mangos and McSherry (l967) noted an inhibition of sodium 
reabsorption in the rat parotid gland after perfusion with saliva 
or sweat from patients. From these observations the concept of an 
abnormal serum factor altering cell membrane function to affect 
ionic transport and secretion by the cell has arisen.
Cystic Fibrosis Serum Factor.
The first indication of an inhibitory serum factor in cystic 
fibrosis patients came when Spock and co-workers noticed a disorganisation 
of ciliary beat on rabbit respiratory epithelial cells after exposure 
to serum from an affected child. This phenomenon was observed 
in sera from all of 75 patients and in none of the same number of 
controls. /
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controls. The sera of the heterozygous parents showed similar 
effects after concentration of the euglobulin fractions. Crawfurd 
in Leeds (1969) using the gills of the fresh water mussel, Dreissensia 
polymorpha, was able to demonstrate a similar inhibition of the 
metachronal ciliary beat using sera of 11 of 12 patients. Of 
163 parents tested, 150 demonstrated the presence of the inhibitory 
factor. Crawfurd interpreted the remaining 13 to be "false 
negatives" in that the positives included a small number in which the 
original negative finding (i.e. lack of inhibition) was reversed 
on retesting. There are obvious variations in the effect on the 
cilia from one mussel to another but more important is the seasonal 
variation demonstrated in the mussels. During the autumn and winter 
months the gills produce excessive mucus when any serum is added to 
them. This results in the adherence of cells eventually to inhibit 
the cilia. This effect undoubtedly makes interpretation of results
more difficult. No inhibitory factor was demonstrable in 
patients less than five months old even although the diagnosis of 
cystic fibrosis had been firmly established (Crawfurd, 1970).
The cilia test has proved interesting but for the sake of standardisation 
a more objective immunological or biochemical assay would be desirable. 
Further investigations of the nature of the serum factor using 
immunological and gel filtration techniques are being carried out by 
this department. It is not yet known if the factor is an abnormal 
product or a normal metabolite accumulating as a result of an enzyme 
defect. /
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defect.
S o M u m R e a I n h i bitory Factor.
>
In 1967 Mangos and colleagues, using' perfusion of the parotid 
duct system of the rat at different rates of flow, demonstrated an 
inhibition of sodium reabsorption after perfusion with saliva or 
sweat from cystic fibrosis patients. The primary secretory fluid 
of the rat parotid has plasma-like osmolarity and sodium and potassium
ionic concentrations* As this fluid passes on through the
striated ducts its composition is altered by reabsorption of sodium 
in excess of water so giving rise to a hypotonic secretion which is 
conveyed to the mouth by excretory ducts. Perfusion of this system 
with saliva and sweat from affected children resulted in a marked 
increase in the salivary sodium concentration at all flow rates. 
Theoretically, factors must be present in this disease to cause 
inhibition of sodium transport in the striated ducts of the rat 
parotid. Inhibition of the sodium and potassium adenosine triphosphatase 
by the cystic fibrosis factor has also been indicated when the activity 
of rat intestinal mucosal membranes was measured in the presence of 
saliva from patients (Besley and Patrick, 1969). Marked inhibition 
was noted at limiting concentrations of magnesium and inhibition was 
eliminated by calcium. Besley and Patrick suggested that "cystic 
fibrosis /
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fibrosis saliva" might contain a factor responsible for the displacement 
of divalent cations from specific combining sites on the enzyme to 
prevent formation of the magnesium-adenosine triphosphate substrate 
complex of the calcium-adenosine triphosphate inhibitor complex.
Since calcium and magnesium are recognised as playing fundamental 
roles in the maintenance of such membrane properties as stabilisation 
of structure, permeability, excitation and enzyme activity, it was 
proposed that the displacement of these ions by a cystic fibrosis 
factor might be significant in the pathogenesis of the disease.
The Basic Defect.
It is evident from the many apparently disjointed pieces of 
information in the literature that it is not yet possible to enunciate 
the nature of the basic defect in cystic fibrosis. Although cystic 
fibrosis appears to be due to a single recessive gene in the homozygous 
condition and could therefore be regarded as a typical inborn error 
of metabolism, all attempts to identify the defect at this level have 
so far been unsuccessful. Current evidence suggests that a 
circulating substance (inhibitory factor) plays a role in changing 
the secretory products by affecting electrolyte transport. From 
the point of view of the molecular geneticist, it would seem unlikely 
that /
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that mutation in a single gene would cause the production of different 
factors affecting electrolyte transport. An important consideration 
might be whether the sodium inhibitory factor and ciliary beat 
inhibitory serum factor were the same and involved also in the 
inhibition of the pancreatic response to secretin as found by Hadorn 
et al. (1968). If a single humoral factor were involved then it 
might be an abnormal product or noimial metabolite produced in abnormal 
amounts by an enzyme defect,
Marsden (1969) in a reappraisal of cystic fibrosis considered 
that biochemical observations and the clinical picture could be 
reconciled in terms of a single generalised inheritable defect 
in sodium ion uptake such as is seen in the sweat and submaxillary 
glands and erythrocytes. The secretion of glycoproteins or acid 
mucopolysaccharides essentially involves the movement of highly 
negative ions from the cell. To maintain ionic balance, cations 
(such as sodium-Na^) must leave the cell simultaneously. With a 
reduced capacity to take up Na^, secretory activity might be impaired 
by a build up of secretory materials in cells concerned such as in 
the goblet cells of the gastro-intestinal tract. Other ions such as 
calcium-Ca**' may serve as an accompanying cation such as is seen in 
the submaxillary gland (Chernick and Barbero, I96I), or molecules 
secreted may become less negatively charged as by the substitution of 
neutral /
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neutral fucose for charged neuraminic acids in epithelial glycoproteins 
(Dische et al. 1959). In cultured skin fibroblasts restriction 
of acid mucopolysaccharide secretion would seem to occur to result in 
accumulated secretory materials (Danes and Bearn, 1968; Matalon and 
Dorfman, 1968). Epithelial glycoprotein secretion can be very 
rapid and takes place in a predominantly hypotonic environment such 
as occurs in cystic fibrosis. This feature could aggravate any 
defect in sodium uptake. This theory of generalised ionic 
disturbance could also explain the impaired bicarbonate (HCO^*) 
secretion (Hadorn et al. 1968). Harsden's interpretation of the 
basic defect was thus a reconciliation of the different aspects due 
to a shortage of intracellular sodium in secretory cells.
Johansen (l970) has offered the hypothesis that the disturbance 
of exocrine glands may be related to the structure or porosity of 
mucopolysaccharide-rich regions in the connective tissue or in the 
mucoid layer immediately adjacent to the secretory cells. The 
extracellular regions may exert control over fluid movement in the 
initial stages of the elaboration of the primary secretion at a time when 
all electrolytes must first be transported from the extracellular space 
and probably also when they pass through the mucoid coat immediately 
external to the plasma membrane. There is evidence that each cell may 
synthesise /
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synthesise at least part of its o\m mucoid coat thus lending it its 
individual cell type specificity which seems chemically related to 
the acid mucopolysaccharides, themselves being important constituents 
of the adjacent connective tissue. These macromolecules form a 
complex network within the ground substance and are known to be 
important in the maintenance of water and electrolyte balance of 
tissues in the body* Such variations in mucopolysaccharide 
distribution may partly explain the variations of composition of 
secretions under carefully controlled conditions of stimulation in 
normal individuals. Considering evidence for a circulating 
humoral inhibitory factor, Johansen suggests that in cystic fibrosis 
a basic substance, probably a polypeptide, interacts with the mucoid 
layer to modify its porosity. In the pancreas the material may 
compete with secretin, also a basic polypeptide, and inhibit its 
optimal effect. Similarly the basic substance may interact with 
a negatively charged layer on the luminal surface of the duct cells 
in the salivary and sweat glands and so inliibit movement of sodium 
to the site of the active process initiating its transport across the 
duct. The wide spectrum of individual variations may relate to the 
normal variation in the composition of the extracellular mucopolysaccharide 
regions in different exocrine tissues. The basic substance interacts 
with such mucoid substances modifying the porosity of these areas to 
ions or fluid movements.
Whatever /
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Whatever else, the proposed basic defect must account for 
the following abnormalities seen in the disease;- the high sweat 
salt due to poor reabsorption, the inhibition of sodium ion reabsorption 
by a soluble humoral factor, reduced water flow in the pancreas, 
mucin precipitation in the pancreas and the ciliary beat inhibitory 
factor of Spock et al.*
The evolution of the concepts of cystic fibrosis has been 
rapid* Indeed, the divergence of investigation since the first 
thorough clinical description of the disease in 1958 has led to the 
finding of a bewildering complexity of abnormalities for which it is 
difficult to conceive a unifying genetic cause* Research for the 
"basic defect" continues along many avenues. Inquiry has been 
fraught with non-absolute findings. The two most constant defects 
are still the raised concentrations of electrolytes in sweat and the 
recently described failure of development of the male reproductive 
tract. This latter now deserves detailed study because of its 
early appearance in the development of the foetus which will become the 
male "cystic fibrosis child".
CKÂPTER TWO
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THE M I Æ  GENITAL SYSTEM IM CYSTIC FIBROSIS.
Anatomical and hormonal aspects of the male genital
system.
Owing to earlier diagnosis and Improved management of cystic 
fibrosis, patients now have a greater expectation of life* As a 
result, attention has recently been focussed on their reproductive 
potential* The adult female is capable of bearing children though 
fertility is impaired due to abnormality of the cervical mucus.
In 1966 Grand et al* observed that of eleven children of ten mothers 
with cystic fibrosis, none were affected by the disease. This was 
taken as evidence for the genetic autosomal recessive nature of the 
disorder* There are, to date, however, very few claims for paternity 
by men with cystic fibrosis. Marks and Anderson (i960) reported 
sterility in a 46 year old male with normal testicular tissue but 
with azoospermia* Analysis of his semen indicated that the 
prostatic secretions were normal but the seminal fluid component was 
lacking. This was the harbinger of many reports of sterility in 
the male with cystic fibrosis.
THE ABhORMLITY OF THE MALE BEPRODUGTITE TRACT IN CYSTIC FIBROSIS*
Denning et al. (1968) reported aspermia in adult males with cystic 
fibrosis. Nonetheless, there was active spermatogenesis in their 
10 cases /
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10 cases (l biopsy; 9 post-mortem)* Spermatozoon numbers were, 
however, reduced and 50 per cent were observed as having abnormal forms*
The cytological aberrations occurred at spermatocyte and spermatid stages 
of spermatogenesis* Early suggested causes for these observations 
were (l) a genetic abnormality affecting spermatogenesis; (2) deficiencies 
of vitamins A or E and (5) defects in the transport of spermatozoa owing 
to diminished water and electrolyte secretion*
The first indication of male infertility due to a failure of the 
normal development of the Wolffian duct was made in an extensive 
study of reproductive function in cystic fibrosis by Kaplan and 
colleagues (1968)* Complete absence of spermatozoa was noted in the 
semen of 25 patients whose ages ranged from 17 to 51 years* Semen 
volume was reduced and more acidic than controls* Fructose 
concentrations were very low as compared to the greatly increased 
concentrations of citric acid and acid phosphatase* The viscosity of 
the semen was not measured but appeared to be greater than normal*
These findings on analysis of the ejaculates from patients with cystic 
fibrosis have been substantiated by recent studies by Rule et al* (1970)* 
Kaplan et al. (1968) postulated that increase of citric acid and acid 
phosphatase of prostatic origin might reflect failure of normal dilution 
with fluid not containing these components* Decreased fructose, of 
seminal vesicle origin, and reduced semen volume lent evidence for a 
seminal vesicle /
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vesicle abnormality*
The vas deferens could not be identified on gross dissection of 
10 necropsy specimens between the ages of 5 and 20 years or in 6 patients 
at herniorrhaphy* They concluded therefore that the aetiology of 
sterility was in fact a specific anatomical defect preventing transport 
of spermatozoa from the testis to the urethra* Valman and France 
(1969) examined at post-mortem the intra-abdominal vasa deferentia 
in 10 boys. In one child vasa deferentia were not found and in the 
other cases they were completely or partially reduced to a fibrous or 
muscular band* Holsclaw (1969) confirmed this anatomical defect at 
25 necropsies and in 12 of 15 surgical explorations for hernia repair 
or orchiopexy. Pathological studies of 32 males by Landing et al* 
(1969) supported these findings. Gracey et al* (1969) described 
an atretic vas deferens in a 15 month old boy with cystic fibrosis 
and Holsclaw found the abnormality present as early as one month of age* 
The defects in the male reproductive tract have been shown to be 
blind-ending efferent ductules at the head of the epididymis, absent or 
rudimentary body and tail of the epididymis, absent vas deferens and 
absent seminal vesicles or if present these latter structures are 
reduced to a dilated cystic structure. The authors considered these 
manifestations to be developmental in origin. Since the epididymis, 
vas deferens and seminal vesicles all derive from the Wolffian or 
mesonephric /
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mesonephric duct in the embryo, defects common to all three systems are 
not surprising* Valman and France suggested that the mesonephric
duct was obliterated during the tenth to twelfth week of foetal life, the 
critical time for the establishment of the Wolffian duct structures.
To the contrary, di Sant’ Agnese (1968) and Oppenheimer and Esterly 
(1969) proposed that the lesions in the male were secondary to the 
obstruction of the epididymis or vas deferens by abnormally viscous 
secretions and therefore analogous to the concept of obstructive 
pancreatic atrophy* However, since vasa deferentia were absent 
from two males less than three days old and five of less than four 
months of age in Valman and France’s study, and since no inspissation, 
inflammation or atresia was demonstrated it appears that an 
intra-uterine maldevelopment of the male Wolffian duct system occurs 
in cystic fibrosis* Albeit the history of the disease has 
been one of non-absolute findings, the pathogenesis of the male genital 
duct may be the most invariable anatomical feature in early life.
NORMAL SEXUAL DIFFERENTIATION OF THE FOETUS.
From their earliest appearance the gonads are intimately associated 
with the nephric system* The gonadal ridges differentiate about the 
fourth week of foetal life while the mesonephros is still the dominant 
excretory organ. These ridge-like thickenings on the ventral
border /
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border of the mesonephros consist of closely packed cells covered by 
an epithelium continuous with that covering the mesonephros.
Because it was believed to give rise to the primordial sex cells it 
has long been termed "germinal epithelium". By the sixth week, 
germ cells can be recognised in the gonad. At this indifferent 
stage of development, the gonad is composed of a medulla (potentially 
the definitive testis) and a cortex (potentially the definitive ovary) 
and a double set of sexual ducts are present. The male (Wolffian) 
ducts are appropriated from the regressing mesonephros whilst the female 
(Müllerian) ducts develop independently alongside the mesonephric ducts. 
The differentiation of the genital tract takes place in the foetus only 
after the differentiation of the gonads which is often explained on the 
basis of Witschi's theory of a dual system of intragonadal inductors 
(Witschi, 1967). A feminising inductor located in the cortex and a 
masculinising inductor in the medulla compete until one gains prevalence 
and imposes the development of the appropriate gonad by inhibition of 
either the cortex or medulla of the primitive gonad. If the different­
iated foetus is female then the Wolffian ducts become rudimentary; if 
male then the Müllerian ducts undergo regression and the appropriated 
mesonephric ducts and tubules undergo further growth and 
differentiation (Table l). Some of the mesonephric tubules lying 
close /
47
close to the testis are retained as efferent ductules and, together 
with that part of the mesonephric duct into which they empty, they 
constitute the epididymis* Caudal to the epididymis, the mesonephric 
duct is invested in smooth muscle and becomes the vas deferens* A 
short distance before the vasa deferentia enter the urethral part 
of the urogenital sinus, local dilations appear destined to become 
the seminal vesicles* By the twelfth week interstitial cells are 
recognisable, the Wolffian duct structures differentiating, the Müllerian 
duct system is regressing and the penile urethra undergoing its initial 
stages of development* By seventeen weeks, Leydig cells are the most 
characteristic feature of the testis and the internal and external 
genitalia have almost completed their development*
Table 1* Chronology of Differentiation of the Genital Tract in
the Male Foetus*
Weeks Gonadal 
Gestation Characteristics
Wolffian
Duct
Müllerian
Duct
External
Genitalia
4 —  
6 —
Indifferent 
gonadal ridges
- - —
r j  _
Seminiferous
tubules
Present Present Undifferent­
iated*
I
12 %=
18 -
Leydig cells
heydig cells 
maximum
Different­
iating
Different­
iation
completed
Regressing
Regressed
Penile urethra 
developing
Development
completed
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Valman and France (1969) believed that the abnormality seen in the 
male reproductive tract in cystic fibrosis reflected a defect in 
development soon after the mesonephros was superseded by the 
metanephros. They believed that the persistence of a recognisable 
epididymis and the caudal end of the vas deferens, as seen in some 
cases of cystic fibrosis, might be evidence for normal development 
until between ten and twelve weeks gestation.
HORMONAL CONTROL OF THE DEVELOPMENT OF THE MALE GENITAL TRACT.
The role of gonadal hormones in the differentiation of the genital 
tract has been determined largely from animal experimentation and in 
particular from the classical in vivo studies on rabbit foetuses 
undertaken by lost (l947, 1953$ 1970). In rabbit foetuses 
castrated in utero at a time when the gonads were already histologically 
sexually differentiated but while the internal and external genitalia 
were still undifferentiated, the genital tract of the foetuses were 
feminised regardless of the genetic sex. This result was confirmed 
by Raynaud at the Institut Pasteur in Paris in 1947 when he used a beam 
of X-rays to destroy the sex organs of mouse foetuses in vivo.
Both in vivo, (dost, 1955) and in vitro. (Picon, 1971) grafts of testis 
initiated masculinisation. Humans congenitally deprived of gonads, 
as /
as may occur in patients with Turner's syndrome and pure gonadal dysgenesis 
demonstrate feminine trends in development regardless of chromosomal 
sex* Thus it appears that the foetal testis imposes masculinity on 
the soma and represses femininity, whereas the ovary has no important 
role in the sexual differentiation of the genital tract. The testicular 
influence is to cause retrogression of the Müllerian ducts, to stabilise 
the Wolffian ducts which regress in the absence of testes, to stimulate 
the development of the epididymes, vasa deferentia and seminal vesicles, 
and to impose masculine organogenesis on common undifferentiated anlagen 
(urogenital sinus and external genitalia). (Fig. 5)#
Androgens, such as testosterone, can act in place of foetal testes 
in their masculinising effects but exogenous androgens fail to inhibit 
the Müllerian ducts (Jost, 1955)" These findings have been taken 
to suggest that the testis produces a Müllerian duct inhibitory factor 
and in addition a masculinising hormone probably androgenic in nature.
This hypothesis is further strengthened by the noted effects of the 
anti-androgenic drug, cyproterone acetate, in male rabbit foetuses.
This drug opposes the masculinisation of the genital tract but fails to 
prevent inhibition of the Müllerian ducts (Neumann, 1969; Eiger, 1966; 
Jost, 1967)"
In /
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MULLERIAN
DUCT
INDIFFERENT 
FOETAL STAGE 
WOLFFIAN 
DUCT
GON
y
AD INTERFERENCE WITH TESTICULAR ACTIVITY
T
TESTIS
a)HULLERIAN INHIBITOR
b)MASCULINISING HORMONE
V \
CASTRATION(PHENOTYPIC FEMALE)
DEFECT IN ANDROGEN METABOLISM 
ANT I-ANDROGENtCyppoterone acetate 
in rabbits)
ENO-ORGAN INSENSITIVITY TO ANDROGEN 
(FAILURE OF WOLFFIAN DUCT 
STABILISATION 
MULLERIAN DUCT INHIBITOR STILL 
OPERATIVE)
PHENOTYPIC PHENOTYPIC 
FEMALE MALE
Fig. 5. Diagram indicating the testicular control of sexual 
differentiation.
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In early in vivo experiments Greene et al. (1959), Raynaud (l957) 
and Dantchakoff (l957), using rats, mice and guinea pigs, demonstrated 
that the degree of masculinisation of female foetuses was related to the 
dose of androgen (testosterone propionate) administered to the pregnant 
females. Jost in 1968 linked the differential response to varying 
concentrations of the same hormone to various thresholds of sensitivity 
exhibited by the tissues involved. He observed that in rats,
masculinisation of the urogenital sinus and increased anogenital
distance were obtained with lower hormone dosage than was required
for the development of the penis. Still higher concentrations of
androgen were required for the stabilisation and development of the 
Wolffian duct system,
POSTAL ANDROGENS.
Review articles by Jost (1968) and Price and Ortiz (1965) have 
placed emphasis on the importance of foetal androgens in the normal
development of the Wolffian duct system. Androgen biosynthetic
pathways have been well established by both in vitro testicular tissue 
incubation findings and in vivo studies (Pig. 6). JSarly human 
foetal testicular incubations by Bloch (1964) and Acevedo et al. (1965) 
demonstrated testosterone synthesis f r o m p r o g e s t e r o n e  and 
|^ 7oc-^ ï^  pregnenolone. At this time the quest was for a temporal 
relationship /
É2
CHOLESTEROL
0=0 c=o
— OH!7 a-H Y 0 R 0X Y
PREGNENOLONE DEHYDROEPIANORÜSTERONE:PREGNENOLONE
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ANDROSTENEDIOLPROGESTERONE
TESTOSTERONEANDROSTENEDIONE
J
Fig. 6m Classical androgen biosynthetic pathways* Enzyme systems
involved are:-
I*. C20,22-desmolase
5
II. A “3P"'hydroxysteroid dehydrogenase 
5  4-
III* A -A~isomerase
IV # 17 a-hydroxyla se
V. C17f20-desmolase
VI. 17p“hydroxysteroid dehydrogenase.
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relationship between male reproductive duct differentiation and foetal 
androgen production. Lipsett and Tullner (1965) were able to 
demonstrate that the conversion of pregnenolone to testosterone 
increased rapidly just prior to and during the differentiation of the 
rabbit foetal Wolffian duct derivatives. The appearance of Leydig 
cells correlated closely with the development of the male 
reproductive system, an effect assumed to be due to androgens.
There are, however, inherent difficulties in the experimental 
approach to such problems in the human. The steroidogenic capacity 
of the human foetal testis and adrenal at the end of the first 
trimester of gestation has been established by histochemical (Cavallero 
-and Magrini, 1967) and in vitro studies (Bloch, 1967), and at midpregnancy 
by in vivo perfusion experiments (Diczfalusy, 1967; Solomon, 1967).
Early androgen production by testes and adrenals from 7.5 to 20 week 
old human foetuses has been investigated in organ culture using rat 
ventral prostate as a bioindicator (Zaaijer and Price, 1968). In 
these experiments foetal organs were cultured in contact with the 
prostatic tissue which is dependent on androgen for maintenance of 
structure and secretory function. After 9.5 weeks gestation all 
testes used experimentally displayed androgenic activity. After 
12 weeks the adrenals also were androgenic. In the earlier age groups 
studied, a few adrenal explants demonstrated little or no androgen 
production. /
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production* Interpretation of such results must be made with caution 
because of the possibility of an adrenal inhibitor being operative 
within the experimental system*
Testicular incubations with radioactively labelled substrates 
have demonstrated the importance of the A5“3p-hydroxysteroid pathway in 
early foetal life (Hamilton et al, 1970)• Using and in 
double label techniques for the estimation of competition or 
"preference" for substrates, testes of less than 12 weeks gestation 
converted dehydroepiandrosterone and androstenediol to testosterone 
more readily than androstenedione. Tissue of more than 12 foetal 
weeks had a greater percentage conversion of androstenedione to 
testosterone and thus reflected the adult pattern (Lucis et al* 1967)*
If these investigations truly mirror the in vivo androgenic biosynthetic 
pathways, then testosterone synthesis from pregnenolone, 17ot" 
hydroxypregnenolone, dehydroepiandrosterone and androstenediol must 
be important during the formative period since the main differentiating 
processes of the reproductive tract have begun by the twelfth week of 
gestation*
Possible Endocrine Aetiology for the Abnormality 
of the Male Genital Ducts in Cystic Fibrosis*
The anatomical nature of the defect in the male reproductive tract
in cystic fibrosis patients has aroused interest* Could there be an
abnormality /
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abnormality in the differentiation process of the Wolffian duct? The 
failure in development has been thought to occur soon after the 
metanephros has superseded the mesonephros as the functional kidney.
(Valman and Prance, I969). The possibility arises that the arrest 
in development prior to the twelfth foetal week might be hormonal 
in aetiology and reflect an impaired biosynthesis of androgen. The 
external genitalia in male patients are however normal, indicating 
that testicular androgen production is not completely absent.
Jost (1968) observed that in rats the threshold of sensitivity to 
androgens was lower for external genitalia tissue than for Wolffian 
duct tissues. Providing the same differential tissue sensitivity 
applies to humans, the theory of a deficient, though not absent, androgen 
production can be used to explain the apparent anomalies found in the male 
patient with cystic fibrosis. There are obvious difficulties in 
investigating androgen biosynthetic pathways in the affected foetus.
Tissue from a foetus which might be affected cannot readily be obtained. 
However, other features of the disease seen in children with cystic 
fibrosis might reflect an endocrine involvement.
ENDOCRIKS ASPECTS IN CYSTIC FIBROSIS.
It is well recognised that, despite stringent dietary management, 
underheight /
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underheight and underweight are among the characteristic clinical 
expressions of the disease. Puberty is delayed and the pubertal 
growth spurt is not only delayed but it is not so marked as in normal 
adolescents. Aspermia, because of the absence of the vas deferens, 
is an almost constant finding in the male. Histological examination 
of post-pubertal testes has revealed a decrease in spermatogenesis and 
frequent abnormal spermatozoa! forms (Kaplan et al. 1968). This arrest 
of spermatozoa! maturation appears to occur at the stage of spermatid 
formation.
Failure to thrive, a characteristic of several chronic diseases 
including cystic fibrosis, has been the justification for the use of 
anabolic hormones in patients with the disease (Dennis and Panos, 1965; 
Good and Bessman, 1966; Dooley et al. 1969; Harris and Waring, 1970; 
Hamilton, 1970). Androgens are known to stimulate protein anabolism 
in many tissues of the body. They are believed to act at the cell 
nucleus to stimulate the production of ribonucleic acid with resulting 
increase of protein biosynthesis (Kochakian, 1965). Such anabolic 
therapy is still very much in the experimental stage. The precise 
mode of action of many drugs remains obscure, and undesirable side- 
effects, due to the androgenic or oestrogenic nature of the steroid 
used, may occur in patients undergoing treatment. Moreover, assessment 
of therapy is in large part dependent on subjective assessment both by 
patient and physician. However, despite variable reports on the effects 
on /
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on lung function, all investigators noted an increase in the rate of 
growth and weight gain following steroid administration* Dooley et 
al* (1969) treating their patients with norethandrolone (Nilevar) 
observed that greatest benefit was derived by pre-adolescent females*
This finding raised the possibility that pre-adolescent females with 
cystic fibrosis have a low endogenous androgen production and so are 
more responsive to administered anabolic steroids*
The features characterising puberty reflect changes of adrenocortical 
function and are accompanied by a rise in urinary 17-oxosteroids, 
these being mainly the metabolites of androgenic steroids produced in 
increasing quantities by the adrenal and the testes during adolescence* 
Indeed, Rosenfield and Eberlein (1969) found increasing plasma levels 
of dehydroepiandrosterone and dehydroepiandrosterone sulphate at 
this time and equated the changing adrenal function with increased 
secretion of these compounds by the gland. The delay in maturation 
in patients with cystic fibrosis might, therefore, reflect deficient 
synthesis or secretion of dehydroepiandrosterone sulphate by the adrenal. 
On reflection, the failure of development of the male reproductive tract 
in the foetus occurs at a time when dehydroepiandrosterone is an 
important intermediate in the testicular biosynthesis of the more 
androgenic steroid - testosterone.
The aetiology of the anatomical defect found in male patients 
and /
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and the delayed puberty associated with cystic fibrosis could be 
related to hormonal imbalance and in particular to à deficit of 
dehydroepiandrosterone and its sulphate ester.
MBTABOIilC EFFECTS OF DBHYDROEPIAJIDROSTEROHB
There is now evidence that DHA exerts an effect over a wide
range of cellular processes. The difficulty in following the effects
of DHA is in part due to the fact that orally administered DHA may be
converted to testosterone and indeed there is in vitro evidence that
many tissues can elaborate testosterone from such precursors as DHA.
In 1962 Howard postulated that testosterone advanced bone age in
humans. Salmon (1965) reported an increased carrier-free radio-
35actively-labelled S-sulphate incorporation into cartilage of
bypophysectomised male rats following the administration of testosterone
and other anabolic steroids. The uptake of radioactive sulphate 
35as S in sulphuric acid had been investigated in the growing bones 
of cockerels treated with cortisone (anti-anabolic) and androgenic 
anabolic steroids (Kowalewski, 1958). The deposition of radioactive 
sulphate in tissues is due to the utilisation of sulphate ions in the 
synthesis of chondroitin sulphate in the connective tissue ground 
substances and in collagen. The anabolic steroid 17a-ethyl-19- 
nortestosterone counteracted the anti-anabolic effect of cortisone on 
growing /
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growing bone when both were administered simultaneously. From 
these observations, Kowalewski proposed that cortisone inhibited 
and anabolic hormones stimulated the production of certain 
mucopolysaccharides, essential in collagen fibrillogenesis, which 
specifically incorporate labelled sulphate. Principe and Bellucci 
(1952) administered testosterone propionate to guinea pigs with 
fractures and demonstrated early stabilisation of the callus. Van
Wagenen and Eurme (l950) had treated immature rhesus monkeys with 
the same compound and produced precocious skeletal development and 
eruption of canine teeth. Androgen treated animals of 2.8 years 
chronological age had a skeletal development of about 7 years.
The temporal relationship between the sexual and osseous 
maturation in humans has long been recognised. For instance, girls
menstruate more in relation to bone age than to chronological age.
In animal experiment histological changes after androgen administration 
to pre-puberal mice have shown that testosterone and DHA advance 
the maturation of the proximal epiphyseal plate of the tibia 
(Howard, 1965). Howard thought that the relationship between 
skeletal and gonadal maturation could perhaps reflect the influence of 
a common maturation-rate-oontrol, operating in part via the adrenal 
cortex, and associated with the increased output of DHA during the 
human adolescent years.
Recently /
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Recently Puche and Romano (1970) investigated the effects of 
D M  and testosterone on the carbohydrate metabolism of bone. Chick 
embryo frontal bone explants were used in in vitro studies and in vivo 
investigations were made of the endochondral ossification of pre-puberal 
mice. Both experimental systems indicated an increased rate of 
calcification produced by these hormones and an increase in glucose- 
6-phosphate dehydrogenase activity. These authors related treatment 
to an increased proportion of glucose oxidised via the hexose 
monophosphate shunt. Oertel (l97l) has also cast D M  in the role 
of a possible regulator of human glucose-6-phosphate dehydrogenase.
D M  has been shown to offer some protection against elastase 
degradation and to reduce metachromatic substances within elastase- 
affected tissues (Mikulaskova and Linet, 1964). The influence of 
D M  on the aortic wall was investigated histochemically in rabbits 
with experimental atheromatosis. After D M  administration a 
diminished degradation of elastic fibres by elastase was observed and 
the quantity of metachromatic substances reduced. These findings 
may have a bearing on the increase of metachromatic substances 
reported in fibroblasts and white blood cells from some cystic 
fibrosis patients.
Granick and Kappas (1967) described the effects of steroids on 
porphyrin synthesis in chick-embryo liver-cell culture. Steroid 
glucuronosides /
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glucuronosides were devoid of porphyrin inducing activity. Sulphates 
of DHA and oestrone demonstrated weak activity as did the free 
steroids. Aetiocholanolone, however, was a strong inducer.
The investigations suggested that the area of activity was the 
.stimulation of haem biosynthesis. This study induced Goldberg 
et al. (1969) to undertake an investigation of urinary steroid 
excretion levels in patients with acute intermittent porphyria. The 
most consistent finding was that of raised urinary levels of DHA.
This steroid introduced intraperitoneally into rats significantly 
raised the level of «T -aminolaevulic acid synthetase (A.L.A. synthetase) 
which is the rate limiting enzyme in haem and porphyrin biosynthesis.
The enzyme is present in excess in the liver in acute porphyria 
whether natural or experimentally induced. The steroid is believed 
to act as a derepressor on the operon controlling A.L.A. synthetase.
let another facet of the subject is that steroids are known to 
bind to sites on spermatozoa (Ericsson et al. 196?). Steroids 
also suppress oxygen uptake by spermatozoa (Mounib, 1964). Studies 
on rats have demonstrated the ability of the epididymis, vas deferens, 
prostate and seminal vesicles to accumulate and retain androgens 
which are believed to bind to specific androgen ’receptors' in the 
cellular cytoplasm and nuclei (Hansson and Tveter, 1971; Tveter and 
Attramadal, 1968; Tveter and Unhjem, 1969). Frankel and Eik-Hes
(1970) /
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(1970) studying concentration gradients of testosterone and DBA 
within the epididymis of the rabbit, recorded higher levels of both 
steroids in the cephalic end of the duct than at the caudal extreme.
It is generally accepted that testosterone is able to influence the 
differentiation of the Wolffian duct and that its stimulatory action 
in the male reproductive tract, particularly in the seminal vesicles 
and prostate, is probably mediated by an increased biosynthesis of 
ribosomal RWA (Villee and Fujii, 1968; Kochakian, 1965)* Moreover, 
the concentration gradient studies of testosterone within the male 
genital tract in conjunction with the known effects of the steroid 
on spermatozoa suggest a further role for testosterone in the maturation 
process of spermatozoa. By preserving endogenous nutritive reserves
in the gametes, high levels of testosterone in the epididymis, 
more particularly the caput epididymis, are believed to inhibit 
maturation by preventing oxidative metabolism.
The process of spermatogenesis itself has a complex of requirements 
for its successful completion. An interaction of gonadotrophins, 
androgens and non-hormonal factors is known to be essential (Steinberger 
and Steinberger, 1969)* The precise hormonal requirements for
normal spermatogenesis are still conjectural though some deductions 
have been made based on experiments with rats. The formation of 
spermatogonia /
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spermatogonia from the germ cells may require testosterone as may 
also the meiotic division of the primary spermatocytes. The 
maturation of the spermatids may not require hormones or may require 
testosterone. The completion of spermatogenesis certainly requires
Androgens are therefore known to be essential for some stages 
of spermatogenesis and deficiency might explain the abnormal 
histology of testes in patients with cystic fibrosis where an 
arrest in development appears to occur at spermatocyte and spermatid 
stages (Denning et al. 1968).
Metabolism of Dehvdroeniandrosterone.
ISOLATION OF DEHYDROEPIAimRQSTERONE.
Dehydroepiandrosterone was first isolated from urine in 1935 
by Butenandt and though in 1958 Callow postulated its possible 
adrenal origin this steroid was for long not isolated from adrenal 
tissue and indeed was not considered as a normal urinary steroid 
metabolite. In 1944, dehydroepiandrosterone sulphate (DHAS) 
was isolated from human urine (Munson et al. 1944) and a decade later 
the occurrence of this ester was detected in peripheral human plasma 
(Migeon and Plager, 1954)* Interest quickened in DHA with the 
realisation /
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realisation that it was secreted by the adrenal cortex and from it the 
bulk of the urinary 17-oxosteroids are derived (VandeWiele and 
Lieberman, I960). Until 1962 DHAS was considered as a catabolite, 
formed principally in the liver from adrenal-elaborated DHA. In 
the same year Baulieu (1962) demonstrated that the concentration 
of the sulphate ester (DHAS) was higher in adrenal venous blood of 
a patient with an adrenal tumour than in the peripheral circulation. 
Further evidence for the adrenal secretion of DHAS came from 
secretory rate studies using radio-isotope labelled steroids 
(VandeWiele et al* 1962; Gurpide et al. 1965). Indeed an unexpectedly 
high adrenal secretion rate of^ 15 mg per day was recorded (VandeWiele 
et al. 1965).
ADRENAL SECRETION OF DEHYDRQEPIAHDROSTEROHE SULPHATE.
Secretion of DHAS from the adrenal may be the result of a direct 
steroid sulphate pathway within the gland* Calvin and Lieberman 
(1964) unequivocally demonstrated, in incubation studies, the pathway 
from A5-pregnenolone sulphate to 17oc-hydroxypregnenolone sulphate 
using homogenates of hyperplastic adrenal tissue. LeBeau et al.
(1964) reported the conversion by human adrenal tumour tissue of 
17a-hydroxypregnenolone sulphate to DHAS (Fig. 7). Alternatively 
sulphation may be a terminal biosynthetic event prior to secretion 
of /
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CHOLESTEROL
PREGNENOLONE Gual et al.(1962)
I7a-HYDR0XY-
PREGNENOLOE
Cohn et al.(1963)
DEHYDROEPIANDROSTEROE Roberts et al.(1961)
PREGNENOLONE -(S)
C a l v i n  &  Lieberman(l964)
V I7O.-HYDR0XY-
PREGNENOLONE - ©
LeBeau et_aU(l964)
4- ____
DEHYORGEPIANDRDSTERONE - ®
Colm, Hulrow, and Dmine, V,C. (1963). J. din. Endocr., 2], 6?I*
Gtial, C., Rojo, B., Lems, A.E., mid Rivera, R. (1962). Sociedad Mexicana 
de Nutricion y Endocrinol., 3rd Meetin/v^  p, 126.
Pie. 7. Diagram of the steps in the adrenal biosynthesis of 
dehydroepiandrosterone sulphate from cholesterol.
Steps in the "sulphate pathway" were confirmed by 
investigators indicated thus ; « _  _ _ _ _ _ _ _  The
symbol - S indicates the 3p-yl sulphate of the steroid,
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of the sulphate from the gland. Certainly sulphokinases have 
been identified in adrenal, testicular and ovarian tissues 
(Wallace and Lieberman, 1963; Pierrepoint et al. 1965; Wallace and 
Silberman, 1964)#
METABOLISM OF DEHTDROEPlAIDROSTIilRONE.
Only 1 to 12 per cent of DBAS is excreted unchanged after 
intravenous injection of a tracer amount (Baulieu, 1965*). Some of 
the DBAS undergoes a "direct metabolism" without breakage of the 
ester link implying a biosynthetic pathway involving steroid sulphates 
as intermediates. A moiety of DBAS is hydrolysed. Gibian and 
Bratfish (1956) isolated sulphatase from mammalian liver acting on 
oestrones and DBAS. Roy (l95?) found sulphatase localised in 
the microsomes of ox and rat liver. Indeed, Warren and French
(1965), Burstein and Dorfman (l963) and Kim and Herrman (1968) have 
demonstrated a widespread distribution of steroid sulphatase in human 
tissues. A moiety of the DBA so liberated from its sulphate may 
be resulphated in the liver, while a further part is metabolised to 
androsterone and aetiocholanolone and then sulphated for excretion, 
i.e. "indirect metabolism".
As well as being a secretory product from the adrenal, DBAS 
is also a metabolic conjugate. The liver is probably the most
important sulphating organ (Schneider and Lewbart, 1956) though it 
is /
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is not unique in this respect. DHAS and DBA are interconvertible 
(Roberts et al. 1961) and the DBA escaping further metabolism in the 
liver is secreted into the gut with the bile and may be resulphated 
in the intestinal wall as it is reabsorbed into the portal circulation.
"Detoxication" products of liver catabolism such as androsterone 
and aetiocholanolone, conjugated with glucuronic acid or sulphuric 
acid so rendering them more water soluble, are quickly excreted in 
the urine and thus have a high clearance rate* Glucuronosides were 
generally considered as end products which were completely excreted. 
However, dehydroepiandrosterone glucuronoside (DHAG) administered 
orally increased the urinary output of androsterone and aetiocholanolone 
glucuronosides (Kellie, 1961). Only 15 per cent of an administered 
tracer dose of p7a-^I^DHAG was recovered as the glucuronoside from the 
urine, indicating that further metabolism must have taken place.
An "indirect metabolism", implicating the splitting of the osidic link, 
was found after the isolation of urinary DBAS following
intravenous injection of p7oc-^ î^ DïïAG. Several labelled 3P-
hydroxy steroids (jva-^ nj 3of p7a-^î^ DHAG .indrostan-lTone, jŸot-^Hjandrostane- 
ITpdiol, A5-androstenediol) were recovered as glucuronosides 
indicating that a "direct metabolism" also probably occurs (Rebel 
et al. 196?)*
DBAS does not have a potent androgenic activity and its biological 
significance /
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significance comes from the peculiarity of its metabolism. The 
biological half-life of DHAS is 8 to 10 hours while that of free 
DHA is 25 minutes (Baulieu, 1965)# It is not known if this long 
half-life is due to protein-binding, difficulties of membrane penetration 
or weak sulphatase activity. However, DHAS may be considered as 
a "privileged hormone substrate" in that it circulates for a long 
time and seems to resist hepatic catabolism.
Thus the roles of DHA and DHAS are not all identified, nor
are they clearly defined. Certainly the facts that DHA and DHAS
are precursors of testosterone, that sulphatases are present in many 
tissues of the body and that, even as a weak androgen, DHA may act
as a metabolic stimulant at cell level, have suggested that
circulating levels of DtIA and DHAS and their metabolism in patients 
with cystic fibrosis should be investigated.
Enunciation of Thesis and Pronosed Mode of Study.
If DHA or DHAS circulated in suboptimal concentrations in 
patients with cystic fibrosis then the following aspects of the 
disease might be explained:-
(a) Failure to complete the development of the 
male reproductive tract
(b) Arrest of spermatogenesis at spermatocyte 
and spermatid stages of development
(c) /
69
(c) Delayed puberty
(d) Restricted pubertal growth spurt
(e) Retarded bone age, and
(f) Increased metachromasia on staining with 
toluidine blue in fibroblasts and white cells.
Such diminished availability of steroid could be the result 
of:-
(a) reduced secretion of DHAS by the 
adrenal glands
(b) reduced sulphatase activity for DHAS 
decreasing the availability of active DHA 
to the cells of the body, or
(c) reduced sulphokinase for DHA resulting 
in its rapid excretion.
Thus the investigation of DHA in cystic fibrosis patients was 
undertaken. Urine was processed to determine the daily excretion 
of total 17-oxosteroids, 17-oxogenic steroids, and total 
17-hydroxycorticosteroids. Urinary DHAS and DHAG were also 
quantitated and in addition the plasma DHAS representing the circulating 
"available pool". Attempts were madeto increase available DHA 
at cellular level and these attempts were monitored by estimating 
urinary and plasma DHAS levels. Some somatic and cellular effects 
were observed.
CHAPTER THREE
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MATERIALS AHD METHODS 
Introduction
In order to investigate a possible deficiency of dehydroepiandrosterone 
(DHA) in patients with cystic fibrosis, methods were sought by which 
low urinary and plasma levels of the steroid could be detected.
Normal urinary excretion of 17-oxosteroids below the age of 6 years is 
reportedly low «  1 mg per 24 hours)(Loraine and Bell, 197l)*
Fractionation employing paper chromatography, demonstrated DHA to 
constitute 4 per cent of the total 17-oxosteroids in children from 
5 to 7 years (Loras et al., 1966). Thereafter excretion of DHA 
and 17-oxosteroids gradually rises to adult levels between 17 and 20 
years. Boys of 14 to 16 years have an output of 600 pg DHA per 
24 hours, representing 16 per cent of the excreted 17-oxosteroids.
Small quantities of 17-oxosteroids are also found in plasma, the range 
throughout early childhood and adolescence being from 1 to 160 pg 
per 100 ml plasma (Rosenfield and Eberlein, 1969).
Since levels of DHA in patients with cystic fibrosis were thought 
likely to be subnormal, it was necessary that the methodology could 
detect nanogram (ng) levels of DHA in the biological material processed 
(50 - /
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(50 - 100 ml urine; 4 - 10 ml plasma). This sensitivity of detection 
was achieved using g.l.c. and by electron capture detection of the 
heptafluorobutyrate derivative of the steroid. Utilising this 
method, rigorous preparative purification of samples was found necessary, 
Losses were envisaged and consequently radioactive DHA was added 
initially to samples. On the basis that recovery of labelled DHA 
represented equivalent recovery of native steroid, correction after 
g.l.c. quantitation was made according to estimations of the recovery 
of the labelled steroid.
Materials 
RADIOACTIVE-LABELLED STEROIDS
All radioactive labelled steroids used in this investigation were 
obtained from the Radiochemical Centre, Amersham, Bucks., England. 
Dehydroepiandrosterone
sulphate- 7c£-^ H
7a- II ( H-DHA) and dehydroepiandrosterone
( H-DHAS) were used in tracer amounts to estimate 
the recovery rates of the experimental procedures. Testosterone 
di-heptafluorobutyrate was used as an internal standard for g.l.c.
7a-^H testosterone ( H-T) wasquantitation of biological samples and 
used to estimate the efficiency of derivative formation.
Prior to use, all radioactive steroids were purified in thin 
layer /
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layer chromatographic (t.l.c.) systems until a single peak of 
Gaussian proportions was. produced on radiochromatogram scanning.
Generally 3 separate systems were required. The purified steroids 
were then stored at 5^ *0 in 50 per cent benzene in ethanol for free 
steroids and ethanol for conjugated steroids.
REFERENCE COMPOUNDS - UNLABELLBD
Standard steroids were obtained commercially either from Ikapharm 
(Ramat-Gan, Israel.) or Sigma London Chemical Company Ltd. (London, S.U.6., 
England.). Small quantities of the glucuronoside and sulphate 
conjugates of dehydroepiandrosterone (DHA), androsterone (AND) and 
aetiocholanolone (AET) were obtained from the M.R.C. Steroid Reference 
Collection (Chemistry Dept., Westfield College, Hampstead, London, N.W.3,).
REAGENTS
Benzene, oyclohexane, acetone and ethyl acetate were supplied by 
Hopkin and Williams Ltd. (Freshwater Rd,, Chadwell Heath, Essex, England.) 
and were of the M.F.C. (Materials for Chromatography) range of products. 
Absolute ethanol (a .R. quality) was obtained from James Burrough Limited 
(Fine Alcohols Division, 60 Montford Place, London, S.E.11, England.). 
"Peroxide-free" diethyl ether was purchased from May and Baker Ltd. 
(Dagenham, Essex, England.). Heptafluorobutyric anhydride and toluene 
("scintillation /
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("scintillation grade") were obtained from Koch-Light Ltd, (Colnbrook, 
Buckinghamshire, England,)• Both PPO and POPOP, the primary and 
secondary solutes incorporated into toluene to produce liquid scintillator, 
were obtained from Packard Instrument Co., Inc., (Downers Grove,
Illinois, U.S.A.), All other chemicals were purchased from B.D.H. 
Chemicals Ltd. (Poole, Dorset, England.) and were, when possible, of 
"Analar" specification.
ENZYI^ iE PREPARATIONS
Sulphatase prepared from Helix pomatia was obtained from Koch- 
Light Ltd.. The enzyme p-glucuronidase used for the hydrolysis of 
urinary steroid glucuronosides was prepared in this laboratory after 
the M.R.C. method (l963) and its potency estimated by the method of 
Talalay et al. (1946).
Limpets (Patella vulgata) were gathered from the rocky shore of 
the Clyde estuary 2 hours after high tide and immediately brought 
back to the laboratory in sea water. The molluscs were removed from 
their shells and the black visceral hump was dissected from the muscular 
foot. Batches of 100 - 200 g visceral humps were homogenised for 
5 minutes with ice-cold water (2 ml per g). After centrifugation 
the supernatant was treated with acetone to bring the concentration to 
60 per cent acetone in water in order to precipitate the enzyme.
The /
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The mixture was allowed to stand in the refrigerator (5*0) overnight 
and the supernatant was then removed after centrifugation at 1,000 
r.p.m*. The acetone precipitate was washed by thorough mixing with 
acetone followed by centrifugation until all the chromogenic material 
had been removed by the acetone. The precipitate was allowed to dry 
in air, powdered and assayed for p-glucuronidase activity.
Assay of Potency of B-glucuronidase Preparation
The limpet powder (200 mg) was dissolved in deionised water (40 ml) 
and 1 ml of the resulting suspension was made up to 12.5 ml with deionised 
water, 0,5 ml of this dilution, corresponding to 200 pg of enzyme
powder, was used for the estimation of p-glucuronidase activity,
0.1 M acetate buffer (4 ml)(5*785 g sodium acetate and 3.25 ml 
glacial acetic acid per litre of deionised water) was placed in 4 tubes. 
Phenolphthalein glucuronoside (50 pg) was added to two experimental 
tubes but not to the two control tubes. All tubes were then placed 
in a water bath at 38^C and allowed to equilibrate. The enzyme 
solution (0.5 ml) was introduced to each tube at timed intervals, mixed, 
stoppered and incubated for exactly 60 minutes. The reaction was 
arrested and the colour developed in all tubes by adding 0.4 M glycine 
buffer (5 ml) (l6.3 g aminoacetio acid, 12.65 g sodium chloride and
10.9 ml /
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10.9 ml concentrated sodium hydroxide 1:1 (wt/v)). Finally 
phenolphthalein glucuronoside (50 pg) was added to the two control tubes.
A Unicam SP. 600 spectrophotometer set at 540 mp and employing Cuvettes 
of 10 ram light path was used to read the optical densities of experimental 
and control solutions against standards of phenolphthalein (5-20 pg).
The number of Fishman units per g enzyme preparation iS equivalent 
to the (ig phenolphthalein liberated from the substrate (phenolphthalein 
glucuronoside) by 1 g of the enzyme extract powder.
Optical densities (O.D.) obtained on assaying the potency of the 
p-glucuronidase used in this study are given below. The spectrophoto­
meter was zeroed against deionised water.
Calculation
O.D.^^q Control 003
O.U.^^Q Standard 153
(20 pg phenolphthalein)
O.U.^^Q Experimental test 160
Therefore
20 pg phenolphthalein s O.D. 150
20.9 pg " 5 O.D. 157
200 pg enzyme powder liberates 20.9 pg phenolphthalein
g
1 g enzyme powder liberates 20.9 % 10
200
104,500 pg phenolphthalein 
Thus 1 g enzyme powder contains 104,500 Fishman units.
Basic /
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Basic Methodology
COLUMN CHROMATOGRAPHY
Glass columns (6 cm x 0.5 cm I.D.) were made to the detailed 
specifications indicated in the text by Thomson, Skinner and Hamilton 
(l2 Cadogan St., Glasgow, Scotland.) and latterly by R.S. Wood (lO 
Hunter St., Paisley, Renfrewshire, Scotland.). Aluminium oxide 
"CAMAG", M.F.C., Brockmamactivities 1 and 2 (alkaline, 100 to 250 mesh), 
was obtained from Hopkin and Williams Ltd.. The activity of each 
batch of alumina prior to use was checked by running a series of 
radioactive standards through a column and assaying the recovery of 
the radioactive label in consecutive 10 ml aliquots of eluate.
THIN LAYER CHROMATOGRAPHY
Merck pre-coated thin layer plates of silica gel î'254 (lâ-yer 
thickness 0.25 mm) were supplied by Anderman and Co. Ltd. (Battlebridge 
House, 87/95 Tooley St., London, S.E.I., England.). These plates 
were used without further washing or activation by heat. Following 
application of samples, the plates were developed in t.l.c. tanks lined 
with Whatman 3 MM chromatography paper (W. and R. Ralston Ltd., 
Springfield Mill, Maidstone, Kent, England.). Approximately 100 ml 
of appropriate solvent was used for each development.
Unlabelled /
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tJnlabelled steroid standards were located on t.l.c* plates after 
spraying with Rhodamine 6 G (O.l per cent in ethanol (wt/v)).
They were visualised as yellow fluorescent areas on a red fluorescent 
background using ultraviolet light (2537 A) from a B.T.L* ultraviolet 
lamp for t.l.c. (Baird and Tatlock (London) Ltd.). Steroids with the 
A^“3"Oxo configuration absorbed ultraviolet light at this wavelength, 
thus facilitating detection.
Areas of radioactive steroids on t.l.c. plates were determined 
using a Panax thin layer radiochromatogram scanner, Model RTLS 1a 
(Panax Equipment Ltd., Redhill, Surrey, England.), in conjunction with a 
Smith’s flatbed recorder (Smith’s Industries Ltd., Industrial Instrument 
Division, Kelvin House, Wembley Park, Middlesex, England.). The 
detector carrier gas was a mixture of argon (2 per cent) and propane 
(98 per cent)(British Oxygen Company Ltd., Special Gases Dept., Deer 
Park Rd., London, S.W. 19, England and Messer Griesheim Ltd., Rare 
Gases Division, 43-45 Knights Hill, West Norwood, London, S.E.27, 
England). The gas flow rate was regulated to 50 ml per minute.
The Geiger-Müller detector was adjusted to a height of approximately 2 mm 
above the t.l.c. plate and all plates were scanned using the 15 x 2 mm 
detector aperture. The detector voltage was set at 1,040 V, 
detector dead time at 200 ps and discriminator bias at 10 mV. A 
scanning /
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scanning speed of 30 mm per hour and a time constant of 100 seconds 
were employed. The range of counting varied with the amount 
of radioactivity to he scanned.
After location, the desired radioactive areas of silica were 
loosened from the plate using a scalpel blade and collected by suction 
through a vacuum thimble (Glass Appliances, 488 Holburn St., Aberdeen, 
Scotland.). The thimbles were then inverted and the steroidal 
material eluted by filtration through the sintered glass base of the 
thimble (Fig. 8).
LIQUID SCINTILLATION COUNTING
Radioactivity in liquid samples was measured using a Nuclear Chicago
Mark 1 Scintillation computer (Nuclear Chicago Corporation, Inc.,
Des Plaines, Illinois, U.S.A.). The scintillation counter was
3 14calibrated for simultaneous counting of ÏÏ and C employing three 
channels. The scintillator used was toluene containing 4 g per litre 
PPO (2,5-diphenyloxazole) and 0.05 g per litre POPOP (l,4“di-
la-\ dehydroepiandro*(2-(5-phenyloxazolyl))-benzene ). Radioactive
sterone sulphate, which is preferentially soluble in aqueous solution, 
was incorporated into the above toluene-based scintillator by dilution 
with 20 per cent methanol. All samples were counted in 20 ml 
scintillator for 20 minutes. Quenched standards (Nuclear Chicago 
Corporation, Inc.) containing an identical scintillator were used to 
establish /
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Fig. 8 . Extraction thimble used in the collection and elution of
silica from t.l.c. plates. Elution of steroids from the 
silica is facilitated by percolation of solvent through 
the silica and sintered glass disc of the inverted thimble.
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establish quench correction curves using external standard channels
133ratio techniques and the internal standard of Ba incorporated into 
the scintillation counter* All results of quantitation by such 
liquid scintillation counting are expressed as disintegrations per 
minute (d.p.m.) taking account of the channels ratio with an internal 
standard*
GAS LIQUID CHROMATOGRAPHY
The gas chromatographic system employed was a Pye series 104,
Model 84 (W*G. Pye and Co* Ltd*, York St*, Cambridge, England*). To 
determine column separating powers, flame ionisation detection (E.I.D.) 
was used in association with the following gas flow rates 
oxygen-free nitrogen carrier gas - 40 ml per minute, hydrogen - 40 ml 
per minute, air - 700 ml per minute. All gases were supplied by 
the British Oxygen Company Ltd.,-
Electron capture detection (E.C.D.) using a Hi source and a 
pulsating voltage of 150 ps was employed in the final quantitation of 
extracts from urine and plasma. Column details and running conditions 
will be indicated in the text.
The recorder was a Leeds and Horthrup Speedomax ¥ (Leeds and 
Northrup, Ltd., Wharfdale Road, Tyseley, Birmingham, 11, England.) 
and a chart speed of 10 inches per hour was employed throughout the 
investigation. /
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Group Determination of Steroids in Urine 
COLLECTION OF SAMPLES
Complete 24-hour urine collections were made from patients either 
in hospital or at home under parental supervision. Specimens were 
stored at 5^C over chloroform (5 ml) which was added as a preservative. 
All urines were tested with "Clinistix" for reducing substances 
which, if present, were oxidised by incubating the urine samples for 
24 hours with yeast (l g per 20 ml urine).
DETERMINATION OF 17-OXOSTEROIDS IN URINE
After measuring the total urine volume, duplicate 10 ml aliquots 
of undiluted urine were pipetted into boiling tubes of approximately 
30 ml capacity. The tubes were placed, unstoppered, into a vigorously 
boiling water bath and 1 ml of concentrated hydrochloric acid added, 
to each tube. Boiling was continued for 10 minutes to effect 
hydrolysis of conjugated 17-oxosteroids.
The tubes were then cooled rapidly in ice prior to extraction of 
the steroids with 10 ml organic solvent (chloroform). After inversion 
of the tubes 20 times, the upper aqueous layer was aspirated using a 
Pasteur pipette attached to a water pump. The chloroform was 
washed /
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washedvdLHi sodi-um hydroxide (2 ml) and then with deionised water (2 ml). 
Following each wash the aqueous phase was removed by suction. The 
organic phase was filtered through Whatman No, 1 filter paper and 5 ml 
of the filtrate transferred to a 10 ml test tube. Evaporation was 
effected under nitrogen, the tubes standing in a water bath at 
40^0, The 17-oxosteroid content of the dried residue was estimated 
colorimetrically by the Zimmermann reaction.
The Zimmermann Reaction
The James and de Jong (l96l) modification of the Zimmermann 
reaction was employed throughout this study. These authors advocate 
the use of a reaction mixture of 0,5 per cent dinitrobenzene and 
concentrated tétraméthylammonium hydroxide in the proportions 2:1.
The separate reagents were stored at 5 0 until used.
The freshly constituted mixture (0.25 ml) was added to the dried 
urine extracts from the above procedure. Duplicate reagent blank 
tubes and standard tubes containing DHA (lO pg) plus reaction mixture 
were set up with each assay. The tubes were stoppered and incubated 
in the dark at 25*0 for 1 hour (Fig. 9)* Ethanol (50 per cent)(2 ml) 
was pipetted into each tube and the Zimmermann colour extracted into 
diethyl ether (3 ml).
When the phases had separated, the upper ether layer was 
transferred /
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Fig, 9. The increase in optical density of the Zimmermann colour with 
time. Routinely 1 hour at 25"C in the dark was used. The 
reaction mixture consisted of tétraméthylammonium hydroxide 
and dinitrobenzene (l:2^v/v)(0,25 ml) added to the dried 
residue. Standard DHA (lO (ig) was used in the above 
experiment and the Zimmermann positive steroid was extracted 
into diethyl ether from the aqueous phase.
84
transferred by Pasteur pipette to an optical cell of 10 mm light 
path. Optical densities were read at 435, 515 and 595 mp on a 
Unicam SP, 600 spectrophotometer zeroed against ether. To correct 
for interfering chromagens the Allen correction formula (l950) 
was applied to the optical densities at the wavelengths given above. 
The corrected optical density (COD) at 515 mp is given by:- 
CODgig = + OOD ggg
where OOD^^^ is the observed optical density at 515 mp
OOD^^^ is the observed optical density at 435 mp
and the OOD^^^ is the observed optical density at 595 mp.
After subtracting the reagent blank readings from both standard 
and test readings, the microgram equivalents of the test samples 
relative to the standard DHA are calculated and, after adjustment for 
the half volume of chloroform extract taken and for the total daily 
urine volume, the final result is expressed as mg 17-oxosteroids 
per 24 hours. Standard DHA obeys the Beer-Lambert law in the diethyl 
ether phase (Fig, 10),
In Table II typical results from the Zimmermann reaction are 
given. Frequent recovery experiments were undertaken and the recovery
of /
85
UNITS
300
IT)
L O
200
CO
C_3
Q _
CD
CD
CD
15 255 10 20
;jg DHA
Fig. 10. Optical density of the Zimmermann colour for DHA in the
range 5 - 25 |-ig (corrected for reagent blank). Note the 
obedience to the Beer-Lambert law.
86
TABLE II. Recovery rates of DHA from water and urine. The complete 
method of assay for 17-oxosteroids was used.
Extraction was made with 10 ml chloroform.
Aliquot of 5 ml taken for the Zimmermann reaction.
TEST WAVELENGTH (mpi) AC AC-RB PERCENTAGE RECOVERY 
OF DHA435 515 595
031 033 012 012
'
REAGENT BLANK
013 032 007 012
STAITDARD DHA 066 163 065 098
(10 p,g) 088
045 157 065 102
029 032 009 013
WATER 002
023 032 012 015
WATER PLUS DHA 098 197 094 101 ~ |
(20 p.g) 089 99.2
093 193 091 101 -
242 311 132 124 -
URINE (adult) 116
245 323 138 132
URINE PLUS 292 436 177 202 1
DHA 190 84.4
(20 fig) 329 466 200 202
AC - Allen correction (l950). 
RB - Reagent blank.
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of DHA added to water and urine was consistently greater than 80 
per cent. For each patient the estimation of 17“0xosteroids was 
made on duplicate samples of urine* When the results of the 
duplicates differed by plus or minus 5 per cent from the mean the test 
was repeated,
DETERMINATION OP 17-OXOGENIC STEROIDS AND TOTAI. 17-HYDROXY- 
CORTICOSTSROipS I%.,pRINE.
17-oxogenic steroids and total 17-hydroxycorticosteroids were 
estimated only when sufficient urine was available.
Estimation of urinary 17-oxogenic steroids was by Brooks and 
Norymberski's method (l952, 1953) hnt using sodium metaperiodate (Pew, 
1961) rather than sodium bismuthate. This method is essentially 
the oxidative procedure advocated by the M.R.C. Clinical Endocrinology 
Committee in 1969 and estimates the 17,20-dihydroxy-21-deoxysteroid8 
(c), and the 17;20;21-trihydroxysteroids (d) (Pig, 11), The 
17-oxosteroids (e) are simultaneously measured in the estimation of 
the 17-oxogenic steroids. Correction for true 17-oxogenic 
steroid levels is made by subtraction of the 17-oxosteroid concentration 
determined prior to oxidation.
This method does not estimate the 17,21-dihydroxy-20-oxosteroids 
(b) or the 17-hydroxy-20-oxo-21-deoxysteroid8 the latter being increased 
in the urine when 21-hydroxylation is defective 
(e.g. /
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(e.g. congenital adrenal hyperplasia). Treatment of these two 
compounds with sodium borohydride results in reduction of the C20 
ketonic group to a secondary alcohol which after oxidation can then 
be estimated a8 lY-oxosteroids by the Zimmermann reaction (Appleby 
et al* 1955).
Thus, if a urine specimen is firstly reduced by sodium borohydride 
and subsequently oxidised with sodium metaperiodate the resulting 
17-oxosteroids will be derived from the 17~oxogenic steroids and the 
17-hydroxy-20-oxo-21"deoxysteroid8 which together are regarded as the 
total 17-hydroxycorticosteroids or tptal^  17-oxogenic steroids 
(m .R.C* Clinical Endocrinology Committee, 1963), Throughout this 
thesis however iotal. 17“hydroxycorticosteroids will be used to refer to 
glucocorticosteroids with these characteristics. Bative 17-oxosteroids 
are reduced to alcohols by this regime and so do not interfere with 
total 17“hydroxycorticosteroid estimations. In health urinary 
17-oxogenic steroid levels should approximate those of the total 
17-"hydroxycorticosteroids •
Estimation of the total 17-hydroxvcorticosteroids
Two aliquots of urine (lO ml) were pipetted into separate 30 ml 
boiling tubes and adjusted to pH7 with 25 per cent acetic acid or 2 N 
sodium /
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sodium hydroxide as necessary. Sodium borohydride (200 rag) was 
added to each tube and reduction was allowed to proceed overnight or 
for a minimum of 2 hours. The reaction was stopped with 25 per cent 
acetic acid (0.5 ml) and the samples were again neutralised.
Oxidation was effected by incubating the urine samples at 37°C 
with freshly prepared 10 per cent (wt/v) sodium metaperiodate (4 ml) 
and 15 sodium hydroxide (l ml). After 1 hour formates were 
hydrolysed by the addition of 2.55 sodium hydroxide (l ml) and incubation 
was continued for a further 15 minutes.
After cooling, chloroform (lO ml) was added to each tube and the 
steroids extracted into the organic phase by inverting the stoppered 
tubes twenty times. When the phases had separated the upper
aqueous phase was removed by suction. The chloroform was washed 
with 5 per cent sodium hydroxide (5 ml) containing 2.5 per cent (wt/v) 
of sodium dithionate. The upper aqueous phase was once more removed
by suction and the organic phase filtered through Whatman No. 1 filter 
paper. Aliquots of 5 ml were taken from each tube and evaporated to 
dryness in a water bath at 40^0 under a stream of nitrogen.
The residues were subjected to the Zimmermann reaction and the 
17-oxosteroids produced by reduction and oxidation were estimated 
against /
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against standard dehydroepiandrosterone (lO pg). After adjustment 
for the 5 ml aliquot of chloroform taken and for the total urine volume, 
results were expressed as mg total 17-hydroxycortioosteroids per 
24 hours. Recovery of 17«-hydroxyprogesterone added initially to 
urine samples was of the order of 78 per cent (fable III).
Estimation of the 17-oxogenic Steroids.
17-oxogenic steroids in duplicate 10 ml samples of urine were 
oxidised to 17-oxosteroids by the oxidative procedure described above. 
Quantitation was by the Zimmermann colorimetric method and results 
expressed as mg 17-oxogenic steroids per 24 hours.
Occasional interference with 17-oxogenic steroid estimations 
occurred due to a yellow complex being formed with the Zimmermann 
reagents. Most patients with cystic fibrosis are currently on full 
therapeutic doses of cloxacillin (3-o-chlorophenyl-5-methyl"-4-isoxazolyl 
penicillin sodium salt monohydrate) as prophylaxis. Interference 
due to cloxacillin therapy was reported by Metcalf (196?) when she 
estimated gross 17-oxogenic steroid levels in patients taking this 
antibiotic. This falsely high result was attributed to a substance 
excreted in the urine which mimicked 17-oxogenic steroids by giving 
a purple complex with alkaline m-dinitrobenzene. When such interference 
was /
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TABLE III. Recovery of 17a-hydroxyprogesterone from adult urine. After 
reduction and oxidation the Zimmermann reaction was used.
TEST
WAVELENGTH (mp)
435 515 595
AC AC-RB PERCENTAGERECOVERY
REAGENT BLANK
STANDARD DHA 
(15 pg)
URINE (ADULT)
URINE PLUS
17a-HYDR0XI-
PROGESTERONE*
(20 pg)
014 020 007
013 020 007
135 332 128
147 342 137
279 678 381
283 681 389
276 733 309
273 739 314
010
010
201
200
348
345
441
446
190.5
336.5
435 78
AC “ Allen correction (l950).
RB - Reagent blank.
* - Correction for possible chromûgenicity differences (between
androstenedione and DHA) was not made.
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was experienced during this investigation (in urine from 9 patients) 
quantitation of the 17-oxogenic steroids was not made.
Estimation of Dehydroepiandrosterone in Urine
Since DHA is excreted mainly as the sulphate or glucuronoside 
ester, an efficient hydrolysis or solvolysis procedure is 
required to liberate the parent steroid*
EVALUATION OF HYDROLYSIS MTHODS
The following schema was devised to test the efficiency of 
enzymatic hydrolysis and solvolysis of dehydroepiandrosterone sulphate 
(Fig, 12). Urine samples (50 ml) were adjusted to pH .6.2 with sulphuric 
acid (40 per cent), sulphatase from Helix pomatia was then added 
(1,000 u per ml) and hydrolysis effected at 37^0 for 24 hours.
Extraction of the free DHA was made with ether (3 x 20 ml). The 
urine was then adjusted to pH 4.5 with sulphuric acid (40 per cent), 
p-glucuronidase was then added (1,000 P.u, per ml) and the hydrolysis 
allowed to proceed for 24 hours at 37 C, Free steroids were extracted 
with ether as before. The same urine aliquot was brought to pH 1 
and solvolysis effected according to Burstein and Lieberman (l958), 
Sodium chloride (lO g) was added to the acidified urine and ethyl 
acetate (50 ml) layered onto the aqueous phase. Following rigorous 
shaking /
Helix pomatia 
SULPHATASE - 
lOOOu/ml
Patella vulgata 
9-GLUCURONIDASE 
IGOGFu/ml
SOLVOLYSIS
URINEf-
ETH
■>
7a-^H-DHAS
pH 6-2
ER EXTRACT I
pH 4*5
ETHER EXTRACTION
■> pH
ETHYL ACETATE EXTRACTION —
94
% OF ORIGINAL 
d.p.m.'s 
RECOVERED
>  26-3
>  23*9
>21 ^
OVERALL RECOVERY 83-7
Fig, 12, Flow diagram for the extraction of total D M  (free, 
glucuronoside and sulphate) from urine.
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shaking, the mixture was incubated at 37^C for 24 hours and two further
extractions with ethyl acetate (20 ml) were subsequently made. The
r 3overall recovery of 7o- H DHAS added initially to the urine was 
83.7 per cent.
Commercially available sulphatase used under these circumstances 
did not afford complete hydrolysis of DHAS, Only 26.3 per cent of the
original 7a-^H
la-\ DHA from ^HDHAS after
DÎÏAS was recovered in the ether extract. Moreover 
p-glucuronidase prepared in this laboratory contains some sulphatase 
activity (23,9 per cent of radioactivity was recovered following this 
hydrolytic procedure).
However, hot hydrolysis at neutral pH as described by Fotherby 
(1959) was found to give good yields of 
benzene extraction (73 per cent)(p.160|. This method, used 
throughout this investigation, has not had a widespread clinical application 
which may in part be due to its specificity for A5“3p-hydroxysteroid 
sulphates.
Glucuronoside conjugates were hydrolysed enzymatically with 
p“glucuronidase. Sulphatase, found to be present in this preparation,
was inhibited by potassium dihydrogen phosphate (Kellie and Wade, 1957),
A flow diagram indicating these hydrolytic procedures, subsequent 
purification and quantitation is shown in Fig. 13*
METHOD /
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URINARY DHAS
50-100ml ÜRINL
0*045uCi
7a^HDHAS
HYDROLYSIS 
BOILING FOR 6hrs,
\/
BENZENE EXTRACTION
URINARY DHAG
50-100ml URINE
0-045)iCi
7a-^H-0Hi
ENZYMATIC HYDROLYSIS pH 4-5 
lOOOFu p-glucunonidase/ml 
BOOOOu Penicillin 
INCUBATE at 37’C for 24hrs.
4^
CHLOROFORM EXTRACTION
ALUMINA
TLC
BENZENE/ETHYL ACETATE (6:4,v/v)
TLC
CYCLOHEXANE/ETHYL ACETATE (I:I,v/v)
_  POP SCINTILLATION 
0 COUNTING
k-
GLC
STANDARD TESTOSTERONE 
DI-HEPTAFLUOROBUTYRATE
HEPTAFLUOROBUTYRIC
< -------- ANHYDRIDE/BENZENE
/
(1:1,v/v) 70"C/30mins.
Fig, 13$ Flow diagram of procedures used in the estimation of urinary 
DBA (sulphate and glucuronoside esters).
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METHOD FOR THE ESTIMATION OF ÜRIUARY DBHYDROEPIAMIiROSTKROm 
SULPHATE (di-IAS ).
Dehydroepiandrosterone sulphate in two aliquots of urine 
(50 - 100 ml) from each 24-hour collection was hydrolysed according 
to the method of Fotherhy (l959)* To each urine sample 0,045 
p. Ci 7a- H DHAS (S,A. 290 mCi/raM) was added to act as an internal 
standard for recovery estimations. Hydrolysis was effected by placing 
the aliquots of urine, without pH adjustment, in boiling water for 
6 hours (Fig, I4), A condenser was fitted to each flask. After 
cooling in ice, the free steroid (DHA) was extracted twice with benzene 
(20 ml) and the benzene extract washed once with deionised water 
(20 ml). The extract was reduced to small volume by evaporation in 
a water bath at 40^0 under a stream of oxygen-free nitrogen and then 
introduced quantitatively with benzene (total 10 ml) onto an alumina 
column (6 cm x 0.5 cm I.D,:l,7è aluminium oxide). The benzene 
fraction was discarded and steroids eluted with 0,3 per cent ethanol in 
benzene. After reduction to small volume the eluate was applied to a 
silica gel plate and the chromatogram developed twice ( 1 hour each run) 
in benzene:ethyl acetate (6:4»v/v), Dehydroepiandrosterone 
was located using the Panax radiochromatogram scanner. Silica in
the area corresponding to the radioactive peak was taken up by suction onto 
the sintered glass disc within the extraction thimble. Elution
of /
7a-?H
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Fig. 14. Apparatus used in the hydrolysis of dehydroepiandrosterone 
sulphate in urine samples (Potherby, 1959).
Urine samples in round-bottomed flasks are placed under 
condensers in a boiling water bath for 6 hours.
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of steroid from the silica was effected with ethyl acetate (3 x 2 ml) 
by inverting the extraction thimble and allowing the solvent to percolate 
through the silica and sintered glass disc into a pear-shaped flask.
After blowing to dryness, the residue was dried completely in a vacuum 
desiccator for 1 hour and thereafter esterified with dried benzene 
and heptafluorobutyric anhydride (equal parts, 25 fJ-l). The reaction 
mixture was heated at 70*0 for 30 minutes according to the method of
Exley and Chamberlain (1967)* Excess reagent was removed under a
0
stream of nitrogen at 40 C. Samples were further purified by 
t.l.c, in the solvent system cyclohexaneîethyl acetate (l;l,v/v).
Prior to quantitation by g.l.c., an aliquot of each sample was taken for 
radioactive counting by liquid scintillation. Standard testosterone 
di-heptafluorobutyrate was injected into the g.l.c. column along with each 
sample. The column employed for quantitation was a 9 foot coiled 
hybrid column comprising 2 feet of 1 per cent SE 30 (Silicone Cum 
Rubber E - Applied Science Laboratories, Inc., P.O. Box 440, State 
College, Pennsylvania, U.S.A.) on Gas Chrom Q, mesh-size IOO/12O,
(Applied Science Laboratories) and 7 feet of 1 per cent NGSebacate 
(heopentyl Glycol Sebaoate - Phase Separations Ltd., Deeside Industrial 
Estate, Queensferry, Flintshire, Wales) on Gas Chrom Q. Injection 
was made with an S.G.E. 10 pi syringe having an 11.5 cm needle (Scientific 
Glass /
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Glass Engineering Pty Ltd., 657 North Circular Road, London, England). 
Final quantitation was hy electron capture detection. The nitrogen 
carrier gas flow was 40 ml per minute. The column oven temperature
o o
was 180 C and the detector oven temperature 230 C.
Evaluation of the Fotherby Method for DHAS Hydrolysis.
To test the efficiency of hydrolysis by the Fotherby method (l959) 
for A^-3p-hydroxysteroid sulphates, recovery of DHAS (20 pg) added to a 
series of flasks containing water (50 ml) was estimated under exactly 
similar conditions over a period of 6 hours bôiling. Following 
extraction with benzene ( 2 x 20 ml), the organic phase was blown dry 
and the residue subjected to the Zimmermann reaction. Percentage 
recoveries are seen in Fig. 15, It will be seen that hydrolysis 
proceeded rapidly for the first two hours followed by a slowing down to 
give maximum recoveries of 84 per cent after 5 hours boiling. In 
practise, cohorts of 6 flasks were placed under condensers in a water 
bath controlled by a time switch. A preheating time of 1 hour was
allowed for the water to reach boiling point and 6 hours allowed for the
hydrolytic action. The system was timed to start at 02.00 hours so 
that extraction could be effected at 09.00 hours.
Because of the lack of specificity of the Zimmermann reaction for
' DHA, g.l.c. analysis of the hydrolysate was undertaken. Further 
aliquots of /
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FiK. 15» Percentage recovery of dehydroepiandrosterone from
dehydroepiandrosterone sulphate introduced into 50 ml aliquots 
of water and subjected to boiling (Fotherby, 1959). Recovery 
from three samples at each time interval was undertaken.
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of DtlAS (20 jJLg) and DiiA (20 |ig) in water (50 ml) were taken through the
method. The dried residues were treated with dry benzene (25 p,l)
and heptafluorobutyric anhydride (25 pi) for 30 minutes at 70°C (p. 120),
Excess reagents were removed under nitrogen and the ester taken into
solution in benzene:ethyl acetate (9:1, v/v) (2 ml) for g.l.c.
quantitation. Each sample gave a single peak corresponding in
retention time to standard DHA heptafluorobutyrate (DHA HPB) (Figs. 16
and 17). Comparison of peak heights with that of standard DHA HPB
indicated a 100 per cent recovery of the D M  added initially to water
and an 83 per cent recovery of DHAS. Recovery of DHAS from water
3correlated well with recovery of H-DHAS added to each urine sample
(73 per cent) (Table XV).
Duplicate samples of dehydroepiandrosterone glucuronoside (DMC)
(20 pg) and androsterone sulphate (20 pg) in water (50 ml) were also
submitted to the hydrolytic procedure in order to determine the stability
of the osidic linkage at boiling point and to assert the specificity
5of the method for A -3p-hydroxysteroid sulphates. Following
extraction with benzene (2 x 20 ml) and washing with deionised water
(20 ml), the Zimmermann reaction was applied to the dried steroid
residue. No Zimmermann positive compounds were obtained. Thus the
5method is specific for A -3p-hydroxysteroid sulphates and is reliable 
for the estimation of DHAS.
HYDROLYSIS /
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l - 5u l  REACTION MIXTURE 
«PTAFLUOROBUTYRIC XNHYDRIOE./BENZENE 
( I  : l  .v / v )
a f
IP
l - 5u1 STANDARD MIXTURE 
0 5ng TESTOSTERONE DI-HEPTAFLUOROBUTYRATE 
lOng DHA HEPTAFLUOROBUTYRATE
DHA
PEAK lEIGHT 
3-05c is
IP
2Qfiq DHAS HYSROlfSED,EXTRACTED AND DERIVATISED 
I - b l  OF 200^ )  DILUTION INJECTED
DHA
€AK CIGHT 
2 35cm#
Fig. 16. (i.l.c. evaluation of the efficiency of the Fotherby
hydrolytic procedure for DHAS (20 ug) in water (50 ml).
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Explanation of Fig. 16.
(a) The reaction mixture does not produce a peak in the region of 
DHA HFB,
10 ng of standard DHA HPB gives a peak of 5*05 cm (b).
Given that 20 pg DHAS = 13.5 pg DHA
and assuming 100 per cent recovery of DHA from DHAS after boiling extract­
ion and estérification
then in 2,000 pi of diluent there should be 13.5 pg DHA 
and 2 pi of diluent should contain 13,5 ng DHA.
But 1.5 pi of the sample gives a peak height of 2.55 cm (c).
Therefore 1.5 pi of the sample contains 8*36 ng DHA.
Thus the recovery of DHA by the Fotherby hydrolysis of DHAS is 
82.52 per cent.
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2m 1 s t a n o a r o  m i x t u r e
Ing TESTOSTERONE DI-HEPTAFLUOROBUTYRATE 
lOng DHA HEPTAFLUOROBUTYRATE
OHft
2(^g:DHA HYDROLYSED,EXTRACTED AND DERIVATISED 
! ^ 1  DF 200Q j 1 DILUTION INJECTED
PEAK HEIGHT 
3'5cms
Fip. 17» ".I.e. evaluation of DHA subjected to the Fotherby
hydrolytic procedure.
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Explanation of Fig» 17.
20 fxg of DHA in 50 ml of water was boiled, extracted 
and esterified*
Assuming a 100 per cent recovery
Then in 2,000 pi of diluent there would be 20 pg DHA
and 2 pi of diluent should contain 20 ng DM*
10 ng of standard D M  gives a peak height of 1.75 cm (a) 
2 pi of sample gives a peak height of 5.5 cm (b).
Therefore 2 pi of sample contains 20 ng DM.
The recovery of free D M  after boiling according to the 
Fotherby method (l959) is 100 per cent.
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HTDROLYSIS OF URINARY DEHYDROEPIAm)ROSTERQHE 
GLUGimONOSIDE (DHAG).
The hydrolysis of DHAG in urine (50 - 100 ml) was effected at 
pH 4.5 by incubation with p-glucuronidase (l,000 F,u. per ml urine) 
for 24 hours at 57*0. The pH was maintained by the addition of 
0*2 M acetate buffer (11.57 ë sodium acetate and 7.5 ml glacial 
acetic acid in X 1 deionised water)(V|q vol.). Penicillin (80,000 
units) was added to prevent bacterial growth and potassium dihydrogen 
phosphate (200 mg) used to inhibit sulphatase activity in the enzyme 
preparation (Kellie and Wade, 1957). Extraction of free DHA 
was made with chloroform (5 % 20 ml). The organic phase was 
washed successively with 0.1 H sodium hydroxide ( V 2Q vol.) and
deionised water ( V 20 vol.) and was then dried by filtration through
3
anhydrous sodium sulphate. Recovery of H-DHA added initially to 
urine samples indicated that recovery of free DHA at this stage was 
72 per cent. Thereafter samples were chromatographed as for the 
sulphate fraction.
Evaluation of the Glucuronoside Hydrolysis Method.
The potency of p-glucuronidase used throughout this study was 
estimated /
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estimated using phenolphthalein glucuronoside as substrate (p* 74).
The enzyme preparation was also known to have some sulphatase 
activity (Fig. 12). The addition of potassium dihydrogen phosphate 
(200 mg) to the incubation mixture inhibited hydrolysis of ^H-DHAS 
(Fig. 18). The hydrolytic potential of the p-glucuronidase 
preparation in the presence of potassium dihydrogen phosphate was 
again tested against phenolphthalein glucuronoside. There was a 
significant inhibition of p-glucuronidase activity. The potency of 
the enzyme preparation was reduced from 104,500 Fishman units per gram 
to 55,805 Fishman units per gram.
Of the 17-oxosteroids excreted by a normal adult male, 84 per cent 
are conjugated with glucuronic acid (Loras et al., 1966). Normal 
excretion of 17-oxosteroids for this group is within the range of 
6 mg to 25 mg per 24 hours (Mason and Sngstrom, 1950).
It was therefore judged that 150 pg DHAG added to 50 ml aliquots 
of water was in excess of 17-oxosteroid glucuronoside levels likely 
to be encountered in the urine of children, A series of 12 
such flasks were incubated for 24 hours with varying amounts of 
p-glucuronidase (in the absence of potassium dihydrogen phosphate).
As will be seen from Fig, 19, maximum recoveries of DHA were achieved 
using more than 20,000 F.u. of p-glucuronidase per 50 ml. (4OO F.u. 
per ml). In practice 1,000 F.u. per ml were employed for 
the /
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^H-DHAS INCUBATED WITH P -G L UC URONIDASE (1000 F.u./ml) 
AND VARYING AMOUNTS OF KH ^PO^ IN 50ml OF WATER 
FOR 24hrs AT 37*C 
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Fi&, 18, The sulphatase-inhibiting effects of potassium dihydrogen 
phosphate on p-glucuronidase powder.
^ Partitioning h-PHAS between water and chloroform 
resulted in 3*3 per cent of the radioactivity being 
recovered from the organic phase.
108
100 200 30 0 4 0 0  5 0 0 6 0 0 9 0 0  10 007 0 0  8 0 0
F.u. p-glucuronidase per ml of water
The recovery of DHA from DHAG (l50 |ig) added to aliquots 
of water (50 ml) and incubated with varying concentrations 
of p-glucuronidase for 24 hours at 37“C, Assay was by 
the Zimmermann reaction.
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the hydrolysis of urine samples* Thus even although enzyme 
activity is reduced by 53«4 per cent in the presence of potassium 
dihydrogen phosphate, the quantity added to urine samples is still 
in excess of the hydrolytic activity required.
EXTRACT PURIFICATION BY COLUM CHROMATOGRAPHY
Following hydrolysis, urine extracts were applied to alumina 
columns and the steroid (DHA) eluted with 0*3 per cent ethanol in 
benzene (v/v).
3The properties of the column were tested by introducing H-DHA 
in benzene onto the alumina and eluting it with 20 ml, 40 ml and 
20 ml of the above solvent. The eluate was collected in 10 ml 
aliquots and the radioactivity recovered (d.p.m.'s) in each sample 
was calculated from liquid scintillation spectrophotometric counting* 
The overall recovery from the column was 96.1 per cent and 95 per 
cent of the introduced radioactivity was recovered from the second, 
third and fourth aliquots (Fig. 20).
The standard principal 17“Oxosteroids were applied to and eluted 
from the column using the same techniques. The Zimmermann reaction 
was performed on the dried residue in each of the 10 ml aliquots of 
eluate. Those aliquots giving a Zimmermann positive reaction are 
shown /
I .
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♦SOLVENT INTRODUCED ONTO ALUMINA COLUMN 
IN 20ml:40ml:20ml VOLUMES
OF d .p .m ls
OVERALL RECOVERY- 
96-1%
I 2 3 4 5 6 7 8 *
ALIQUOTS OF 10ml OF ELUATE
LxJ
I'
10
Fig* 20. Recovery of la-\ dehydroepiandrosterone from a Fotherby-type 
column (6 cm x 0.5 cm I.D.) containing 1.7 g aluminium oxide. 
Eight 10 ml aliquots of mobile phase (0.3 per cent ethanol 
in benzene) were collected.
Ill
3shown in Table IV. The retention of H-T was also determined by 
submitting the 10 ml aliquots to liquid scintillation counting.
It will be seen from Table IV that androsterone, aetiocholanolone 
and testosterone are also eluted with the DHA.
Urine extracts were applied to the column and 0.3 per cent 
ethanol in benzene (v/v) was introduced in two fractions (20 ml 
followed by 40 ml). The salient 30 ml aliquot (representing the 
second, third and fourth 10 ml aliquots) was collected and reduced to 
small volume pending further purification by t.l.c..
THIH LAYER CHROMATOGRAPHY OF FREE STEROIDS
Residues were taken up in ethyl acetate (6 x 10 pi) and transferred 
to silica gel plates using micro-capillary pipettes. Each sample 
was applied as a spot 2 cm from the edge of the t.l.c. plate. The
chromatogram was developed in the solvent system benzene:ethyl 
acetate (6:4, v/v) for two 1 hour periods, allowing the plate to 
dry between runs*
After spraying the plates with 0.1 per cent Rhodamine 6 G in 
ethanol, cold standards, developed in the above manner,were visualised 
under U.V. light. The resolution of the system was related to 
standard testosterone and characteristic running times are given in 
Table V.
Since /
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TABLE IV. Retention of some C19 steroids on an aliminium oxide 
column (6 x 0*5 cm I.D.; 1*7 g alumina)*
Solvent (0*5 %  EtOH in Benzene) 20 ml 40 ml
ALIQUOTS (10 ml) 1 2 3 4 5 6
BEHYDROEPIANDROSTERONS + 4~ 4- - —
AUDROSTERONE “ 4- 4- 4- 4- -,
AETIOCEOEANOLONB 4* 4- 4- 4* 4-
*11-0X0-AETI0CH0LAM0L0NE - — — 4* 4-
TESTOSTERONE — 4- 4* 4* 4* 4*
* AS REPRESENTATIVE OP THE 11~0XY»17“0X0STER0IDS•
Solvent (0*5 per cent ethanol in benzene) was applied as 20 ml 
followed by 40 ml*
10 ml aliquots of eluate were collected.
Zimmermann positivity in aliquots are indicated thus:- +,
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TABLE 7 . Separation of steroids by t.l.o* in benzene;ethyl 
acetate (6:4, v/v).
DEVELOPMENT 2 x 1  HOUR 
* s - TESTOSTERONE
ll-OXO-AETIOCHOLAHOLOKE
FREE STEROID R VALUE * 
s
PRBONANETRIOL 0.15
PREONANEDXOL 0.56
11p-HYDROXIAETIOCHOLANOLONE 0.56
11-KETOAETIOCHOLANOLONE 0.57
11 p-HYDROXYANDROSTERONE 0.71
ll-ÎŒTOANDROSTEROM ++ 0.71
TESTOSTERONE 1.00
ITcc-HYDROXYPREGNENOLONE 1.14
17a-HYDROXYPROGESTERONE 1.28
EPIANDROSTERONE 1.31
DEHYDROEPIANDROSTERONE 1.36
ANDROSTERONE 1.43
AETIOCHOLANOLONE 1.47
PREGNENOLONE 1.52
ANDROSTENEDIONE 1.54
PROGESTERONE 1.77
++ ll-OXO-AroROSTEROME
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PANAK RADIXHRÛNAIOGRW SCANS 
RANGE 3 c .p .s .
TINE CONSTANT 100 s tc s .  
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Fig. 21. Separation of DHA from testosterone in benzene:ethyl
acetate (6:4, v/v). The position of standards sprayed with
Rhodamine 6 G and visualised under U.V. light correlates well
3 3with H-DHA and 'H-T located by radiochromatogram scanning.
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Since radioactivity had initially been added to each urine
sample, t.l.o. plates carrying urine extracts were scanned and the
3area corresponding to the radioactive peak of H-DHA was removed and 
eluted* The t.l.c. system used-gives good separation of DHA and 
testosterone (Fig* 2l)* Thus testosterone heptafluorobutyrate 
may be employed as a standard for g.l.c* estimations since testosterone 
native to urine samples is removed during this purification step*
ESTERIFICATION OF STEROIDS
The low levels of steroids in childrens' urine and plasma 
demand sensitive methods of detection* Electron capture detection 
of steroid derivatives with a high electron affinity allows nanogram 
(ng) and picogram (pg) quantities to be detected (Sxley, 1966).
The heptafluorobutyrate esters, first used by Clark and ¥otiz (l963), 
have strong electron capturing characteristics due to the introduction 
of 7 fluorine atoms into the steroid molecule. Urine extracts and 
steroid standards were therefore treated with heptafluorobutyric 
anhydride according to the method of Exley and Chamberlain (1967).
butyrate (PHA HFB).
Dehydroepiandrosterone (l mg) was esterified with dry benzene (50 pi) 
and /
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and heptafluorobutyric anhydride (50 pi) for 30 minutes at 70*0. Excess
reagent was removed at 40*0 under a stream of nitrogen. A small
amount of ^H-DHA (10,000 d.p.m.'s:S.A. 290 mCi per mM) was added
3to the standard prior to estérification. Partitioning H-DHA between 
70 per cent methanol in water and n-hexane (l:l, v/v) resulted in a 
quantitative recovery of radioactivity from the methanol phase.
However, following estérification and partition between the above 
solvents, a near quantitative yield (99.9 per cent) of radioactivity 
was recovered from the hexane fraction. These results indicate 
quantitative estérification of the 3p-hydroxysteroid.
The hexane fraction was reduced to small volume and applied to a 
t.l.c. plate. This was then developed in cyclohexane; ethyl acetate 
(l:l, v/v) for 1 hour. Following radiochromatogram scanning and 
elution of the appropriate area, 99 per cent recoveries of radioactivity 
were consistently achieved. Subsequent dilution in benzene:ethyl 
acetate (9:1? v/v) was made to standard concentration thus giving 
stock solutions of 1 pg per 1 pi (for F.I.D.) and 10 ng per 1 pi 
(for E.G.D.). Gas liquid chromatography of standards esterified in 
this way gave a single peak (Fig. 22) (p.118).
Preparation of Standard TestosteroneM-heptafluorobutyrate.
Testosterone /
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Testosterone heptafluorobutyrate was prepared under exactly
similar conditions as DHA HFB* Subsequent partition, as previously,
3resulted in 94.6 per cent of the initially added H-T being recovered 
from the hexane phase (i.e. 94.6 per cent estérification had been 
effected).
Estérification of testosterone may occur at C17 and at 03.
The products of the above estérification method are the 17 mono- 
heptafluorobutyrate and the 3,17 di-heptafluorobutyrate. This 
latter derivative reputedly decomposes when dry on silica gel to form 
stable 17 mono-heptafluorobutyrate. Following partition, the residue 
from the hexane phase was applied to a t.l.c. plate in benzene:ethyl 
acetate (9:1, v/v) (6 x 10 pi) and the chromatogram developed in 
benzene.:ethyl acetate (4:1, v/v) before the application solvent had 
dried. A two-dimensional development consisting of two 45 minute 
runs was made. At no time was the t.l.c. plate allowed to dry.
Fig. 23 indicates the location of H.V. absorbing steroids. The 
least polar U.V. region (testosterone di-heptafluorobutyrate) 
was scraped from the plate and eluted with benzene:ethyl acetate 
(9:1, v/v) (3 X 2 ml) and acetone (3 x 2 ml). An aliquot, taken for 
liquid scintillation counting, indicated percentage conversion to the 
di-ester. A conversion of 72 per cent of testosterone to testosterone 
di-heptafluorobutyrate may be achieved by this method. According 
to /
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I Ong DEHYDROEPIANDROSTERONE 3-HEPTAFLUOROBUTYRATE
IP,
Fig, 22, Tracing obtained on gas liquid chromatography of standard
dehydroepiandrosterone heptafluorobutyrate after purification 
by t.l.c..
119
DIRECTION OF SOLVENT FLOW 
(SECOND DEVELOPMENT)
CO
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-SOLVENT FRONT
_I
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LU "—"etc
CD oo O ■TESTOSTERONEOR 101
Pig. 23* Two dimensional t.l.c. separation of testosterone
heptafluorobutyrates in ben%ene:ethyl acetate (4:1, v/v). 
Development for 2 x 45 minutes.
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to recoveries, dilutions were made of 1 pg per 1 pi (for F.I.D.) 
and 1 pg per 1 pi (for EUC.D.). Prior to t.l.c* purification, 
g.l.c. analysis of the esterified residue indicated two products of 
heptafluorobutyrate derivatisation (testosterone mono- and di- 
heptafluorobutyrates). After t.l.c., a single peak (testosterone
di-heptafluorobutyrate) was recorded on g.l.c. analysis (Pig. 24),
Estérification of urine extracts
Residues obtained from t.l.c. plates developed in benzene:
ethyl acetate (6:4, v/v) were dried in a vacuum desiccator for 1
hour. Estérification was by reaction with dry benzene (25 pi) and
heptafluorobutyric anhydride (25 pi) at 70 “ C for 30 minutes.
Derivatives were further purified by t.l.c* in the solvent system
cyclohexane:ethyl acetate (l:l, v/v) for 1 hour. Running times of
standard free and esterified steroids relative to the solvent front
are given in Table VI. Plates carrying urine samples were
%
scanned and the area of the peak of esterified H-DHA (corresponding 
in R^ with that of standard DHA ID?b ) was eluted with benzene:ethyl 
acetate (9:1, v/v) (3 x 2 ml) and then acetone (3 x 2 ml).
GAS LIQ.UID CHROMATOGRAPHY
5
Whereas Potherby’s hydrolysis method is specific for A -3p~ 
hydroxysteroid sulphates, hydrolysis by p-glucuronidase lacks 
comparable /
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In g  TESTOSTERONE HEPTAFLUOROBUTYRATE (EXLEY AND CHAMBERLAIN,1 9 6 7 )
2 PEAKS INDICATE FORMATION OF TESTOSTERONE 3 , 17-DI-HEPTAFLUOROBUTYRATE 
AND TESTOSTERONE I7-MONO-HEPTAFLUOROBUTYRATE
In g  TESTOSTERONE 3 , 17 - 0 1-HEPTAFLUOROBUTYRATE 
FOLLOWING TLC SEPARATION OF DERIVATIVES
I !
IP
Fig. 24. G.l.c. analysis of testosterone heptafluorobutyrates prior 
to t.l.c. (a) and of testosterone di-heptafluorobutyrate 
after a two-dimensional t.l.c. separation in benzene: 
ethyl acetate (4:1, v/v) (b).
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TABLE VI. Separation of standard steroids (free and heptafluorobutyrate 
derivatives) in cyclohexane: ethyl acetate (l:l, v/v).
FREE STEROID
DEHYDROEPIANDROSTEROLîE
AFDROSTERORE
AETIOCHOLANOLORE
EPIARDROSTSRORE
ITa-EIDROXYPROGESTERGNE
TESTOSTERONE
%f
REPTAFLUOROBUTYRATE 
DERIVATIVE (HPB)
%f
0,27 3P-HYDR0XYL HPB 0.53
0.28 3ot-HYDROXYL HPB 0.51
0.31 3a-HYDR0XYL HPB 0.55
0,25 3P-RYDR0XYL HPB 0,47
0.19
0.19 3-ENOL, 17-HYDROXYL HPB 0.44
17P-HYDR0XYL HPB 0.20
Development for 1 hour (single run)
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comparable specificity. Moreover, the t.l.c. systems described do not
afford complete separation of either free androsterone, 
aetiocholanolone and DHA or of their heptafluorobutyrate esters 
(Tables V and Vl). Liquid phase and operating conditions for g.l.c. 
were thus selected with a view to separating these 17-oxosteroids. An
internal standard, which was not endogenous to the sample, was also 
required for g.l.c. analyses.
Haahti et al. (1961) reported that androsterone, aetiocholanolone 
and DHA could be separated by the use of two columns: one of methyl
silicone polymer (SE 30) and the other of neopentyl glycol succinate 
(NGS). a 9 foot hybrid column incorporating these two phases 
proved to be successful in separating these three compounds (Prof.
K. Griffiths - personal communication). Minor modifications to this 
column are stated below.
Preliminary silanisation of the column
Prior to packing, the empty glass column (6 mm X.,D.) was 
rinsed with concentrated hydrochloric acid, washed with deionised 
water and silanised with 5 per cent (v/v) dimethyldichlorosilane in 
toluene for 15 minutes. The column was ready for packing after a 
methanol wash and thorough drying.
Coating /
124
Coating the Support with Li
G-as ChroiQ Q, 100 - 120 mesh, was used as the support. The 
packing of SE 30 was prepared by dissolving the phase (0.5 g) in 
toluene (lOO ml) (i.e. 0.5 per cent solution of SE 30, wt/v). Likewise 
a 0.5 per cent solution of NC8 was prepared by dissolving the phase 
(0*5 g) in chloroform (lOO ml). The relationship between concentration 
of phase in solution to percentage coating was that suggested by 
Dr. T. Simpson of Torry Research Station, Aberdeen. A 0.5 per cent 
solution of phase was routinely used to give a 1 per cent coating of 
support. Each phase was applied to 15 g of support by the filtration 
method. The phase was slowly introduced to the support in vacuo 
and the coating process aided by a constant swirling of the mixture.
Once the vacuum was broken, the round-bottomed flask containing the 
mixture was quickly inverted over a Buchner filter and suction 
applied by a water pump. In this way the solvent drained evenly 
through the bed of the support which was then gently transferred, 
without washing, onto a 200 mm diameter watch glass. The coated 
support was allowed to dry at room temperature.
Packing and Conditioning the Column
Packing the column was aided by suction from an oil pump applied
to /
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to the detector-end of the column and hy the use of a hand-vibrator 
(phase Separations Ltd.). The first 2 feet of the column was 
packed with 1 per cent SE 30. This phase has a higher maximum 
operating temperature than NGS and so was conditioned before packing 
with RGS. A slow flow of nitrogen carrier gas (oxygen-free) was
maintained through the column as the temperature of the column oven was 
raised slowly to 220^0. Conditioning at this temperature was allowed 
to continue overnight. In this way excess phase was "bled" from the 
column. When the remaining 7 feet of the column had been packed with
1 per cent NGS a silanised glass wool plug was inserted into the 
injection end of the column and conditioning carried out again utilising 
a slow carrier gas flow rate but at the lower temperature of 200°C.
The carrier gas flow rate was increased slowly to 40 ml per minute 
and the temperature dropped to 195^0. These conditions were 
maintained for a further 12 hours before coupling the column to the 
detector.
Operating Conditions
The separating powers of the column were determined by E.I.D..
Urine and plasma extracts were quantitatively analysed using E.C.D. 
together with the recovery rates of radioactivity which had been 
added to the biological material initially.
The /
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The 9 foot column prepared as described did not give a baseline 
separation of androsterone heptafluorobutyrate, aetiocholanolone 
heptafluorobutyrate and dehydroepiandrosterone heptafluorobutyrate 
when 0,5 p.g of each ester was injected into the column (Fig, 25). 
Neopentyl glycol succinate was replaced by neopentyl glycol sebacate 
(l per cent loading) and a lowered operating temperature of 180^0 
was used to accommodate the phase requirements (maximum stable 
operating conditions - 180"C). Resolution of these steroid 
derivatives was satisfactorily achieved (Fig. 26). This latter 
column was therefore used throughout the investigation. The column 
oven temperature was held at 180“C and the detector oven operated at 
230“C when using the E.C.D. system. Samples were injected onto
the column using an S.G.E. 10 pi syringe fitted with an 11,5 cm 
needle.
Linearity of the Detector
The detector gave a linear response for dehydroepiandrosterone 
heptafluorobutyrate over the range required for analysis (Fig. 27b), 
Likewise the response to testosterone di-heptafluorobutyrate was 
proportional to the amount injected (Fig. 27a). Linearity of 
detector response to varying amounts of the steroid derivative was 
determined /
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Fie. 25. Separation of the heptafluorobutyrate derivatives of
dehydroepiandrosterone, aetiocholanolone and androsterone 
using a 9 foot hybrid column comprising 2 feet of 1 per 
cent SE 30 and 7 feet of 1 per cent NGS (succinate).
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Fie. 26. Separation of the heptafluorobutyrate derivatives of 
epitestosterone, testosterone (di-HFB), androsterone, 
aetiocholanolone, dehydroepiandrosterone and epiandrosterone 
using a 9 foot hybrid column of 1 per cent SE 30 (2 feet) 
and 1 per cent NGSebacate (? feet).
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9 'HYBRID COLUMN
7 ' 1 2  NGS ON GAS-CHROM Q 
2 ' 1 2  SE30 ON GAS-CHROM Q 
OVEN T 180 ‘ C 
DETECTOR T 2 3 0 " C 
Ng CARRIER GAS FLOW RATE- 
40m l/m 1n  
ELECTRON PULSE ISQus
ng HSTD$1ERDIE DI-HFB INJEETED
5 10 15 20
ng DHA HFB INJECTED j  I
Fig. 27. Electron capture detector response (peak heights) to
varying amounts of testosterone di-heptafluorobutyrate (a) 
and dehydroepiandrosterone heptafluorobutyrate (b).
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determined
a) by using peak height only
b) by using peak area determined from the width of the
peak at 50 per cent of the height x height
c) by peak area extrapolated by triangulation where the
area is determined by halving the product of the peak width 
on the baseline and the peak height of a triangle superimposed
on the signal peak.
The linearity of detection using all three modes of quantitation is 
shown in Pig. 28. Quantitation using peak height was Chosen 
since fewer errors were likely to occur in the measurement of peak 
heights and since operating conditions were to be maintained constant 
as outlined.
An internal standard - testosterone di-heptafluorobutyrate - 
was injected with each sample. Exley and Chamberlain (1967) had 
determined that the molar response of testosterone di-heptafluorobutyrate 
was twenty to fifty times greater than the response of the hydroxyl- 
heptafluorobutyrates such as dehydroepiandrosterone heptafluorobutyrate. 
Using the conditions and column described, 0.5 ng of testosterone 
di-heptafluorobutyrate gave a peak height of a similar magnitude to 
that given by 10 ng of DHA HPB (Pig. 16b). Standard amounts of 
DIIA HPB /
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X - P E A K  HEIGHT 
.—  PEAK AREA BY TRIANGULATION 
 PEAK AREA (WIDTH AT HALF PEAK H E I G H T x P E A K  HEIGHT)
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'ig. 28. Linearity of detector response (ECD) determined from 
peak height and peak area measurements.
132
DIIA HFB and testosterone di-heptafluoroButyrate were injected daily 
prior to sample analysis. Quantitation was made by a comparison of 
peak height ratios of native DHA HFB against internal standard 
testosterone di-heptafluorobutyrate and the standard trace of a 
known amount of DHA HFB against standard testosterone di-heptafluoro- 
butyrate (p, 158).
Plasma dehydroepiandrosterone sulphate estimation.
Venous blood (lO - 20 ml) was withdrawn from patients with cystic 
fibrosis and from a series of children who were being investigated 
for non-endocrine disease. The blood was heparinised and the 
plasma separated. The plasma was thereafter processed immediately
or stored at -15*0 until assayed.
Determination of plasma DtlAS was according to the method of 
Brownsey et al, (l972). This method had been recommended to this 
laboratory (W.H.) by Prof, K, Griffiths, Tenovus Institute, Cardiff, 
prior to its publication, A flow diagram of procedures used is 
shown in Pig, 29. Dehydroepiandrosterone sulphate-
(0,045 pOi per mM:S.A. 290 mCi per mM) was added to each plasma sample 
for recovery estimations. Samples were extracted twice with four 
volumes of ice-cold acetone. Following extraction the tubes were 
placed in ice for 20 minutes and then centrifuged at 1,000 r.p.m, 
at /
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l
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l
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FOR SCINTILLATION
HEPTAFLUOROBUTYRIC
4- - - - - 1 ANHYDRIDE/BENZENE
W (I/I,v/v) 70‘C/30mins.
GLC
i . -
«. .29. P l o w  d i a g r a m  o f  t h e  p r o c e d u r e s  u s e d  i n  t h e  e s t i m a t i o n  o f  
p l a s m a  d e h y d r o e p i a n d r o s t e r o n e  s u l p h a t e *
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at 4"C using an ^ ÏSE 2L centrifuge. The acetone layers were 
removed, pooled and reduced to approximately 2 ml volume at 40^0 under 
a stream of nitrogen. Methanol (20 ml) was added and the lipid
material removed by washing with petroleum ether (80 - 100^  C)
petroleum/
(20 ml). The ether phase was discarded. The methanol layer 
was once more reduced to small volume (2 ml), diluted with deionised 
water (lO ml) and extracted with diethyl ether (2 x 30 ml) to 
remove unoonjugated steroids. The ether phase was again discarded.
Ammonium sulphate (6 g) was dissolved in the remaining aqueous 
phase and the conjugated steroid (DHAS) extracted with diethyl ether: 
ethanol (3:1, v/v) (3 x 30 ml). Quantitative recovery of 
was obtained using this concentration of ammonium sulphate (5O per 
cent, wt/v). This finding is in agreement with results of extraction 
procedures reported by Edwards et al, (l953)* Pooled extracts of 
diethyl ether:ethanol were reduced to small volume at 40*C under 
nitrogen and the residue was applied as a 2 cm streak to a t.l.c, 
plate. The chromatogram was developed for 3 hours in the solvent 
system tert-butanol;ethyl acetateammonia (82:100:40, v/v),
^f of standard steroids and their sulphate and glucuronoside
esters are given in Table VII. The radioactive area, representing 
H-DilAS added initially to the plasma, was located by radiochromatogram 
scanning /
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TABLE VII, Separation of standard steroids and their sulphate 
and glucuronoside esters hy t.l.c, in tert-hutanol: 
ethyl acetateî5N ammonia solution (82:100:40, v/v).
STEROID ^f
DEHYDROEPIMDROSTEROUE 0,78
AKDROSTERONE 0.78
AETIOCHOLAUOLORE 0,79
TESTOSTERONE 0,76
ANDROSTENEDIONE 0.77
DEHYDROEPIANDROSTERONE SULPHATE 0,28
ANDROSTERONE SULPHATE 0,30
AETIOCHOLANOLONE SULPHATE 0,31
DEHYDROEPIANDROSTERONE CLUCURONOSIDE 0,07
ANDROSTERONE GLUCURONOSIDE 0.08
AETIOCHOLANOLONE GLUCURONOSIDE 0,07
Development for 3 hours (single run).
Location by U.V, visualisation using 0,1 per cent Rhodamine 6 0 in 
ethanol.
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scanning and was eluted with diethyl ether (3 x 2 ml) and ethanol 
(3 X 2 ml). The eluate was collected in a boiling tube (50 ml 
capacity) and blown to dryness under nitrogen. Ethyl acetate (lO ml), 
deionised water (lO ml), sodium chloride (2 g) and 40 per cent sulphuric 
acid (0.8 ml:reaction mixture pH l) were added to the tube.
Solvolysis was carried out by shaking the mixture and incubating at 
50*C for 4 hours (Burstein and Lieberman, 1958). From Fig. 30 
it will be seen that at 50^0 the solvolysis of \-DHAS in water 
proceeds rapidly for the first four hours. Thereafter the rate of 
solvolysis reaches a plateau level at 80 per cent solvolysis. After
four hours samples were again shaken and the ethyl acetate layer
removed. A further extraction with ethyl acetate (lO ml) was made.
The pooled ethyl acetate extracts were neutralised by washing with 
5 per cent sodium bicarbonate (2 x 5 ml) and subsequently washed with
deionised water (2 x 5 ml) prior to reduction to small volume. The
residue was applied to a silica plate in ethyl acetate (3 x 10 jal).
Each sample was applied as a single spot and the plate was 
developed /
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SOLVOLYSIS OF ^H-OHAS IN WATER ( 1 0 m l )  AT 5 0 ' C  
ETHYL ACETATE EXTRACTION
X
2 47 8 9 ID II 124 5
TIME (HOURS)
Fig. 30. The recovery of "H-DHA from 'H-DHAS solvolysed at 50°C 
according to Burstein and Lieberman (l958). Recovery was 
estimated from four samples at each time interval.
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developed in 'benaene;ethyl acetate (6:4, v/v) as before (p. Ill)*
■5
After scanning, the area corresponding to the radioactive peak H-DHA 
was removed and the steroid eluted with ethyl acetate ( 6 x 2  ml).
The residue, after blowing to dryness, was further dried for 1 hour 
in a vacuum desiccator * Heptafluorobutyrates were prepared according 
to the method of Sxley and Chamberlain (1967). Excess reagent 
was removed under nitrogen and the residue redissolved in benaene: 
ethyl acetate (9:1, v/v) (50 pi). An aliquot (5 pi) was removed
for liquid scintillation counting* Following injection of standard
D M  HFB and testosterone di-heptafluorobutyrate into the g.l.c. 
system previously described, each plasma extract was injected along 
with a standard amount of testosterone di-heptafluorobutyrate.
Quantitation of Dehydroepiandrosterone in Extracts 
of Biological Samples.
Standard solutions of DHA HFB and testosterone di-HFB were 
injected into the g.l.c. system daily prior to sample analyses.
A known amount of testosterone di-HFB was injected as a standard 
together with the esterified urine or plasma extract. Quantitation 
was then made by a comparison of the ratios of peak height of standard 
DHA I-IFB to peak height of standard testosterone di-HFB with the peak 
height of DHA HFB in the biological sample to the peak height of 
testosterone /
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testosterone di-HFB added as internal standard. Correction was 
made for the dilution of the final residue relative to the amount 
injected, for the total 24-hour urine volume or for 100 ml plasma, 
and for the percentage recovery as estimated by the recovery of H-DHAS
3
which had been added initially to samples. The mass of the H-DHA 
HFB injected into the g.l.c® system along with the biological 
extracts was deducted when significant.
Urinary DHAS and DHAG and plasma DHAS are measured as free 
DHA but results are expressed as pg DHAS or pg DHAG per 24 hours and 
pg DHAS per 100 ml of plasma.
An example of the estimation of DHA in a 24-hour urine sample 
and a plasma sample is given in Figs. 31 and 32 and the appropriate 
explanatory texts. High levels of DHA were found in the biological 
fluids from this patient who had a virilising adrenal tumour.
These results indicate that the methodology used is valid for 
determining elevated levels of DHA as well as the low levels which 
occur in samples from cystic fibrosis patients and which are now to 
be reported.
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Fig. 31. Tracing of a urine extract from a patient with a 
virilising adrenal tumour.
a) Standard trace
b) Urine extract - sulphate fraction
c) Urine extract - glucuronoside fraction.
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Explanation of Pig. 31# (Work-out of DHA in urine)
Standard trace (Pig. 31a)
1 ng T di-HFB gives a peak height of 9*4 cm 
10 ng D M  HFB gives a peak height of 7.8 cm
Urine - Sulphate fraction (Pig. 31h).
1 ng of standard T di-HFB gives a peak height of 9.2 cm 
Since this peak height differs from that obtained in the standard 
trace (Pig. 31a) the corresponding peak height for 10 ng D M  HFB 
in the second trace was calculated thus:-
Let the peak height for 10 ng DHA HFB in the second trace 
be X cm. Then by comparison of peak height ratios:-
X - 7.8
9I2 9.4
and X = ,9.t.2 ? U 8 .
y .4
But the peak height of native D M  HFB in the second trace is 6.7 cm
Therefore there are ng DHA HFB in the sample injected
^ (1 Hi of 10,000 Hi)
and 10 X 9.4 x 6.7 x 10,000 . . ng in the urine residue
^10 of the residue contains 2,545.27 d.p.m.'s = 2.396 per cent of 
that added initially (106,193.7 d.p.m.'s).
Thus /
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Thus if the recovery of the native steroid is equivalent to the 
3 3
recovery of H-DHA from H-DHAS added to the urine, then there 
is 23,96 per cent of native steroid present in the final residue. 
Therefore in the aliquot of urine processed (5O ml) there are
10,.^. .101.000 y.,,100
9.2 X 7.8 X 25.96
The total 24-hour urine volume was 440 ml.
Therefore 10 x 6,7 x 9.4 x 10,000 x 100 x 440 ng of DHA are excreted 
9.2 X 7.8 X 23*96 X 50 per 24 hours
3,223,413 ng of DHA are excreted per 24 hours
3.2 mg of DHA are excreted as the sulphate moiety per 24 hours
i.e. 3.2 mg DHAS per 24 hours,
Hrine-Glucuronoside fraction (Pig. 31c).
1 ng of standard T di-HFB gives a peak height of 9*4 cm 
corresponding to the peak height of 1 ng in the standard trace (Fig. 31a) 
Therefore by a comparison of peak height ratios with Fig, 3la 
10 ng of DHA HFB would give a peak height of 7.8 cm in 
the third trace.
But the peak height of native DHA HFB in the third trace is 5.4 cm
Therefore there are 10 x 5.4 ng of DHA HFB in the sample injected
7.8 ' (1 Jil of 1,000 Hi)
And 10 X 5.4 X 1,000 ng in the urine residue
7.8
% o  /
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/lO of the residue prior to g.l.c, contains 4,125.55 d.p.m.’s =
3.745 per cent of the ^H-DM added initially (110,173 d.p.m.'s).
Thus 37*45 per cent of the native steroid is present in the final 
residue.
Therefore in the 50 ml aliquot of urine processed there are
7.8 X 37.45
In the total urine volume (440 ml) there are
10 X 5.4 X IfPOO X 100 X 440 ng of DHA
7.8 X 37.45 X 50
i.e. 162,684 ng of DHA per 24 hours
Therefore 162.7 pg of DHA per 24 hours are excreted as the glucuronoside
conjugate
i.e. 162.7 pg DHAG excreted per 24 hours.
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PLASMA
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Fig, 32. Tracing of a nlasma extract from a patient with 
a virilising adrenal tumour.
a) Standard trace
b) Plasma extract
ion of Fig, 32 (Work-out of DBA in plasma)
Standard Trace (Fig. 32a)
1 ng T di-HFB gives a peak height of 9»45 cm 
10 ng DHA HFB gives a peak height of 9*7 cm
Plasma extract (Fig. 32h)
1 ng of T di-HFB injected as internal standard gives a peak 
height of 10.6 cm.
Since this peak height differs from that obtained in the standard 
trace (Fig. 32a) the corresponding peak height for 10 pg DHA HFB 
in the second trace was calculated thus :-
Let the peak height for 10 ng DHA HFB in the second trace be x cm. 
Then by comparison of peak height ratios
= 5LsI  
10.6 9.43
and X = 9.7 x 10.6 cm
9.43
But native DHA HFB in the second trace gives a peak height of 3.2 cm.
Therefore there are 10 x 9.43 x 3.2 ng DHA HFB in the sample
10.6 X 9.7 injected (l pi of 100 pi)
and 10 X 9.43 x 3.2 x 100 ng in the plasma
10.6 X 9.7 residue
3Recovery of H-DHA prior to g.l.c. injection is 32.59 per cent 
Therefore /
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Therefore there are 10 x 9.45 x 3.2 x 100 x 100 ng of DHA in the plasma
10.6 X 9.7 X 32.59 processed (4 ml)
Thus there are 10 x 9.45 x 3.2 x 100 ng of -DHA per 100 ml
10,6 X 9.7 X 32.59 x 4 of plasma
i.e. 22,565.1 ng DHA per 100 ml plasma (sulphate ester)
22.57 pg DHAS per 100 ml plasma.
CHAPTER POUR
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RESULTS
INTRODUCTION
Since the earliest recorded diagnosis of cystic fibrosis in this 
hospital in 1948, 196 children have been diagnosed as having the disease, 
Of these, 60 were alive on the 31st December, 1971, the oldest 
being 19 years. The investigations reported here were carried out 
on 48 patients of this group. The majority of urine collections 
were made at home under parental supervision and some children 
were too young for complete samples to be collected reliably.
PATIENTS UNDER STUDY
The male children with cystic fibrosis ranged from 4 to 20 years 
and the girls from 1 to 15 years. The patients investigated are 
listed in Table VIII. An identification number, age and clinical
status is also shown. The protean nature of the disease has
already been noted and in 1958 Shwachman and Kulczycki reported a 
system for the clinical evaluation of the child with cystic fibrosis. 
This scoring system is shown in Table IX and it was applied to all 
patients at the time of urine collection and blood sampling. A 
rating of "excellent" was achieved for 5 of the 48 patients - all 
being /
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TABLE VIII. TOTAL NUMBER OP PATIENTS INVESTIGATED BY AGE AND SEX 
WITH THEIR CLINICAL RATING OP DISEASE SEVERITY.
Male Children with Cystic Fibrosis
Patient
E.Bo
C.B.
S.C.
T.McA.
D.G.
D.8.
R.S.
T*R.
A.McG.
U.S.
J.R.
R.R.
R.G.
P.B.
S.C.
J.H.
G.FGMcM.
I.D.
O.B.
D.McG.
M.C*
P.S.
R.W.
D.J.,
Patient
Number
1
2
3
4
5
6
7
8 
9
10
11
12
13
14
15
16
17
18
19
20 
21 
22
23
24
Age
Years
4
4
5
6 
7 
7
7
8 
8 
9 
9 
9
10
10
11
12
14
14
14
15
15
16 
18 
20
Clinical 
Status *
MILD
EXCELLENT
GOOD
MODERATE
MILD
EXCELLENT
SEVERE
SEVERE
GOOD
MODERATE
MILD
GOOD
MODERATE
SEVERE
MODERATE
MODERATE
MILD
SEVERE
MODERATE
GOOD
MODERATE
GOOD
SEVERS
GOOD
Female Children with Cystic Fibrosis
Patient
B.C. 
S.B. 
E.R. 
R.McI. 
S.McDc 
N.W. 
J.L. 
w'.P.
C.N. 
A.G. 
M.D. 
C.C. 
A.K. 
L.C. 
C.H. 
A.J. 
L.C. 
R.H. 
A.McM. 
V.C. 
L.McK. 
M.McN 
S.C.
Patient
Number
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
Age
Years
1
2
3
3
4 
4 
4
4
5 
5 
5
5
6
7
8 
8 
9 
9
11
12
13
14
14
15
Clinical 
Status *
EXCELLENT
MODERATE
EXCELLENT
EXCELLENT
GOOD
SEVERE
MILD
GOOD
GOOD
SEVERE
MODERATE
MODERATE
SEVERE
MODERATE
MODERATE
MILD
SEVERE
GOOD
MILD
SEVERE
MILD
MODERATE
MILD
MODERATE
Shwachman System of Clinical Evaluation (Shwachman and Kulcsycki, 1958)
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being younger than 8 years. The severity of the disease is not 
necessarily associated with advancing age since patients rated as 
"severe" ranged from 4 to 18 years. More boys were available for 
study in the pubertal and post-pubertal age ranges (lO boys of 11 years 
and older were alive as opposed to 6 girls) and of these 3 had a 
"good" clinical rating. None of the surviving girls achieved this 
grading.
m i m  ÂML1SSS
All the results of the steroid analyses on 24-hour urine 
samples are shotm in Tables X and XI. The 17-oxosteroid, 17-ozogenic 
steroid and total 17-hydroxycortioosteroid results are shown in 
columns D , E and E. Those patients undergoing treatment with 
anabolic hormones are indicated in the tables.
Estimation of 17-ozosteroid excretion was undertaken on all 
urine samples. When urine volume was adequate the 17-oxogenic 
steroids and total 17-hydroxycorticosteroids were also determined.
A yellow chromogen was found to interfere with colorimetric steroid 
determinations in 9 of the 59 urine samples assayed. This was 
attributed to cloxacillin (p. 91) which is normally prescribed as 
prophylaxis to these patients. Under these circumstances, it 
sèemed incongruous that only occasional interference should be 
experienced. /
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experienced. A more subjective approach to the results indicated 
that these difficulties were experienced in urine samples collected 
in hospital and from children with reliable parents who insisted on 
full therapy at home. Thus it would seem probable that many of 
the children with cystic fibrosis under study were not having 
regular administration of antibiotic therapy.
Total dehydroepiandrosterone (pg per 24 hours) is recorded in 
column I of Tables X and XI. The breakdown of this total value 
into glucuronoside and sulphate fractions is given in columns G 
and H. Where no DHA was detected on g.l.c. analysis, recovery
of dehydroepiandrosterone along with total urine volume 
was used to estimate the possible maximum level present in each sample. 
Results are thus expressed as being less than this maximum possible 
level (columns G and k ). If DRA was not measured in the urine 
glucuronoside and sulphate fractions, then total DHA could not be 
recorded (column I).
TOTAL ITrHYDRGXYCORTIGOSTERGIDS IN CHILDREN WITH CYSTIC FIBROSIS 
Statistical comparison of the total 17-hydroxycorticosteroid 
levels in urine from children with cystic fibrosis and in urines from 
normal children, as assayed by this laboratory, revealed no significant 
difference. /
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difference. Likewise, neither norma], values from this laboratory 
nor the levels found in cystic fibrosis patients differed significantly 
from control values reported by Chodos et al. (1965) (Table XII).
IT-OXOkSTEROID excretion BY PATIENTS WITH CYSTIC FIBROSIS
Estimations of 17-oxosteroids were undertaken on urine of 
patients with non-endocrine disease in the 6 to 10 years age range. 
These values (0*54 - 0*28 mg per 24 hours) did not differ significantly 
from values reported by Prout and Snaith (195B) (Table XII)• The
method closest to that used in this study was used for comparison 
(i.e. method 4 of Prout and Snaith employing spectrophotometric 
readings at three wavelengths and application of the Allen correction). 
Urine samples from normal children of 11 to 17 years proved difficult 
to obtain. Since the 6 to 10 year old subjects had urinary 
17-oxosteroid levels approximating those reported by Prout and 
Snaith (l958), the normal values reported by these authors were 
used for comparison with results obtained from children with cystic 
fibrosis. No significant differences from normal were found in 
the age ranges 1 to 5 years and 6 to 10 years but the affected 
children between 11 and 17 years had a significantly lower excretion 
of 17-oxosteroids than normals of the same age range (l*95 - 1.625 mg 
per /
153
TABLE. XIII.0 A COMPARISON OP URINARY 17-OXOSTEROIDS IN NORMAL CHILDREN 
AND CHILDREN WITH CYSTIC FIBROSIS
Age Range 
(Years)
1 - 5
* 17-Oxosteroids mg per 24 hours
6 “  10
11 » 17
CYSTIC FIBROSIS PATIENTS
0.26 - 0.18 
(n = 12)
I'TORHAL PATIEHTS +
0.41 i 0.58 
(n = 12)
WO signipica:jt dipperence
+
0.63 - 0.48 
(n = 19)
EC SIGIIIPICA'
+
1.95 “ 1.625 
(n = 14)
ilCNIPICANT
0,89 - 0.61 
(n = 11)
T^ DIFFERENCE
4*
3.71 - 1.76 
(n = 31)
IIPPEREWCB
* Mean - 1 Standard Deviation
4- Prout, M,, and Snaith, A.H., (l958)
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per 24 hours as opposed to 3*71 Ï 1.76 mg per 24 hours) (Table XIII).
UKIKARY DSHYDROEPIAKDROSTEROBÏÏ
Several authors have reported normal values for the daily 
excretion of dehydroepiandrosterone in children. , Table XIV 
gives a series of normal values obtained from a review of the 
literature. To compile a list of normal values of steroid excretion 
for all age ranges would be a massive undertaking. For the purposes 
of this investigation comparison was made with normal values 
determined by a methodology comparable to the one used in this 
thesis. For this reason the results of Berger et al. (1970) 
obtained by g.l.c. analysis of urine samples were utilised. However, 
only Loras et al. (l966) differentiate between D M  present as the 
glucuronoside conjugate and as the sulphate.
Many authors have disputed the presence of DIM in the urine 
of pre-pubertal children. Paulsen et al. (1966) could not 
detect DHA in the urine of any child below the age of 8 years.
Likewise, Beas et al. (1962) found no D M  in the urine of 5 boys 
and 7 girls aged 5 to 7 years. However, Loras et al. (l966) 
were able to isolate 21 pg of D M  from 6 pooled 24-hour urine samples 
from children of 5,6 and 7 years respectively. Similarly, 
Vestergaard /
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Vestergaard (1965) found DHA present in pooled urine samples from 5 to 
7 year old boys and girls. Also an extract of the urine from a 
6 year old girl gave a distinct, though small, peak in the area of 
DHA on g.l.c. analysis. Berger et al. (l970) reported excretion 
of DHA in 6 boys of 4 years to be in the range 0 to 80 p,g per 24 hours.
In the g.l.c. traces which follow, the quality of the peak 
representing DHA from urine samples processed as described can be 
seen. The first tracing (Fig. 33) from a boy of 14 years (patient 
number 19) demonstrates DHA to be present in both glucuronoside and 
sulphate fractions though a preponderance is excreted as the sulphate. 
Figure 34 shows g.l.c. tracings from a 9 year old girl (patient 
number 41) where no peak corresponding to DHA was present in either 
urine fraction. On the other hand, a small peak in the area of 
DHA could be detected on analysis of urine from a 5 year old healthy 
girl (Fig. 35) and also from a 4 year old patient with cystic 
fibrosis (patient number 30) (Fig. 36). Using the reported 
methodology, DHA is measurable in urine from 4 year old subjects 
and upwards. When not detected D?IA must be presumed to be either 
absent or less than the tolerance of the method.
Quantitation was made on the basis of the peak height corresponding 
to DHA in relation to standard injected with each sample. To 
correct /
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Fig. 33. Tracing obtained on g.l.c. analysis of urine extracts from 
natient 19, (male; 14 years).
Total urine volume - 820 ml; volume analysed - 50 ml 
Sulphate fraction - 0.5 pi of 500 ul injected
Glucuronoside fraction - 0.5 ul of 50 ul injected
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Fig. 34. Tracing obtained on g.l.c. analysis of urine extracts from 
patient 41, (female; 9 years).
Total urine volume - 1,060 ml; volume analysed - 100 ml 
Sulphate fraction - 4 pi of 50 pi injected 
Glucuronoside fraction - 5 pi of 50 pi injected
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STANDARDS
URINE
SULPHATE FRACTION
URINE
GLUCURONOSIDE FRACTION ’
Fiæ. 35» Tracing obtained on g.l.c. analysis of urine extracts from 
a 5 year old normal girl (upper respiratory infection). 
Total urine volume - 455 ml; volume processed - 100 ml 
Sulphate fraction - 2 |il of 50 fil injected 
Glucuronoside fraction - 1.5 pi of 50 ul injected
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Fip, 36. Tracing obtained on g.l.c. analysis of urine extracts 
from patient 30 (female; 4 years).
Total urine volume - 4-00 ml; volume processed - 100 ml 
Sulphate fraction 3 ul of 50 ul injected 
Glucuronoside fraction - 3 ul of 50 fil injected
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3
correct for methodological losses the recovery of the H-DHA added 
initially to samples was estimated. The percentage recovery of
from 15 random urine samples at various stages in the analyses 
will he seen in Table XV. Correction was made for all aliquots 
removed for liquid scintillation counting. The recovery of
DHA and of cold standard amounts of DHA were of the same order as
that for 7a-^H DHA. The reported tendency for the Toc-tritiura 
label to become detached was therefore not a significant problem 
in these experiments*
The total urinary dehydroepiandrosterone and dehydroepiandrosterone 
sulphate estimated by these means are given in Tables XVI, XVII and 
XVIII* Normal values by Berger et al. (l970) and Loras et al. (l966) 
are given for comparison and the clinical rating of each child with 
cystic fibrosis is recorded. In Table XVI high levels of total 
DHA are found in patients 5 and 9 with mild and good clinical ratings 
respectively. However patients with the same rating (patients 11 
and 12) did not have a correspondingly high excretion of DHA.
The unexpectedly high urinary DllA level in both patient 5 and 
patient 9 does not correlate with an elevated plasma level of DBAS 
(Table XIX). DHA from urine from patient 5 with hypospadias is 
excreted mainly as the glucuronoside conjugate. The significance 
of /
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of this finding in relationship to the thesis, which concerns, in part, 
the role of DflA in the masculinising processes, will he discussed 
fully in the next chapter. The three patients classified as 
severe (numbers 7, 8 and 14) all had a low excretion of total DM,
Of the older male patients 8 out of 11 had low urinary levels of D M  
(Table XVII)• Only three boys (numbers 19, 22 and 24) approximated
the normal levels quoted by Berger et al, (l970). Patients 19 and 
24 have high levels of total D M  which is excreted mainly as the 
sulphate. These boys have satisfactorily entered into puberty 
and the possible significance of these high levels will be considered 
in the next chapter. Female patients with cystic fibrosis 
demonstrate a more strikingly low level of total DHA, (Table XVIII),
The apparent anomalous finding of a single high level of D M  in a 
severely affected child of 12 years (patient 44) is due to her having 
had anabolic steroid therapy at the time of urine collection (see 
next chapter for the effects of anabolic hormones),
PLASMA LEVELS OF DEHYDROEPÏADDROSTERODE IH CHILDREN WITH CYSTIC FIBROSIS 
Dehydroepiandrosterone was assayed in plasma samples from 56 
patients with cystic fibrosis - 19 boys (4 to 16 years) and 17 girls 
(5 to 15 years). The results are shown in Table XIX, Patients 
on anabolic hormone therapy are indicated. Circadian rhythms in 
the /
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the plasma 17“OXOsteroids in normal adult subjects have been 
investigated by Migeon et al. (l957) who found peak levels of DHA at 
8 a.m. Conversely Laatikainen and Vihlco (1968) reported highest 
levels of DHA to occur in the late afternoon. Vaitukaitis et al. 
(1969) withdrew blood from 7 subjects at 8 a.m. and at 9 p.m. and were 
unable to demonstrate any diurnal variation in DBAS. The majority 
of blood samples taken for this investigation were withdrawn in the 
afternoon between 2 and 5 p.m.
Migeon et al. (l957)> employing a micro-Zimmermann reaction, 
were unable to detect plasma 17-oxosteroids until the age of 5 to 
7 years. Rosenfield and Eberlein (1969), employing g.l.c. analyses, 
demonstrated DI-IA.S to be present in plasma pools from normal male 
children from 1 to 5 years. Normal values for plasma 
dehydroepiandrosterone in children, as reported in the literature, 
are given in Table XX. The results of Yamaji and Ibayashi (1969) 
obtained from g.l.c. analyses of plasma extracts from normal children 
will be used for comparison with the results obtained from children 
with cystic fibrosis.
Gas liquid chromatographic analyses of plasma samples are 
demonstrated in the following traces. Patient 14, during 
treatment with ethyl estrenol, had a high level of plasma DI-IA (Pig. 57), 
On /
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STANDARDS
\/
PLASMA EXTRACT
; I
I I
_<
Fi%. 37» Tracing obtained on g.l.c. analysis of plasma from patient 14
(male; 10 years) after treatment with ethyl estrenol.
4 ml of plasma processed; 5 fil of 250 ul injected.
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STANDARDS
\/
Fig. 38. Tracing obtained on g.l.c* analysis of plasma from patient 44 
(female; 12 years) during a period of treatment with ethyl 
estrenol.
4 ml of plasma processed; 1 ul of 150 jjl injected.
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a
Fie. 39> Tracing obtained on g.l.c. analysis of plasma from a 6 year
old normal girl (b) and from patient 30 (c) (female; 4 years). 
Fig. 39 b: 11.2 ml of plasma processed; 2 ^1 of 50 (il injected. 
Fig. 39 c: 12 ml of plasma processed; 2 ul of 50 p.1 injected. |
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On the other hand, a much smaller level was recorded from patient 
44 who was receiving the same treatment (Fig. 38). Small peaks 
corresponding to DHA were observed in plasma extracts from a 
6 year old normal girl and from a 4 year old child with cystic
fibrosis (patient number 30) (Fig. 39)*
The final recovery of DHA, added initially to plasma
samples as DÏÏAS, was 33*65 - 7*6 per cent from 15 random
samples (Table XXI), The percentage recovery of labelled-steroid at 
each stage of the analytical procedure is given after correction 
for aliquots taken. Prior to solvolysis recovery is estimated by 
liquid scintillation counting of DHAS and to facilitate
solubilisation of this water-soluble conjugate in the organic scintillator, 
a diluent of 20 per cent methanol was incorporated into the scintillator.
A comparison of plasma levels of DHA in patients with cystic 
fibrosis with normal values (Yamaji and Ibayashi, 1969) revealed a 
significant difference in the older age range (ll to 15 years) of 
both sexes. The levels in affected girls of 3 to 10 years old did 
not differ significantly from the normal values whereas boys of the 
same age group had levels just significantly lower than normal 
(Table XXII).
SÎIMMARY OP RESULTS
The excretion of total 17-hydroxycorticosteroids in children 
with /
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TABLE XXI. PERCENTAGE RECOVERY OF [7a - DHA in 15 RAÎÏDOM
PLASMA SAIÏPLES AT VARIOUS STAGES IN THE ANALYSIS
PERCENTAGE RECOVERY OP ^H-DHAS and ^H-DHA
-)f STAGS IN ANALYTICAL PROCEDURE
Sample
9 11 15 16 21Number
1 95.66 81.14 60.57 48.88 36.71
2 92.19 84.15 66,68 34.63 35.82
3 90.62 83.42 69.55 50.89 39.67
4 86.31 81.11 65.75 45.02 37.85
5 95.30 68,60 54.50 34.10 29.30
6 89.30 52,80 77.65 54.80 38.99
7 89.00 57.00 55.50 43.50 30.10
8 86,10 54.90 62.60 38.50 26.30
9 81.10 60.20 45.80 29.40 22.00
10 62.00 56.70 44.10 42.00 41.10
11 66.40 58,50 50.60 50.50 50.30
12 74.70 61.80 55.50 42,60 36.09
13 63.20 51.70 45.70 39.20 24.47
14 78.16 64.80 68.10 42,60 26.50
15 81.21 72.40 62.57 45.60 29.59
Mean - 82.08-11 .1 65.95-11.7 58.78±9,9 42.81-7.03 33.65-7.6
1 Standard 
Deviation
Stage 9 - Following Extraction with Diethyl Ether:Ethanol (3:1, v/v) 
Stage 11 - After First t.l.c. separation (t-Butanol:Ethyl Acetates
5N M-Î OH, 82:100:40, v/v)
Stage 13 ” After Solvolysis
Stage 16 “ After Second t.l.c. separation (Benzene:Ethyl Acetate,
6:4, v/v)
Stage 21 - Prior to g.l.c.»
Counted as H-DHAS using a diluent of 20 per cent methanol in 
the toluene-based scintillator.
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with cystic fibrosis does not differ significantly from normal, 
likewise the excretion of 17-oxosteroids in the age range 1 to 10 
years is not abnormally low in these children. However, urinary 
17-oxosteroids in affected children of 11 to 17 years is significantly 
lower than accepted normals. Normally the urinary excretion of 
17-oxosteroids rises gradually from the age of 7 years to puberty 
and normal adult levels are generally reached between 17 and 20 
years. Prior to puberty the adrenal cortex is the main site of 
production of the precursors of the urinary 17-oxosteroids and this 
is reflected by the similarity of 17-oxosteroid levels in male and 
female children of this age range. However, Rosenfield and 
Eberlein (1969) considered that plasma DHAS levels, attributed in 
large part to adrenal secretion, could reflect the maturation of the 
adrenal cortex. They reported that increased secretion of DHAS 
may start as early as 9 years in the female child and may reach 
adult levels at 13 or 3.4 years of age. In this study plasma 
DHAS was significantly lower than normal in the 11 to 15 years 
age range (Table XXII). Thus adrenal function in the cases of cystic 
fibrosis here investigated is normal in the whole paediatric age range. 
However, in the pubertal and post-pubertal age ranges, the ability 
to synthesise DMS, as reflected by low plasma levels, is impaired. 
This /
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This impaired function is a feature mainly of the adrenal and in the 
male may also be partly testicular. It might be postulated that 
the phenomenon called "adrenarche" is inadequate but, whatever the 
aetiology, there is defective production of dehydroepiandrosterone 
sulphate in both sexes during puberty and the period which follows. 
Further discussion of these findings takes place in the next chapter,
CMâPTER FIVE
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The recently described defect in the male genital tract, consider­
ation of which has already occupied part of the introductory sections 
of this work, has been attributed both to a failure in differentiation 
of the mesonephric duct (Kaplan et al. 1968; Gracey et al. 1969;
Landing et al. 1969) and also to secondary obstruction of that duct 
(di Sant' Agnese, 1968; Oppenheimer and Esterly, 1969).
The male subjects studied in Landing's survey (1969) ranged from 9 
days to 25 years and in 31 of 32 an absent vas deferens and reduced 
epididymis were demonstrable. Wang et al. (l970) observed that 
these defects were neither age dependent nor related to the clinical 
severity of the disease. It therefore seems unlikely that a 
progressive obstruction of mesonephric duct structures occurs.
Olson and Weaver (1969) lent further evidence for this view when 
they reported investigations of the genital tracts of 15 male infants 
who died within the first year of life* All demonstrated characteristic 
abnormalities without any evidence of inflammation or obstructive 
changes. These findings strongly suggest a developmental failure.
Generally, the absence of the vas deferens is considered to be 
a relatively rare abnormality of the male genital tract, bilateral 
absence /
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absence occurring in only 1 to 10 per cent of men with aspermia.
The gonads of such patients usually exhibit normal hormonal function 
and gamete formation. Further, fertility may be restored in men 
who have undergone vasectomy by anastomosing the vas deferens even 
up to 18 years post-operatively (Waller and Turner, 1962). Therefore 
the findings of impaired spermatogenesis, with arrest at the spermatocyte 
and spermatid stages (Kaplan et al. 1968; Denning et al. 1968), as 
observed from histological examination of testicular tissue from 
post-pubertal males with cystic fibrosis, can not be related to an 
obstruction phenomenon.
Valman and France (l969) suggested that differentiation of the 
mesonephric duct was normal until 10 weeks after conception since 
recognisable fragments of epididymis and vas deferens were present 
in some subjects with cystic fibrosis. However, the reduction of 
the mesonephric duct to a fibrous cord suggests a failure in development 
soon after the appearance of the metanephric duct, probably between 
the 10th and 12th foetal week (Valman and France, 1969)«
These observations suggest a possible androgen deficit in foetuses 
with cystic fibrosis reflected by a failure in the differentiation 
and maintenance of the mesonephric duct structures and in the arrest 
in spermatogenesis, operative at spermatocyte and spermatid stages. 
Together /
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Together with the malabsorption and chronic disease experienced by 
these patients, an androgen deficiency may also contribute to the 
retarded bone age, general failure to thrive, delayed puberty and the 
delayed and limited pubertal growth spurt so characteristic of the 
disease.
Using foetal testes in incubation systems with radioactive
steroid substrates, Hamilton et al. (l970) demonstrated a greater 
5conversion of A -androstenediol and DBA to testosterone than of
androstenedione to testosterone in testes of less than 12 weeks.
After 12 weeks the adult pattern of greater conversion to testosterone
5from androstenedione rather than from DI-IA and A -androstenediol is 
evident (hucis et al. 1967). Thus DHA is an important precursor 
of the most androgenic steroid, testosterone, during the period of 
differentiation of the male genital tract. It vd.ll be remembered 
that higher levels of androgen (Jost, 1968) are required to differentiate 
the male internal duct structures than are required at a later stage 
to masculinise the male external genitalia. The role of foetal 
androgens on both somatic and psychological development is now well 
recognised and is diagramatically shown in Fig. 40. The fact 
that androgens are required for male psychosexual identity is well 
demonstrated in reverse in the feminising testicular syndrome wherein 
the /
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TESTIS 
(ANDROGEN BIOSYNTHESIS)
0
DHA
HO
17p™reductase
OH
ADO
HO
3 p“hydr oxy s t er o id 
dehydrogenase 
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OH
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INTERNAL
GENITAL
DUCTS
Flgo 40. Testicular androgen synthesis and action during sexual 
differentiation of the male foetus.
DHA:
5
ADO: A - androstenediol
T : Testosterone
Dehydroepiandrosterone 
5
176
the phenotypic female (XY chromosomal constitution) thinks and acts 
completely in a female fashion because "she" lacks the necessary 
peripheral ability to respond to normal and even elevated levels of 
circulating testosterone*
Gupta (1965) has calculated that on its own merit DHA has an 
activity of 2 per cent of testosterone on the development of the 
male reproductive tract» The androgenicity of DHA as bio-assayed 
by the comb-growth test is /^^th that of testosterone (Pieser and 
Pieser, 1959)* As an important intermediate of testosterone synthesis 
during the differentiation period, its contribution to the imposition 
of masculinity on the foetus must be considerable*
These arguments and the extent of the physiological and metabolic 
importance of DHA such as are now recognised and which have been 
considered in Chapter 2 have led me to a consideration of the possible 
significance of this hormone in cystic fibrosis*
If DHAS circulated in suboptimal concentrations then an 
endocrine aetiology for the maldevelopment of the mesonephric duct 
in the male foetus with cystic fibrosis could be proposed* Such 
a diminished availability of steroid might result from reduced 
secretion of DHAS by the adrenal, or from reduced sulphatase for 
DHAS so decreasing the availability of the free active DHA at a 
cellular level, or from reduced sulphokinase for DHA which would 
then /
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then result in rapid elimination of DHA from the body* The 
investigations presented here have demonstrated normal DHA levels 
in urine from pre-adolescent children and low levels in the pubertal 
and post-pubertal age ranges* It is therefore unlikely that a 
sulphokinase defect is operative in cystic fibrosis.
Two periods of intense androgen activity can be recognised - 
one during foetal development associated with the differentiation 
of androgen dependent tissues, a process which is almost complete 
by the 18th week of gestation (Table I, p* 47), and the other at 
puberty associated with the development of the secondary sexual 
characteristics. The capacity of the foetal testis to 
synthesise androgens and the temporal relationship of steroidogenic 
activity for differentiation of the mesonephric duct have been 
discussed fully in Chapter 2. Large quantities of DHA and DHAS 
are secreted by the human foetal adrenal cortex and are attributed 
to the relative deficiency of 3p-hydroxysteroid dehydrogenase/h^’’^  
isomerase activity in this tissue. On the basis of this enzyme 
deficiency it appeared unlikely that the foetal adrenal cortex 
secretes androstenedione or testosterone in significant amounts.
However, while the conversion of pregnenolone to progesterone has 
proved to be insignificant in human foetal adrenal tissue (Taylor, 197l), 
in vitro /
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in vitro conversion of DHA to A^-3-oxosteroids has been demonstrated
by foetal adrenal (Bloch et al. 1962; Shirley and Cooke, 1969;
Taylor, 197l). conceived that substrate specific
dehydrogenase/A
3|3"hydroxysteroid dehydrogenase/A^*^ isomerase activity in the foetal 
adrenal might operate for DHA. He also suggested that the capacity 
of A^-5-oxosteroid formation might be restricted to the male foetus 
and that the resulting androstenedione (the major A^-3-oxosteroid 
extracted from the incubation mixture) might also be involved in the 
maintenance of an androgenic environment for the male foetus.
Thus since androgen deficiency during foetal differentiation 
could account for the anomalies of the male genital tract in the 
patient with cystic fibrosis, it is therefore possible that subnormal 
levels of DHA are implicated in the maldevelopment. This follows
from the fact that DHA is a pre-hormone of testosterone, at least 
at testicular level, during this active period of differentiation.
At birth the adrenal gland is proportionately 10 to 20 times
greater than that of the adult, this being due to the hyperplasia of
the foetal zone thought to be responsible for the secretion of large 
quantities of DBAS (Cooke and Taylor, 1971)• With the involution 
of the foetal zone of the adrenal cortex during the neonatal period, 
the plasma levels and urinary excretion of A -3p-hydroxysteroids fall 
to very low levels, which state persists until the onset of adolescence 
It . /
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It is not until after puberty that the adrenal reattains its birth 
weight. Plasma DHAS levels are age dependent (Rosenfield and 
Sberlein, 1969) and begin to rise at about 8 years of. age. Rosenfield 
and Eberlein (l969) related an increase in plasma DHA and DHAS to an 
increased secretion by a maturing adrenal cortex. The similarity 
in 17-oxosteroid excretion by male and female children in the pre­
pubertal age range reflects the common adrenal origin of precursors 
of this steroid group.
Unfortunately, the unique opportunity to study adrenal and 
testicular tissue from a foetus which might have been affected by 
cystic fibrosis did not present itself. However, study of affected 
adolescent children has shown that plasma DIAS does not have the 
usual relationship to age (Rosenfield and Eberlein, 1969)* In 
my series, 5 boys and 4 girls of 11 to 15 years have significantly 
low circulating levels of DHAS (Table XIX, patients 15, 16, 17,
20, 21, 43, 45, 47 and 48.). Also, plasma DIAS was within the 
normal range in female patients of 3 to 10 years and just significantly 
lower than normal in male patients of the equivalent age range 
(Table XXII, p.170a), ' It seems, therefore, that a failure of the
maturation process in the adrenal cortex for DHAS occurs in patients 
with cystic fibrosis and is reflected by low plasma DHAS levels.
Because of the slow clearance rate of this conjugate from the 
blood, /
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blood, plasma DHAS levels approximate the secretion of DHAS from the 
adrenal.
A paucity of information is available regarding adrenocortical 
function in children with cystic fibrosis, Di Sant' Agnese 
et al, (1953) reported an increase in 17-oxosteroids in the urine 
of a 14 year old pre-pubertal boy following ACTfi administration.
He also noted the anomalous, though characteristic, normal response 
in urine electrolyte excretion following salt restriction as opposed 
to the lack of response of the sweat electrolytes to subcutaneous 
deoxycorticosterone administration,
Chodos et al, (1965) investigated a series of 19 patients with 
cystic fibrosis. They estimated total 17-hydroxycorticosterold 
excretion, 17-oxosteroid excretion, plasma concentrations of 
17”hydroxycorticosteroids, cortisol and corticosterone before and 
after AGTH administration and the disappearance rates of hydrocortisone 
and corticosterone administered intravenously.
They found that these parameters of adrenocortical function were not 
strikingly different from those of normal children. The results 
presented in the preceding chapter show too that the patients 
investigated had normal adrenocortical function i.e. total 17- 
hydroxycorticosteroid levels in urine from 32 patients with cystic 
fibrosis (2 to 17 years) did not differ significantly from levels 
excreted /
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excreted by normal children (Table XIl).
Note too that in my extensive group of patients the 1'7-oxosteroid 
excretion, in patients aged 1 to 10 years, did not differ significantly 
from normal. However, children from 11 to 17 years did have a 
significantly lower excretion of 17'-oxosteroids. Excretion of 
DFA in the older age ranges (ll to 20 years) was subnormal in 
8 of 11 boys and in 6 of 7 girls (the one exceptional case (patient 44, 
Table XVIII, p« 162) having had anabolic hormone therapy during the 
period of urine collection)* Circulating levels of DHAS were 
significantly lower than normal in both males and females in the 
11 to 15 age range. Plasma levels did not differ significantly 
from normal values in the 5 to 10 years age range in female patients 
and were just significantly lower than normal for the corresponding 
males.
Prom these results it is apparent that the increase in 17-oxosteroid 
excretion and increase in plasma DHAS associated with puberty and 
reflecting a complete maturation of the adrenal cortex and also 
of the testes in the male, is not well defined in the adolescent 
with cystic fibrosis.
Compare these results with those of Chodos et al. (1965) and 
Plensborg and Johnsen (l972). Their patient age ranged from 
5 /
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5 months to 13 years and from 2 months to 15 years respectively.
The levels of 17-oxosteroids did not differ from those of normal 
control children though Flenshorg and Johnsen reported subnormal 
values for 11-keto-aetiocholanolone and for ll-hydroxy-aetiocholanolone. 
The significance of these findings is not known and they suggest 
none. In a series of 18 children with cystic fibrosis (aged 10 
months to 23 years) Flensborg found normal urinary levels of DHA 
(personal communication).
Thus in summary, it seems probable that during the two peak 
periods (the 6th to 18th intra-uterine week and at puberty) of 
adrenocortical function for DHAS production a failure can be postulated, 
which accounts in theory for the "endocrine" features of cystic 
fibrosis.
Since the defects of the mesonephric duct, characteristic of 
cystic fibrosis, are now here believed to be developmental in origin 
and since this failure in differentiation may be the result of the 
failure to attain the prerequisite threshold of androgen (p. 175) 
it might be expected that further anomalies of the male genital tract 
could occur in patients with this disease.
Wang et al. (l970) were able to investigate 141 male patients with 
cystic fibrosis and of these 9 boys were found to have an inguinal 
hernia /
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hernia and 3 had a hydrocele. This combined incidence of both 
inguinal hernia and hydrocele was 8.5 per cent. The incidence of 
these anomalies in the general male population is 1 per cent for 
inguinal hernia and less than 1 per cent for hydrocele (Swenson, 1969; 
Campbell, 1964). liolsclaw and Shwachman (l97l) investigated 325 
male patients with cystic fibrosis and reported an increased incidence 
of herniae, hydrocele and undescended testes (unilateral and bilateral).
Of the 24 male patients in this investigation one (patient 5) had 
hypospadias and one (patient 22) had a left-sided hydrocele. These 
abnormalities associated with the urogenital tract were thus present 
in 8.3 per cent of the present series* It is interesting to 
postulate that these abnormalities are also related to the factors 
which have been incriminated as causing the failure in development 
of the mesonephric duct. There is some evidence that this could 
well be soj the evidence being based on recent knowledge of the 
functioning of the various components of testicular tissue.
The steroidogenic capacity of the interstitial (Leydig) cells 
of the testis is well established. Studies of testicular function 
in incubation systems have largely employed slices or homogenates of 
testicular tissue and any steroidogenic activity has been attributed 
to Leydig cell function.
However, /
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However, recent developments in the techniques of micro-dissection 
have enabled the isolation of individual seminiferous tubules.
Tubular cells isolated in this way from rats were cultured and then 
incubated with radioactive-substrates (l)ufau et al. 1971 )« While 
Leydig cells have been confirmed to be the major source of testicular 
androgen (Christensen and Mason, 1965), the tubular components have
been shown to have a steroid converting capacity with the ability to
5form testosterone from androstenedione, A -androstenediol and DM.
Much smaller quantities of testosterone were formed from more remote 
substrates such as pregnenolone, and 17oc-hydroxyprogesterone (Dufau 
et al. 1971)• Since high levels of testosterone are known to be 
necessary for the maintenance of spermatogenesis, Dufau and colleagues 
suggest that the tubular cells produce high local concentrations of 
testosterone necessary for the maintenance of spermatogenesis from such 
precursors as DHA. Bell (l972) has confirmed these findings of 
differential androgen production in the human testis. The Leydig 
cells, then, produce testosterone which is released into the peripheral 
circulation for systemic use and intermediate steroid metabolites 
which diffuse into the tubules there to be converted to testosterone so 
maintaining a high local concentration presumably to stimulate 
spermatogenesis* If in cystic fibrosis circulating levels of
dha/dhas /
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Lïïa/BÏ-IâS are subnormal, as the results of this thesis would indicate, 
then suboptimal concentrations of such testosterone pre-hormone 
would he present at the tubular level. Defective spermatogenesis 
could then he related to a failure in local testosterone production 
and hence a failure to maintain an androgenic environment.
There is now evidence in the literature that clinical syndromes 
arise as a result of defective testosterone biosynthesis. Also 
in certain diseases testosterone production is progressively 
diminished. Thus Zachman et al. (l972) were able to show absent
17,20 desmolase activity in a child with male pseudohermaphroditism 
(a phenotypic female with an XY chromosomal constitution). Also, 
testicular incubation studies using testicular material from patients 
with Klinefelter's syndrome have demonstrated a progressive deficiency 
of testicular enzymes (Hamilton, 197l). Patients with’myotonic 
dystrophy have also a deficient testosterone production which could 
be related to the characteristic degeneration of testicular tissue 
(Hamilton, 1973)* Thus not only in cystic fibrosis but in other 
subjects such defects as hypospadias, undescended testes and herniae 
may result from yet unrecognised defects in testosterone synthesis.
While the investigation of testicular function in male adolescent 
children with cystic fibrosis was outwith the scope of this 
investigation, /
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investigation, the results presented in Tables XVII and XXII (pp. 161 
and 170a) demonstrate low plasma DHAS levels and low urinary D M  
levels in this age range. As in any study, particularly those 
concerned with cystic fibrosis where the extent and degree of involvement 
of the various tissues is so variable, exceptions to the thesis 
must occur. Patients 9, 19 and 24 have increased levels of urinary 
D M  as compared with accepted normal values. The D M  in these cases 
was excreted predominantly as the sulphate conjugate. None of the 
patients were undergoing treatment with anabolic hormones (see 
later discussion, p. 188). Two, patients 9 and 24, were given 
"good" clinical ratings and patient 19 had a "moderate" degree of 
involvement. Despite the finding that the abnormality of the male 
genital tract may be one of the most invariable features of the disease, 
it is recognised that exceptions do occur and claims to paternity, 
though few, have been made. It may be that these three patients 
have, and have always had, adequate androgen biosynthesis for normal 
differentiation and testicular function. Two (patients 19 and 24) 
no longer reside in the Glasgow area. Analysis of plasma obtained 
from the third (patient 9) showed DHAS to be present at a concentration 
of 6 pg per 100 ml (Table XIX, p. 163a), This result was 
incorporated in the overall results for the 3 to 10 year old males 
which /
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which on the whole were just significantly lower than normal (Table 
XXII, p.170a). However, on its own merit, a level of 6 pg DHAS per 
100 ml plasma was probably well within the normal range.
Patient 5 also excreted high levels of DHA although the 
sulphate:glucuronoside ratio was reversed, the D M  being mainly 
conjugated with glucuronic acid. One can but speculate on the 
significance of such a finding, particularly on its possible relation­
ship to the hypospadias noted in this patient# The hypospadias 
suggests a deficient androgen concentration during the period of external 
genital differentiation but clearly his pre-pubertal plasma level of 
DHAS (5*4 pg DIMS per 100 ml plasma) was normal (Table XIX, p#l63a).
One could postulate an enzyme deficiency at testiùular level 
wherein either 3P-hydroxysteroid dehydrogenase and/or 17p-reductase 
were deficient, so resulting in high levels of DHA (i.e. failure to 
convert D M  to androstenedione, A -androstenediol and thence to 
testosterone). The accumulated DHA might then be preferentially 
conjugated with glucuronic acid for rapid clearance from the body 
(it will be recalled that normally the gut and liver resulphate D M  and 
in cystic fibrosis the gut and liver are known to be involved).
It is known that the clearance rate for DMG approximates to the 
glomerular filtration rate.
There /
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There is a parallel for this thinking in the now well-recognised 
variety of congenital adrenal hyperplasia due to defective 3B- 
hydroxysteroid dehydrogenase which is associated with hypospadias in 
the male.
A number of patients undergoing treatment with anabolic hormones 
had near normal or elevated levels of total urinary DHA and normal 
or high plasma DHAS levels (patients 14, 16, 28, 52 and 44; Tables 
X, XI and XIX.), The type of anabolic hormone given to each of 
these patients is indicated in the aforementioned tables.
Two preparations with a favourable anabolic/androgenic ratio were 
given to a selected number of patients with cystic fibrosis.
The rationale for this step taken by the physician (¥.H,) was 
as follows.
Incubation studies on foetal testicular tissue, using as substrate 
DHA and androstenedione, showed that, oxymetholone, a C2-substituted 
C19 steroid, and ethyl estrenol were inhibitors of 5|3- 
hydroxysteroid dehydrogenase so blocking the conversion of DHA to 
androstenedione.
CH3 OH
OH
H-C
»
OH C^H^
ÏÏ
OXTMETHODOHE 
(l7o:™niethyl-»2-»hydroxyraethylene 
dihydrotestosterone)
ETHYL ESTRENOL 
(l70"-ethyl-5“desoxO“19" 
nortestosterone)
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Oxymetholone is believed to block enzyme action by competitive 
inhibition through the formation of the enol at C2 and C3. It is 
thought that the enol binds irreversibly at the site of enzyme activity. 
This compound has been further shown to inhibit ITp-reductase for 
W k  and androstenedione. The combined action then is to raise 
the level of circulating DHA (Hamilton, 1972; Hamilton, unpublished 
observations)« It thus seemed logical that these, drugs could be 
used in an attempt to raise circulating levels of DHA in patients with 
cystic fibrosis, Oxymetholone has been used largely to treat
hynoplastic anaemia, the dosage levels being in the region of 100 
to 500 mg daily. At this dosage level some workers have suggested
that it may have carcinogenic effects (Johnson et al, 1972) but, in 
children with cystic fibrosis, a much smaller dose of 2,5 to 5 mg 
daily was used.
The use of anabolic hormones in cystic fibrosis is not 
unprecedented (Dennis and Panos, 1965; Good and bessman, 1966;
Dooley et al, 1969; Harris and Waring, 1970) although previous 
administration has been purely for anabolic effect* However, it is 
of interest that Dooley et al. (1969) noted that pre-adolescent 
female patients with cystic fibrosis derived greatest benefit from 
anabolic steroid therapy. The purpose of administering these 
agents /
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agents to a selected number of patients with cystic fibrosis in this 
hospital was as an attempt to exploit their enzyme-blocking properties 
to raise levels of circulating DHA (Hamilton, 1970) which, in this 
investigation, were found to be subnormal, particularly in the adolescent 
age range. It must be emphasised that the use of anabolic hormone 
therapy in cystic fibrosis is still very much in the experimental 
stage. Patients chosen,for this form of treatment were either 
severely affected children (patients 14 and 44) or children with a good 
clinical status who were likely to benefit from an anabolic stimulus 
(patients 22 and 32) (Table XXIII), Ethyl estrenol was the first 
anabolic hormone preparation to be administered but unwanted oestrogen­
like side effects (e.g. gynaecomastia) were observed. The 
administration of this drug, however, seemed to result in near-normal 
to high levels of total urinary DHA. In patients 14 and 22 
this was predominantly excreted as the sulphate ester. In 
patient 44, however, the sulphate/glucuronoside ratio for urinary 
DHA vfas less than unity. Patient 14 responded to ethyl estrenol 
therapy with a very high plasma level of DHAS (Pig. 37, p. 165),
However, patient 44, after the same treatment, still had low plasma 
levels of DHAS compared with normal values (Pig. 38, p. 166 ).
Patient 22 also had low plasma DHAS levels despite treatment with 
oxymetholone (Table XXIII), Blood and urine had been collected 
one /
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one month after replacing ethyl estrenol therapy with oxymetholone, 
Near-normal values of total urinary DHA were then maintained though, 
for a short time after the change of therapy, DHA was excreted mainly 
as the glucuronoside, A urine sample collected 3 months after the 
start of oxymetholone therapy indicated urinary DHAS levels to he again 
in excess of DHAG levels. In this patient ethyl estrenol therapy 
resulted in higher urinary levels of total DHA than did oxymetholone 
administration. This is in contrast with the findings from analyses
of urine samples from patient 14, One month after cessation of 
oxymetholone therapy in patient 14 near-normal levels of urinary total 
DHA were maintained although the DHA was excreted mainly as the 
glucuronoside. Six months afterwards, low levels of urinary total
DHA were detected. Patient 32, after 6 months therapy with oxymetholone 
had increased urinary levels of DHA and also of plasma DHAS, It can 
be seen that the results of anabolic steroid therapy on this group 
of patients with cystic fibrosis are variable. However, treatment 
did result in near-normal levels of DHA in urine and this coincided 
with a period of increased linear growth (Hamilton, 1972), Frequent 
plasma analyses would be advantageous to relate dosage of anabolic 
hormone to response of DHAS levels in an attempt to maintain physio­
logical plasma concentrations of DHAS, It might then be possible 
over /
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over several years to speak more authoritatively to the effects of 
normal plasma DHAS levels in patients with cystic fibrosis.
Thus, from the results of the investigations done on children 
with cystic fibrosis presented in this thesis it would appear that 
there is a real failure in adrenal production of DHAS at puberty 
which persists even after the appearance of clinical puberty. This 
is consistent with the concept that adrenal androgen activity is 
responsible for the early signs of puberty before the gonads take 
over. To be more explicit there is a failure to increase secretion 
of DHAS in the pubertal and nost-pubertal age ranges. Adrenocortical 
function as determined by the excretion of total 17-hydroxycorticosteroids 
is within the normal range. The thesis is therefore offered that 
were more known regarding the total cellular actions of DHA, this 
demonstrated failure might account for more of the clinical features 
of cystic fibrosis.
Attempts to raise circulating levels of DHA by using anabolic 
steroids, in particular oxymetholone, resulted in impressive height 
and weight gains which were associated with increased urinary DHA 
excretion. In the future were this therapy or another achieving 
similar effects to be practised as routine, frequent assay of plasma 
DHAS levels would be necessary to monitor the raising of plasma DHAS 
to /
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to physiological concentrations thus ensuring the desired effects 
with the accompanying effects on osseous maturation.
Other forms of treatment for children with cystic fibrosis have 
tended to follow popular opinion. It will be remembered that 
clozacillin was occasionally found to interfere m  th steroid 
colorimetric estimations (in 9 of 59 urine samples) and that the 
"affected" urine samples were either collected during hospitalisation 
or from children whose parents rigorously applied therapeutic measures 
at home. This in itself speaks to the capricious value of any 
treatment which cannot readily be monitored and it seems that even the 
fundamental, though essential, administration of antibiotics is often 
neglected by the parents.
Though this thesis does not resolve the quest for the basic 
aetiology of cystic fibrosis, it points to a defect at cellular and 
metabolic levels. It must be remembered that cystic fibrosis 
affects many cell types. If a single transmittable genetic defect 
is to account for the range of abnormalities associated with the disease 
then the common defect in the many cell types must surely rest at 
such a basic metabolic or cellular level.
CHAPTER SIX
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The most consistent physical manifestations of cystic 
fibrosis in the male are abnormalities of the vasa deferentia, 
enididymes and semina], vesicles. These abnormalities 
of the male genital tract have been attributed by others to 
a failure in differentiation of the mesonephric duct at about 
the 10th to 12th foetal week.
From the literature, incubation studies employing human 
foetal testicular material have demonstrated dehydroepiandro­
sterone (DHA) to be an important pre-hormone of testosterone 
at this time* Thus DHA must be regarded as important in 
the maintenance of an androgenic environment necessary for 
the stabilisation of the mesonephric duct and its derivatives 
in the male foetus. It is accented that DHA and testosterone 
advance bone maturation which in children with cystic fibrosis 
is frequently retarded* Also, androgens are required for 
the maintenance of normal spermatogenesis* This process is 
known to be arrested at spermatocyte and spermatid stages in 
children with cystic fibrosis * DHA, then, is an important 
precursor of androgens (the pathway being important during 
foetal development) and on its own account has widespread 
metabolic activity*
S ince /
Since tissues from a foetus known to have cystic fibrosis 
were not obtained, a study of dehydroepiandrosterone production 
pre-natally was not possible* However, a study of DHA 
in urine and blood samples collected from 48 children (from 
1 to 20 years old) with cystic fibrosis was undertaken*
Following addition of
3
Trc-'H DHAS for recovery purposes
aliquots of urine from 24"hour collections were submitted to 
6 hours hot hydrolysis at neutral pH (Fotherby, 1959)c This 
hydrolytic method is specific for A"-3p"hydroxysteroid sulphate: 
DHA conjugated with glucuronic acid in urine was hydrolysed 
by a 24 hour incubation with p-glucuronidase (1,000 F.u. per 
ml urine) at 37"C employing a sulphatase inhibitor (potassium 
dihydrogen orthophosphate)* Following extraction, purificati( 
by column chromatography and t*l*c. was effected. The dried 
residues were dérivâtised with benzenerheptafluorobutyric 
anhydride (l;l, v/v) for 30 minutes at 70°C and quantitation 
of the DHA ester was made by electron capture detection on 
a Pye 104 m'.I.Co system* A correction was made according
to the recovery of DHA added initially to urine samples*
Group estimations of 17-oxosteroids, 17-oxogenic steroids 
and total 17-hydroxycorticosteroids were also made on the urine 
samples /
samples when sufficient urine was available*
Plasma DBAS was estimated in 36 children (3 to 16 years 
of age) with cystic fibrosis according to the method of 
Brownsey et al* (l972).
Levels of total 17™hydroxycorticosteroids excreted by 
children with cystic fibrosis, as presented in this thesis, 
are not significantly different from those of normal children 
and are thus in agreement with the findings of Chodos et al. 
(1965)* The 17-oxosteroid excretion in affected patients 
from 1 to 10 years did not differ significantly from that of 
corresponding normal children* However, patients with 
cystic fibrosis in the 11 to 17 years age group had a 
significantly lower excretion of 17-oxosteroids than normal* 
DHA was detected in the urine of some children as young 
as 4 years of age and was found to be within the normal range 
in children up to 11 years of a.ue* Excretion of DHA in 
the older age p'roup (ll to 20 years) was subnormal in the 
majority of children with cystic fibrosis (in 8 of 11 boys 
and 6 of 7 girls)* Circulating levels of DÏÏAS were also 
significantly lower than normal in both males and females in 
the 11 to 15 years ag:e range*
Prom /
From these results it is aiouarent that the increase in 
17“-oxosteroid excretion and the increase in nlasma DHAS 
associated with normal puberty does not take nlace in the 
adolescent with cystic fibrosis even although clinical 
miberty may be well established, albeit at a later than 
average time. These findings reflect a failure in the 
maturation of the adrenal cortex and nossibly also of the teste 
in the male.
